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ABSTRACT · III 
Alteration~ of steroid metabolism in hypertension have been 
. . . 
investigated with male and female nor~l and essential hypertensive subjects~ \ . . 
. 
. 'I'htee groups. _of urinary metabolites have b~en quantitated: 1~ ·and~ost"er~~e, _ .· 
etiocholanolone and dehydroepiandrosterone (11-deoxy-17-:-keto~terqd.ds, c19o2.:.·. 
"= 
KS) ,· ·2, 11-keto and 1113-hydroxy androste!:"one ' and 11-keto and 1113-hydroxy · 
. " . I . 
~ti~chola:nolone 1 (11-oiy-17-ketosteroi~s, c19o3-Ks)_, an~ 3. 17:-ketogenic 
. 
steroids (KGS) oxidised to et.iocholancilone, 1113-hydroxy androsterone and 
·. . . . 
1113-hyd~oxy ~tiocholanolone. The urinary steroids were hydrolysed enzy-
. . ·- . 
mat;l.cally • f~actiopat~d . on silica gel columns and estima.ted. as 'trimethyl 
silyl ether derivatives by .gas ·l.iquid chromatography. 
The'fol1owing statistically significant differen~ea · were found 
· - • I I ' • ' 1 ~ 
· . 
.. r - . • ~': • ih th~ excretion of metabolites by normal and hypertensive , subjects~ I • 
~  c'190/l~K~ ~~acti~n1; the excretion of et~~ch~lano):~ne 'Siucuronide 
. and · dehydr.oepiandros~erone sulfate was mar?dly reduced in the hyperte~sive . 
. . . \':, . . J-
group (P 0.001), and t;he ratio of the 5a/513-reduced metabolites· was higher. 
(P 0;001). The latter suggested ·a relative de~iciency df · 513-reductase 
~- . . ) 
activity in· the· hypertensive gr'oup·. 
2 • . c19oj-17KS fraction:_ the ~xcretion of the sa-reduced metabolites 
was .. higher (P 0_.01) in the hypertensive group,, and the Sa/513 ratio was also 
increased (P 0.01), due to the increased Sa-compounds. ~o significant , 
I 
reduction was found for "the 513~reduced metabolites. 
'· 
3. KGS fraction: . the ·excretion df both SeX.- and . 513'- reduced compounds 
' I ' ~ 
) 
··" 
was higher ·~p O~ OS)D in -~he hypertensiv~ . -~-~~up '1~ ~he .. 513~compounds. pre~omi~- .· . · ~ · 
.. a ted i:n both normal and hype_rtensive groups. · 
1 
increased. excretion of · · 
. . 
513-reduced metabolites may sugge~F that the 513-reductase .activity· is more 
' 
active in the metabolism of the 17-~eto_genic steroids than the.ofi9o2-17K~. 
,n ·~ 
... . 
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· ' .. 
'. 
. . ' 
The influence (j)f the "il..:.oxy" function and. corticosteroid 
' . 
. "Side chai~" on ' the relative Sa- and .513- reductase enzyme activities 
. . . •. 
' 
and ~he . infl~e~ce of T;liood pressure ha~ 'been discussed •.... ( 
l . . Comparison ~pf the proportions of reduced metabolites y( 
'. 1 • 
' ' 
urine of normal and · es.~~ntial hypertensive su~jects indicates that they 
I ' 
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INTRODUCTION 
. Hypertension 
. ~· .. 
\ 
The medical and 'socioeconomic. importance of hypertensive disease 
. . . . . . . 
may be realised from a ~ecent statement that "a calculation based on car~ful 
estimates shows that over 8-10 million persons in the U.S.A •. have significantly 
. . 
elevated blood pressure, and ~ypertensive vascular disease accounts for 
approximately 200,000 deaths per year" (Moser and Goldman, 1967). 
The term hypertension, as commonly used, implies an elevation of 
systolic and diastolic blood pressures. Arteries are largely autonomous, and 
the normal artery tends to contract ~gainst a rising pressure, and to relax 
when that pressure falls·. The mechanism of this auto.:regulation is still far 
from clear. 
. ,:, 
The tension in the vessel wall varies with the radius of the 
ves~el, as well as with the filling tension and may involve a myogenic factqr 
(Byrc:>m, ,19~9). 
. . . 
The dividing line between normal and high blood pressure is difficult 
t9 defin~. .Evans and Rpse (1971) have suggested tha.~. "in a'n operational 
sense, hypertension should be defined in terms · of a blood pressure level above 
. . 
: which iiwestigad.on and 
holds the view that the 
treatme-'>nt do more good, thr :~rm·:· ·.Pickering '(1970) . 
termS "normotension" .and '~ypertension" were devised 
... ,.•, 
to help doctors to make a diagnosis. This ~ritical dividing line w:l:ll vary,. 
. .. 
of course, with age, sex,. medical facilities avail~ble, follow up procedures 
and personal . assessment of "good" and · ''harm". Con~idering. these factors, it is 
not surprising that different levels of diastolic/systolic blood pressur~ ·· 
. . , 
have bee~ defined to distinSui~h normotensi~n . from hypertension • . Pickering ·-
(1970) quotes ' t~e follo~ng values as given by different w~rkers: 140, 
. ' 90 , . 
G.A. Perera (1948); !2.Q_, C.B~ Thomas· (1952) ;- ari~ .!!!.Q., W. · Evans, {1956). 
. 90 \ J • • • 110 
. ' 
: .. , ' \ . .~ ' ,' ' . 







' : . ; 
' > . ~; -; ., 
'/ I 
. . 






High blood ' pressure is a sign, not a disease. it has a complex 
relationship with vascular ' dis.ease, whlch is ·often 9·;,mpto~ess until ·i~ is far 
~ .advanced. There are severai ·disease ·states in which hypertension may. be a 




• • J 
They include: .slomerulonephritia, py'elonephritis! re~al. artery 
' ' 
stenonis, coarctation of aorta, polycystic kidneys·~ desseminate~ ·lupus,. 
eclamsia, brain tumor, poliomyelitis, acromegaly, primary hypoehyroidism, pheo-
.. . 
) 




. ~ . . 
- . 
I.n each of thes'e situations, the actual mechanism by whicl) the 
J 
blood pr'essure is elevated may or may not be peculiar to that disease, but treat-
men~ of the · disease usually cures the associated hypertension, . However, in some 
85-90% of the hypertensive population, there is no evident. cause for the high . 
blood pressure (Pickering, 1~70). Such patients have been described as 
. ' 
' e.ssential ' hyperte~sives, but some people prefer the t~rm "primacy hypertension" 
' (LBidlaw, 1973). Essential hypet;ten.s:f.<Jn is a symptomless disease at first, 
• 
when an e~evated blood pressure is the only positive finding. UrinalY,sis, 
.I 
intravenou~ pyelogram, blood and renal function tests reveal no ·abnormalities. 
However, .the ~later consequences of hype.rtension may affect the ' t~rget organa 
such . as, brain·, fundi, heart or kidney, Although no specific cause ha's been 
"'; ~ ";. ' 
identified' as responsib~e for th~ hi~h blood. pressure in essen~ial hypertension' . 
• ' 
such factors as in~er~rice, age, and environmental conditions may be involved. 
·--· 
However, the extent to, which these factors are involved obviousl y varies con-
sidera~ly between individuals. 
Any type of .hyperten.sion may rapidly become· "mali~ant"", or may 
remain in a relative!?' .·stable ''benign" phase,'~· as ,originally: reco~ized b.Y· 
,. 
Volha~d and Fahr ·(1914)'. 
C) • 
This -d.ifferentiQ.,tion is based on th~ ' seve~ity' of the 
:. . . 
•. 
hypertension, but not on its kind. The ~lignant ,phase·. is charactedse~ ~~en "· 
hypertension' ~s associ~ted with .graqe iy chB:Oges in ·· th~ optic fun~i (Lai~law; 
, :_ 
( -
197~)' and . thop~h it may os:cur at any age in 'either .sex, is.· ~oat common at 
. . about 40 yea~s of 'age and rarely develops after 60 {Pickering,. -1~70).. ·. The 
' ' . ' . . ~·· ··- -.· " 
' .. 
. ' ' 
. . . -, 1 • , •• · ·: , • • , • ,· "' ; • ~ ' ' ' ' r 
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casual . qiastolic pressure is nearly always over 130 mm llg. 
. 3. 
The more frequent benign phase occurs in all· types .o~· hypertension, 
, ! • ~ ., 
~~ • I ' ' 
.but ,.is more common when the ons.et occurs in middle aged or elderly subjects~ ·· 
' ' 
\. 
and pa~ticula~ly in those with essential hypertension (Pickering, 1970). The 
.$ . . . 
arterial pre_ssure during the be~ign phaae i~ usually tower than in the malig-
nant phase, and the patients in the early part of t't!e phase are usually symp~om-
less apart from the elevated blood pressure. Later cardiovascular complications 
' I ' 't. ' 
may occur such 'as card'iac enlargement and heart failure' and occasionally lead 
to the malignant phase~ But, whethet... such complications function as a pre-
cursor and. contribute to the malignant ph:as~ ;f.s debatable •. 
' . . . 
. . 
The literature on the enqocrine and non-endocrine aspects of hyper-
. . 
tension ~s very extensive and a complete review of ,·this subject is beyond·· the 
scope o.f. th~hesis ~ . However, the endocrine aspec~s of hypertension will be 
' . . 
reviewed as they relate t9 four'categories of hypertension, namely: Renovascular, 
Catecholamine, ·stero~d and Essenti.al (Bartter .et. al, 1970), 
This wtil provide the background for .the present investigation of 
\ 
steroid metab'olism in essential hype~te~sion. · 
Endocrine Aspects of Hypertension 
r-
1. The Renin-angiotensin system 
The' renin-angi6'tensin system holds a critical position iri any dis- . 
c~ssion of hypertepsion. 
:~' ~ 
\ - ' . , ~ 
The kidney, ~n add~ti,;m to having an ~xcretory funct;ion; 
. . . -
has what resembles an endocrine f~nction in secreting .an entyine, .renin~. into .· 
,; 
the blood stream, This function· was demonstrated by ·Goldblatt (1934) who 
.,. . 
redu¢ed th~ blood supply to a dog's kidney by compression of the renal artery; 
.. 
a procedure which produced ·. a persistant hypertension. It was. initially assumed . 
. ' 
· that the .renin was· directly responsible for the pres~or func.tion of t~e kidney, ~~ 
. ~ ·~ . " . . ~ ·- . .. . . 
',:-
. . , 
' . 
but ~ubsequent experim~nts ~h~we~ · that renin exer~ed its · action. by producing ·a· ·' · 
t"'""-:-- · .~ 
. ...: ' . . 
.... 
_..potent vasoco.nstrictor,. angiotensin II. 
I . . ' 
'J 
' • • I 
~ ' ) . 
.. . 




· Formation and storage of renin 
, 
Renin is a proteolytic enzyme that is ·synthesized in the juxtaglo-
merula:r: apparatus of the kidney. This structure has two parts in the mammalian 
kidney (Faarup, 1965), One part, consisting of granular storage and secretory 
- ' 
cells called juxtaglomerular cells (J.G. cells), is located near the afferent 
> • 
glomerular arteriole. The other .part is termed the macula' densa and consists 
I 
of large columner cells located near the epithelium of the distal tubule. 
Jl '•, .... 
. .,~ :, 
' ' 
Cook and Pickering (1958) have shown by microc.Iissection of the 
. kidney that renin is located · in the ~G. cells; and that the relative ~bundance 
of the secretory granules in these cells closely parallel bo~h the secretion 
and quantity o.f. extractable renin (ToJ:>ian et al, 1959) ~ Later, use of renin-
antibodies provided further evidence that renin was localized in the granula~ 
J.G. cells (Hartroft, 1964). Recently Ge~est and co-workers have isolated a 
'renin-like .enzyme in th-e brain tissue of dogs which (a) is independent of kid-
ney and plasinan renin, (b) in presenc·e of substrate forms an_giote~sin anq (c). 
administration of aldosterone decreases its activity while- progesterone in-·· 
creases it (Ga~ten et al, 1971). 
Factors stimulating··.;release of renin 
. 
· .Several stimu,ii are known to cause the release of renin from ·the 
kidney, as indicated below. 
. - . 
Sodium balance 
A low iltake · o~ _so,di~ it;lcrea'ses ·and a high intake decr~ases Jhe 
secretion of renin. Diuretics .such as mercurials {md thiazides, _which· cause a· 
. depletion of b-ody sodium, also stimulate its . secretion (de Champlain et al, ,.. . 
1965; Conn et al~ 1965b), anc;l it has _been suggested that· the sodium concentration 
' 
. . . , \ 
in the renal tubule of the macula dens~ is involved :t'n these situations (Vat\der 
' 
·& Miller.' 1964 ; .. Von SchW!rman et al, 1965). The rple of extracellular cations ... 
. . . 
. rn the release c:>_f renin has als~ b~~n inve~tigated:: Increase4 plasma sodium and 
potassium ;inhibits while calcium stimulates the rele~e of renin (Vander~ l~ho; -
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.s.·. ~ : .·· 
Arterial pressure 
.. 
A'decrease in arterial press~re increases the secretion of· renin as 
can be demonstrated by constric~ion ~f the renal ijrtery. The J.G~ cells appear 
to be · sepsitive to the stretch in tl:te arteri~l wa~l, · and 'to act as baror~ceptors • 
. , I 
The increased blood pressure presumably "stretches" the granular cells and 
. . r 
inhibits the release .- of renin, whereas a decreased pressure reduces the dis-
tention and enhances renin release (Tobian et al, · 1958; Skinner et al, 1963; 
Lowe, l\,4; Brown et al, 1965b). 
Extra cellular fluid 
The volume of the extra cellular fluid also seems to affect renin 
I 
secretion, since the latter is stimulated b)_acute blood loss ·and _depressed .by 
. . . . 
·' . 
hypertransfusion (Gross et al, 19~4p). Mlld _hemorrhage also appears to activate 
<ii'. . • -
the release of renin through ~he . renal s~atheti~ nerves (Hodge et al, 1966; 
. ... ~unag: .et al,· 1966) ~ 
.. Sympathetic nerves and norepfnephrine 
-. 
The renin content o-f t ti_e __ denervated kidney has been shown to be _greatly 
. .. J. • ·.('" 
J· 
/ reduced as ~ompared to normal kidneys (Taquinf et al, 1964; Tobian . et al ,· 1967). 
I ' 
. . . . 
1 · Infusion of norepinephrine directly into the renal- artery also stimulates renin 
' . . 
. . ' . 
release from the kidney (Bunag et al, 1966; Udea et · al, 1970)_·. More recent 
. •'\. ' . . 
stqdies have shown t~at circulating norepinephrine stimulates the -J.G. cells 
• ' I • 
and renin secretion, ~nd indicate that the sympathetic nervous system may be 
. involved thr_ough a a-receptor mechanism (Ganong, 1972; Tanigawa et al, 1972) .• 
Formation of angiotensin- I and II ·h_ 
,, 
i) 
from the kidney into the renal vein it : . 
r , 
. ' 
After the release of renin 
" - f .. ,• - ' ' I • - · 
acts upon, a speci~ic sub~.ti'tate ,- termed _angiotensinogen,· which is an ~-globu!in_. 
Angi?tensinogen is ilormaily ·present: in the blood arid ·iS synthe~ized ._in the liver. ·. 
.. ,. . .. . 
· The renin acts,specifically at the leucyl-leucine link~£ the substrate and 
. ' . 
. 
splt"ts off a decapeptide called an~iot~nsin I~ .' ~hich is further broken doWn by : 
a second en~, termed a . conve_rting e nzyme, ~ich is preseht in larg!!~t . c:;o~- : .. · · . .- · 
Q •• 
' ... ' • 
•' , ~ ... . 
, .'~·.I 
; .. ..... ::: .. :',.; . . . . \ 
' \ 
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,-," . centrati~n in the lung. ·· The· product 'angiotensin ·II is fo~e~~· removal of 
two c..:.terminal · am:I,:no acids, _leucine and.'histidine," to give the octapeptide. 
Vasopressor activi'ty of i'lngiotensin II 
Angiotensin II is one of the most.potent vasoactive substances 
known, being about 6-8 times as potent.as norepinephr~ne (Page and Bumpu~, 
I> 
.1961). 
Infusion of angiotensin II into man causes an increase in the · . 
arteri.al ~res~ure, _a ·~ecre~sed pulse, ra~e, heart beat and ~ardiac output, and 
· a \onstriction of the pulmonary artery. Infusion of angiote~sin' II . ·directly 
into the brachial artery' of the human 'produces .vasconstriction in the forearm 
muscle and hand (Page· .and Olmstead, 1961; Bock and Gross, 196i; Bono et al, 
1963)~ Similar effects have been demonstrated in the cat (Barer, 196]) and 
the dog (Olmstead apd Page, 1965; McCubbin et al, 1965h Recently it · has been 
s~own that infusion of angiotensin ·· I~. · ~t low rates into the. vertebral arteries 
of anaesthetized' dogs causes elevation of ' blood pressure (Ferrario et al, 1970; 
. ' ~evers et al, 1970). A~inistration of angiotensin II . intravent~icularly i~to 
the brain of male rats causes antidiuresis, 'loss o.f so?ium and potassium · 
(Severs et al, 1971). Others have reporte~ . that direct administration of angio- . 
6 • 
tensin II into' the brain leads to an increase in the re~ease of acetylcholine 
in ~he cat" (Elie ~nd Panisset, 1970) , vasopressin in the rat (Severs et al, 
I 
1970)' and noradrenalin in the rabbit during sympat~etic ne~e. stimulati~ 
.· . (Sch~mann et al, 1970) • . H~wever, the mechanism ·involving centra~ nervous . s~stem· 
and angiotensin II is not cdmpletely understood. 
0 ' 
· Destruction of angiotensin II 
<l· 
The·.biological activity of angiotensin II. in the biood stream' is 
limited ·since' it is·rap~dly dest~oyed • . It has al~o been observed that when 
renin is incubated in vitro with renin substrate for a , prolonged period; . 
... 
angiotensin II disappears .due· .to the action of a group o"f peptidases calle.d 
, 
ang{otensi~ases (Page .and H~lmer, 1940). 
I • • I • 
These· enzymes are present in 'the : 
. ' . 
' I • ' , ,.., 
. , 
. 
'· ' · · r~ r ' • • , , : •• 
.. . ·', • .·./.:\ .. 
' ' 
l , ~ ' • I ' ' ' : • • :·, ,~·. ' : ; ·.,' :·:.~.,)~:~,; 
• " • • ' , t ·.- ~ -
' . 
. • ' 





. I · 
7. 
-' I 
. normal kidney, intestina~ muco~a,, plasma and red blood cells. Ang~otensi~ II 
. . 
, is also destroyed by trypsin, chymoteypsin, and peps~n. (Pickering, 1970). 
. . . 
Action of angiotensin II on aldosterone sec~etion 
The major physiological stimqlator of aldosterone biosynthesis 
anq secretion in man is angiotensin I! which acts as a trophic· •.hormone on the 
·zona glomerulosa of the adrenal cortex (Mulrow, 1966; Davi~, 1967). 
Aldosterone is a pote~t mineralocorticp~d and specif~cally affects 
0 . ,· . . ( 
the transport o~ el:~~lyte~ ac,ross ep:i.-~~~11~1 ~urfaces ~. tn the dis.t4al. 
tubule of the nephron it ' induces sodium retention which results in ,a r~tention -
• '\ ' 6 . 
of water and an incpease in the p~asma volume and re~al-arterial pressure 
(Mulrow, '1969) o This in turn su~resses the secretion of renin which leads to 
. . 
a fall in the concentration of angiotensin II and.thereby a reduced secretion 
' ' 
of aldosterone by the adrenal. This delica.te me-chanism provlqes a n~gative 
f~edback control of the renin-ang:f.otensin-aldosterone system.· The precise 
' locus at which angiotensin II stimulates the secretion of ald~s~~rone_ is not 
completely und-erstood. However, it seems likely that it stimulates some 
.step in the
1
_steroid bio~ynthesis between cholesterol and progesterone (Ganong " 
. , ' 
aO:d Van _Brunt,. 1968; Davis; 1971) o _ The inter-relationships in the renin-
angiotensin system can be su~rized diagramatically as follows: 
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Plasma renin level and hyeertension 
Several disease_s · in thE}-human are associated with h~pertension, and 
the involveme.nt ot renin ~th these diseases has b"een .c.omprehensively revi~w~d 
. . 
by· Brown et al (1965a). Th~ hypertension may be associated· with a high; norinal, . . 
.. . . ' ' 
or low renin activity ' as discussed below. It is impor~ant to ~ntion· here 
that plasma renin activity is greatly dep~nde~t on sodium balan~e, aldosterone 
., 
secretion and· po~ture. 
-·· 
Plasma· renin levels . 
-.The plasma-renin. level ·qas ·been · found :_o be elevated in the· '· 
following-hypertensive states: malignant _hypertension (Skeg8s-et al, i95l), 
. . - . . -- . . . ' - ... ' . tii; . ·. 




. .... ' . \ . . . . . ' . . ·_ ' . • 
. I . , ' . • • •' . 
: 1964b), ~enal a~tery stenosis {~rown e~- al, l96_~a) '·. ~eco~dary . _a.~d,o~~~ron~~~· :: ~ ... ,- __ ·. 
· hemorrhage (Peart, 1965) , sodium losing renal -disease, cases of · renin . · .. . .: 
' - - - • - • ¥ • • • • • - • • • ~ - : • 
' .. ' 
' . • .. . ~ . • , • • I ' , o, 1 
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9. 
sec~~ting tumors (Brown et al, 1966) and 1•15% of pat~ents with essential · 
hypertension. . _ 
The plasma renin level may be normal in 60-70% of the pa~~e~ts;~~ 
. . 
esgential h~~;tension, pheochromocytoma and Cushing's.syndrome (Brown et al, 
1966), a~d c_ot;i§tently low in Conn's .. syndrome (pr_imary aldosteronism) . 
(Conn et al, 1969). More d~tailed informatio~ on this ha~ been provided by 
. ... ..·, , 
Laragh who studied· 219 ·essential hypertensive p~tients and reported that 27% 
. 
/ . ·I.t;J. 1950 Deming and 'Luetscher •reported the · presence of a sodium 
,. 
_.,'I ' . • • . • 
ret~ining factor in the urine of patients with cardiac failure. The occurrence 
. . 
·a£ this factor wa~ also_ suggested · by studies on electrolytes in sweat and 
saliva (Conn and Louis, 1950; Berger et al, 1951; Bongiovanni and .Eisenmenger, 
·. ! 
1951). By 1952, the substance had been isolated from beef adrenals and shown . 
to cause an intense sodium retention in •the adre~alectom!sed ra·t (Grundy et al, 
1952; Simpson et al, 1952). ' I Chemically it proved · to be an 18-aldehyde of 
cortices t.erone . and was called aldosterone (Simps~n et al, · 1953, 1954) • 
.., 
Aldosteron~, is a potent mineral:_ocorticoid ·.with ·about 25-50 times 
'-
---.., . 
the activity of deoxycorti~terone acetate in the renal retention of sodium 
by adr•nalectom:lsd · animals . ~~• 1954); It effects the tranSport 
of ._electrolytes across the epithelial nephi"ou-, particulJlrly the dista l tubule 
• I , . • - ' .. ' f '-..... , ... 
. . . 
of the kidney (Vander et al, 1958), the intestinal mucosa 'and the salivary and 
sweat :glan4s (¥inn and Welt,· 1963) • 
. . 
. · ... 
... · .. 
' .· 
. ' . 
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Regulation of aldosterone secretion· 
p 
· unlike ' other adrenal steroids, aldosterone is not' under the 
. . 
co~l~te c·on.trol of t_he pituitary gland. It is now beUeved that irts secretion 
is regul~ted by sev~rai factors' including the renin-angi~-t~nsin system, 
.. .... 
·. 
electrolytes and ~CTH; as disc~ssed beJow. 
--Renin:~giotensin 
-----
The -involvement of the renin-a~giotensin system i~ th; regulation 
Q ., 
. ~ . -
of aldosterone secretion has been extensiveJ.y reviewed (Davis, .1963; 
Blair-West et .al, 1963; Gano~Van. Brunt, 1968) ~ Administrat~o~ of renin 
~"---- .' : ./ 
... or. ~mgiotensin II stimulates
411 
bo.th 6aldo~teroh~etion .and the _·gro~h of the 
zona glomerulosa, ~hereas .nephrectomy prevents .these, effects (Davis ~t al, 
• • •• • ~ • l[ 
196lb; Mulrow et al ,. 1962·; Mulrow and Ganong, 1964). InfuSion of angiotensin II 
into the jugular vein of man also stimulates aldosti.ronO secr~~le ·. ·. 
direct infusion into the ~dr~nal arterial vein ca~s.;s ~ .'gr~ater and ;..,~~ . . 
longed effect (B~ron et at-, 1961; Ganong, 1962a; Ames et al, 1965; Laragh ~~ 
196'4)'. Ganong and Mulrow (1962b) also 'found that elevation of· endogenous renin 
' . . ' ' . , 
due to renlt1 ar~ery constriction leads to an increase in aldosterone secretion. 
Electrolytes 
" 
' There is evidence that•th~ concentratiop of potas~ium . in 'the pla~a 
. 
may directly affect aldosterone secretion. . Potassium loading ~ncreases and 
depletion decr~as~s its secretion and preventa'the stimulation t~at normaily . 
foll¥' sod~~m ~eple~ion "(Lar~g~ ~nd ~~oerk, 195J; :Eilers . and Peters~n·, . l964; .. 
,Gann et 1, 1964). Perfusion studies with isolated do.g adrenals have also ·· 
I ' B ' [/ 
indi~ated that potassium acts directiy on the adrenal gland (Bla~r-West et al, 
.. 
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It is unlikely that ·.the conc·entration ofJ serum s~dium plays 'a direct 
rol~ in aldosteron~ production, since ·i~ man tt~ sodium level does not alter 
• I o ,~ ... ~ 
s;l.gnifi~antly durtng sodium deplet.ionr. , However, s.everal o,dier electrolyt~s . ~ 
have be?m foun.d to influence .aldosterone secr;:~t~n •. : For ·~ample, magne~iu~ 
.,...!t. ,~rr-, t .... • 
. . r . 
deficiency stimulates aldost~rone secretion :Ln :the rat. (Ginn ~i, 1967), 
while cesium·, rubidium, and ammonium stimulate its in. vitro ·~ormati.on ~~ · ~at • 




. /. ' 
ACTH does not appear to· directly control the.production of aldo-
l · ' .. 
sterone since hypophysectomy f'ail'a to cause a~rophy 
I . 
of the zona gl~merulcisa 
..... J 
of the adrenal gl~rid, . unlike· the inner zones of the adrew l cortex (De~e, . · 
.iJ ' ' 
· 1962; Laidlaw, 1973). Large dose~ ~f ACTH .will however· stimqlate aldosterone · 
. . f 
. .. , . 
secretion initially in the human, but the rate soon return~ to the control • 
' . 
lev~l with continued administration (Liddle et 'al, ' 1956; Forsh~ et· al, 1961'; 
Tuaci et al, 1967). 
In sodium depleted rats an intac't p:f;tuitary seems to b~ essential 
. f~r ·t ·1rm~l . st~mulat.ion and ~int~nance ~£ ~ldosterone production, since 
hypo hy~ectomy impairs aldos~erone product'ion. iii thi8 situati!Jn... But the 
. . ~ 
· steroidogenic ef~ect of ACTH . on aldosterone secretiOn is ~ot the same as it - I 
It has been suggested that in addition to .A~- . ' is for glU:cocorticoids. 
' ' 
pituit~ry factors are necessary f or the aldosterone response. to. sodtum 
. 
depletion {P~lmore et· al, ~970). In des ~ however, a large dose of ACl11 alone 
. . 
. ' 
produces an elevation in aldos tsrone production- (Ganong and Va~· Brur;t, 1968~. _ ·
,. .. • . 
" .  
. Aldosterone and hypertension ~ · 
' . ~ . Aldo~n~ does not induce hyp~rtension di-rectly in· man, but throuse~ 
--
. . ·. 
secondary "alterations in sG'dium metabolism. Its eff ect on sodium and· water· 
·_j ' .. . .. . . . . . . . . 
·r 'ete'ntion/ increases tha extra cellular fluid volume which may then lead ."to t he· 
. "' "" . - . . ' . . . . . . 
• . I 
- devel~ment of hypertension. It has been 
' . 
s~gge.sted that an. incJ;ease in the • 
. ~ 
f :-1·. ,. . ' . . .. 
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sodi¥m ·~nd water content of the renal arterioles decreases their radii, and 
' • Q ' 
·  thereby increases their resistance to flow ~hich produces the hypertens~n . 
r 
;:, . . ' . . . ·, . ,. . ~ 
(Finn and Welt, 1963; Conn, 1964a). Hypersecretion of aldosterone has been 
' . . 
" • ' </ I 
· ·associated with hypertension in several'1conditions which may be divided lnto 
~· ' , , " ~ r , • 
' 0 ... 
; two groups, those with -increased plasma renin activity," and those with ~ow 
plasma renin activit~. The first! group in.cludes :, secondary aldosteronism, renal 
' ' 
artery stenosis, ~fignant hypertension, renin secret~ng tumor, and som~ 
individuals rece~v~ng oral contraceptive pills. The l~w renin group inc1udes~ 
-· . ~ l' ' f primary aldos terollism, adrenocortical hyperplasia, and Cushing 1 s syndrome ~: • 
0 • • ' I 
! (Bartt~et al, 1961; 'Laidl~w, '1913) • . In addition· to the indirect action~ of 
~ldos~e~one, it ~Y have a direct effect .on blood . press~re ~!nee it ~as r~~~ntly 
~ . 
' been demonstrated that infusion of this hormone into decerebrated rabbits on ,. 
· norma~, hi~h and low salt diets, induces an, elevation in bl ood pressure ~ 
_(Bu~st)rn et al, 1971). The mechanism of this action is obscure, but may_ involve 
,; 
an effect on the kidney or barorecepto~ sensitivity • 
• r '' • • ' ' 
.(a) Prima!Y aldosteronism (Conrl 1s Synd~ome) · 
I 
·r ·-. , 
_The term primary aldosteronism implie~ that the oversecretion ·of ~ldo­\ . 
sterone arises from within ·the adrenal . ~orte~, and is typically_ associated wi th 
an aldosterone produ~ing tumor. Primary aldosteronism has also been called 
. I . . ; 
Conn 1 s synd'rome in recognition of the classical identificatio_n of this syndrome 
/ ' , I · ' . , ~- • 
(Conn, 1955a,b). The first diagndsis was ·made on a 34 year old woman who · 
(• 
pre~ented with the symptqms of seyere weakness, . low serum potassium and 
• · ~ . ' • {l ' ' ' , 
elevated bloo~ pressure. A~ surgery a large golden-yellow tumor o~ t~e adrenal " 
. ' . 
· was observed and excised, . and by· the tenth post-operative d~y, all 
. . . . 
sympt~ms h~d 
. . 
' r •1 r 
disappeared. Conn' (1961) has s~ggested thS;t t .his ·p·atient· presents a classical 
. . 
example of hjpokalemi~ primary aldostaronism which can be distinguished by t he 
q 
_follolrl:ng diagnostic criteri~.= hypertensioh, hypok~letnia, ~ormal 17-hydroxy-
corticoste~oid a~d _ 17-ketos~eroid _ excretion, normal renal arteriogram, excess-















specific gravity, · continuous .weaknessf~ nocturia and headache. In few cases 
' . 
of ~ri~ary ~dosteroni~~ how~ver, the tum~r~ have been. found . to produce 
excessive am~~nts of corticosterone, ald~sterqne (Mader and Iseri, 1955; 
• I -· • 
··Ayres et al,. .1958 ;· Neher, 1958), and ~.18-hydroxycorticosterone (Abbott et al, 
1966) •. 1• 
- ~-- '; 
Pat~ents with pri~ry aldosteronism have been found to ha~e • 
suppressed plasma renin activity (Genest et al, 1964; Conn et al, 196~b) and 
. \ . . 
. Conn has sugge~ted that the ov.erproduction of aldosterone together with 
, , I .... 
·suppressed renin activ~ty . is uniqu,ry diagnostic of primarr aldosteronlsm. 
\ ' 
In some cases primary aldosteronism .. may not be present with al1 the 
. ' ., . .. 
• ,. 1 • 
features given abo~. Norm9~alemia has been associated with printary aldo-
i 
' osteronism in sev~ral reports (Conn et .fll, 1964b; 196Sc._-; 1966; ·1967). However, 
- .. J ' { . ' l . 
a recent review,' s'tates that only 8% of the normokalemic patients actually had 
.... . 
pri'mary aldo~teronism ..(Rovner:. 1970a). These pat,ients have been suggested to 
. .. 
'• . •'{·' 
represe~t early stages of primary ~ldqsteronism before s~g.nificant alteratigns 
I 
· in !Jl.efr blood potassium l~vels. have occurred/ · : ', '~ 
• 0 • ~ 
A few isolated cases .!of primary aldosteronism with high aldosterone 
r - J/ • • ' 
' p'roducti.on ~ut without an adrenal tumor have also been reported, where both 
I 
the zona g~ome~losa and fasciculatawere pfound :to be hyperplas.tic at surgery 
( 
. . r--1 ... 0 
(Van · Buchem ·et al, 1~56; Kret~hm~, .1959; Moran et a1, 1960; Genest et al, 
1960b). / 0 • 
On the basis of t~ obee~at~on tlt'at plasma ~e;~~n activity may be 
: I 
... ; J .1 ' \ 
supprea~ed in a soignificant perc;entage of. patients with essential hypertension; 
Conn b~,iginally preqic'ted that ~s many as 15-20% of the essent~al hypertensive 
0 • 
population may have undi:agnosed':'tidtena1 adenomas. He also found that the 
. . 
disease was 2~ times ' more . common in women than in men, and that 70% of the 
. patients "were between 30- 9 • years of age ( C,onn, · 1961) • However, a high inci- · 
dence ~f · adrenal adenomas 
been confirmed by other ·w 
.·1 
_y- t • f. ~ ! '• 
4·-~-;_IJ 
among the essential hypertensive popuiation has not 
rJ:rs. In one study, ~13 hyp~rtensive cases were 
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. --
-investigated and a mean of 4.4% ,found to have 
with increased serum renin levels (Ehrlich, ·1968). - A further 13.3% had in-
$creased serum renin with. normal aldosterone, 11.8% had low renin. with normal 
. . . . ' ~ . 
.  
aldosterone, but no cases had yrimary aldosteronism as qefined ·by Conn. More 
. ~ 
recently, 'Rovner (1970b) from ~9nn is· labora_tory, reported th~t 8% of a gro~p of· 
._._.- ' . 
unselected hypertensive patients had primary aldosteronism. By contrast, 
' ~plan . (1970) .believes that primary;, aldosteronism is a rare 'disease and probably 
~ \,!. 
· ' acc~unts for ~ess than i% of the essential hypertensive populat'ion. 
(b) Secondary aldosteronism · .. 
' 
... 
Secondary aldost~ronism refers to the hypersecretion of aldosterone 
,. . t . second<!ry to stimulation .from sources outs.ide the adrenal gland. In 1960 Gross 
\ __ ,.:; 
post~lated that renin .exerts a C~ntrol functiDn ~n the secretion of aldosterone 
.. 
and· maintain~ electrolyte balanc~. La~er, increased aldosterone excretion 
(Genest et al, 1960a)and secretion. (Laragh et al, 1960a,b) were observ~d in 
hypertensive subjects·, and the _infusion of angiotensin II -into a normal man 
was shown to also.inc~ease the secretion and excretion of aldosterone.' These 
findingstprovided a link between th~ kidney, hY,Pertension and alda~terone • 
. 
Three dif~erent factors ~hie~ jay be involved in the stimulation of aldosterone 
~ecretion in. secondary aldosteronism, are angiotensin II, ACTH and potassium. 
These effects .are considered below. 
Angiotensin II 
It is now well established· that the renin-angiotensin system is a · 
major controlling factor in aldosterone secret_ion (Davis, .1963; Mulrow and 
. . . 
' 
Ganong, 1964; Gross et al, 19~5; Gan~g et al, 1966; Peart, 1970)~ Several 
. \ . . . ' 
factors that affect the level of angiotensin II will also affect . the secl:--'et:l.on 
- I . 
of aldosterone. · The most common st~u~ator of angiotensin ·II formation is 
4 t;' 
decreased pressu~e in the renal arterioles, which may be caused by a decrease, 
. - . . 
.in the effective arte'rial blood volume or, by· obstruct:i.on of the blood flow into 
~ 
.... ~ / the Ki dney. A decrease in ·~xtracellular fluid volume also leads to a decrease 
... 









secret~on. The 'increased plasma renin concentration ·leads -t:·o an increased. 
, c 
level of angiotensin II, which stimulates aldosterone secretion by the adrenal 
cortex. Stich a situation occurs iri renal artery stenosis producing ·reno-
~ . , . 
vascular hypertension (Kaplan; 1969). It may be important to mention here 
'that most renovascula·r disease does n~t produce hyyertension (Eyler et al, 1962) , 
since most arterial stenosis do -not pro.duce enough dbstruction of the blood 
flow to increase the release of renin. 
With hypov~lemia, which occurs following the acute loss ' of fluid 
asiociated with diuretics, hemorrhage or gas~rointestinal disturbances, there 
is a progressive wastage of. salt and activation of the renin-angiotensin-
aldosterone,system. 
A similar situation is found in cirrhosis of the liver with ascites • 
l 
., .· .. 
A 4 progressive decrease in the hffective blood volume leads. to very. high levels. J . L 
of r7nin, angiotensin ~nd a~dbsterone, and to sodium retention and potassium 
I 
excretion. 
) ~ unusual situation where excess. angiotensin is produce~ is due to 
an inherent lack of sensitivity to endogenous angiotensin through'the failure 
of the blood vessels to r~spond·in a normal manner. This results in an · 
I . • • • • I . ' . 
increased angiotensin II production which sti~ulates aldosterone secr~tion 
' . 
and is accompanied by hypokalemia and alkalo~is, but hypertension is absent. 
l 
(Bartter, 1962; Martin .and White, 1972). 
Increased plasma levels of ald9sterone are found during pregnancy 
,. 
· ·and in _women taking oral contraceptives, but complications do not usu~lly 
; ,. 
o'ccur·:) Since the majority of · the aldosterone is bo1,1nd to pro~ein (Layne et al, 
1962; Kean et al, 1969; Horne et al, 1970). There are also ~solated repprts 
of renal tumors producing excessive amounts of reniri, which ~n tu~ elevates 
. . 
.' the angiotensin II level and produces a secondary aldosteronism (Robertson 
et al, 1967; Hoshino and Seid~, 1968). ~ 
, . . ' 
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Adrenocorticotropin (~CTH) · · 1 · --
Whereas ·ACTH is known to be a major hormone f_or adrenocorticoids 
in man, its role in the stitm~lat_j}on of ald:osterone synthesis is of ;Less 
fi> importance. ~i-s_timula~ory · effect of ACTH on aldosterone secretion has however 
' 
been demonstrated in ' the rat (Singer and Stack-Punne,- 1955), sheep (Blair-West 
:' 
et al,_ 1962), ox (Kaplan and Bartter, 1962), dog (Mulrow and Ganong, .1961) 
' . 
and also . in man with large, doses (Forsham, 1961). In man it appears most 
. . . 
likely that ACTH functions ~ainly in a supporting role ~n the secretion of 
aldosterone· (Davi'B, 1961a) • 
. In certain situations, sec'ondar:y aldosteronism may be associated' 
with eleva'ted ACTH secretion due to lack of cortisol synthesis. Cortisol . 
synthesis is blocked in congenital· adrenal· hyperplasia due to inborn enzy-
. . ' 
·. matic defects • .'Hexe the negative fee~ back mechan~~m between th~ p'ituitacy 
. and , ~drenai' cortex is not operative, which leads to. excessive production or' 
ACTH .which in turn causes a hypersecretion of ald_osteT;o.ne (New & Peterson, 
1967; Sutherland et al, ·1966). Recently it has been suggested ·from indirect 
evidence that there are .hormones other than ACrii. which may cau·se a hyper-
production qf aldosterone in this· situation (New et. al, .1973). 
In situations of surgical stress .or acute hemorrhage, it has ~lso 
~ been suggested that ACTH plays a role in the stimulation of aldosterone 
'synthesis · (G~nong et al, 1966). 
Potassium 
Serum potassium concentrations appear to' have a marked influence on 
· ald.oster.one secret:i~n. It has been demonstrated both in vitro and by per-
.. . 
fusion studies. wit~ - the adrenal, _that :potassium' .ac'ts dire~tly on the a~ren~l 
gland (Blair7West et al , , 19.62; Davis et al, 1964). Elevations in serum ·· 
. . . 
potassi~ increase an~ d*'plet;Lons decrease aldosterone _' secreti9n• Potassium -
' . 
depletion also pre~ents the .rise in aldosterone ~ue ·to . sodium depl~tion 
'I ' 
(Laragh and Stoerk, 1957;' Davi~ et· al, 1963; 'Gannet al, l964), and_ p4ti~~t~ -
.... 
,• . ~ . . , 
. . , ... .. . .. . 
• r ~ • ' ' . , • 
" 
' . 
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given exo~enous potass~um or' suffering from a disease associated with 
' . . hyperk~lemia, exhibit a' form of secondary aldo~teronism. 
3. Glucocorticoids . 
' ' 
(a) Cushing's. Syndrome 
, . . I , . 
The possibility of a rela~ionship between the patSbgenesis of 
. ' 
: hypertension. and the adrenal cortex, was suggested by t}le association of 
'· . 
- . 
high bloo'd pressure with ·cushing'.s syndrome. 
This .. disease was .first desc~bed by Cushing in 1932, and was 
attributed at that time b~, pituitary hyperactivity due to. a basophilic -~umor 
), of t~e pituitary. Later evidence indicated that this disease could be 
associated with increased cortisol secretion in the abseri<;:e of pit_uitacy 
. . . 
tumQ~ and with bilateral adrenal hyperplasia (Soffer et al, 1957). Cushing'B 
. . . 
syndrome may be associated ~than adenoma or .~arcinoma-of the a~renal cortex 
. . 
(Soffer et al,_ 1961), excess ACTH produc~ion from a pituitary tumor (Salassa 
et al, 1959) ,· or overactivity of · the basophil ce).ls of the t>it~itary gland 
.. I . - . 
(Marks, 1959; Simkin et al, 1962) .. ·r~ each case there is ~m excessive 
· .. . 
pro~uction of cortisol a~ciated with hypert·e~si~n (Scholz et al, 1957; Peart, 
. 1967). ~dosterone secretion i: usua~l; low (Christy lnd Laragh, 1961; . 
. . r . 
·Peart, 19'61), and removal .of the source of excessive cortisol relieves the 
t.. : 
J • - I 
hypertension 'in most cases (Rakt:;r et al', 1964). 
. . ~ 
Th~ mechanism, by.which cortisol or corticosterone increase ~he . 
. .. 
blood pressure is not clear.since they are not potent p7essor agents. The 
' . . . ' i 
effect has been attributed to their weak mineralocorti~oid activity, wbich·is 
• J • • 
observed when they are admLnistered in high .doses (Christy and L8ragh, 1961). 
• I: f • • ' • ' 
· · . • , I ' • 
~re recently, elevated secretion of deoxycort~coste~one .has been 
• • f • 
·' .-
. 
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(b). Congenital adrenal hyperplasia 
Congenital forms o~ adrenal hyperplasia are inherited disease~ 
characterised by defects in the biosynthesis of corticosteroids by the adrenal 
. . 
cortex, and .are usually. identified by ~linical sigris and symptoms of· exce~~~ve u 
sex hormone production. In a~dition, some types are associated with 
elec.trolyte iptba,lance, hypertension a~d hypoglycemia. 
· Congenital adrenal.hyperplasia has been id~ntif~ed in association 
' . ' 
. ' 
with six different enzyme defects (Bondy, ~969), two of which are associated 
with hyP.erte~sion; namely, . l7a-hydroxyl~se and 11e-hydroxylase deficiencies, 
17a-hydroxylase deficiency results in an .!~ability of the adrenal 
c6rtex to produce cortisol; so that· excessive amounts of corticosterone and 
Q • • 
. 
d~o~corticost~rone are produced (Biglieri et al, 1966; Goldsmith et al, 
1967). Since these latte~ steroids hav~n~ ef~ect ~n the hypothalamic control 
of ACTH release; and the negative feedback of cortisol is absent,, the 
p~od~ction of ACTH increa~es and leads to-a buildup of cortisol precusors. 
Aldosterone is usuall~ not detectable bec~use of the salt retaining effect ' 
. ' 
, of the· deoxycorticosterone which suppresses its formation through supptession 
of renin secretion. The mine.ralocorticoid actiori of deoxycorticoster.one is 
. . . 
.._/ . 
also responsible for the hypertension associated with ~hi~ enzyme defect. 
~ 
lie-hydroxylase deficiency a~ain results in an inability·to 
produce cortisol and excessive fo.rmation of deo~~ort'ic:'os\rone . and -~ndr~~ehs 
":' (Eberlein and ·Bongiovanni, :1955; Ca~echo et al, 1966; Gab'rilove et al, 1965)-. · 
~ ' 
The hypersecretion of the deoxycorticosterone is responsible fqr th~ hyper~ 
tension. The associated excessive production _of androg~ns results in masculin-
isation. 
4. Pheochromocytoma 
The adrenal medulla is a modified form · o~ the autonomic sympa~heti~ . 
. ' 
nervous . system, and has a metab~lic link' ~ith the sympathetic nene endin'gs ~ '. 
' 
·which store· and release the 'c!-techola~~es; ·· epinep~r.ine and a norepinephti~e •.. 
·' I a•' I 
' . ... . ' .r .-
.. ' 
. ' . '•?-~~ . · ' ....... / 





This organ is not often associated with disease; however tumors of the chro-
---~ffin cells of the medulla have ·been shown to secrete elevated levels of 
' ' 
catecholamines, a condition that has been classified as pheochromocyt-oma. 
Pheochromocytoma is charact~rised by excessive production, storage 
and release of catecholamines, hypertension, increased heart .beat, sweating 
and hyperglycemia. The arterial pressure may rise as high _as 300/180 mm Hg 
(P'age and Copeland, 1968;. Crout, 1966). 
The main secretory produc.t of the medullary tumor in pheochromoj:y-· 
toma is norepinephrine; however, on rare occasions, tumors have been -observed 
ta secrete epinephrine, hydroxytyramine (Engel and von Euler, 1950) and dopa-
. mine (Robinson e't: al, 1964). Pheochromocytoma may also occur without ·an 
elevation ~n blood pressure (Leather' et al, 1962). 
The diagnosis of .pheochromocytoma ' is usually bas~d on-the ~rinary 
excretion of vaniilyl m~de~ic aci~ (VMA): a meta~olite of epinephrine and 
norepinephrine, and in additioh, on the levels of free catecholamines in urine · 
or blood. Estimation of VMA reportedly detects 90-95% of all ·cases (Git1ow 
I , 
' . .'l, ' 
. . . . - ~ 
The cardiovascular man'\fest'ations o'f ~uiochromocytoma are pri-et al, 1961). 
marily due to. the excessive production of catecholamines; however,athere are 
' 
other fa~tors which cari modify the degree of _hypertensio~ ?aused by the circu-
. - . 
lating catecholamines. Patients with pheochromocy~oma have a greater response 
to norepinephrine and its vasoconstriction e~fect . produces. a greater change in 
L • 
' their blood volumes than normal, r~sulting in .an i~crease in blood pressure· 
(Brunjes et ala 1960; ~gleman and Sjoerdsma, l964). The actual mechanism by 
. . . 
whi~h the high.level of norepinephrine is maintained in pheochromocytoma is 
not clear. It has been shown that drugs like tyrhmine and reserpine bind at 
. . "•' ' ~he nerve endings, causing a .~elease of _norepinephrine into the circulat~on. · 
. .. 
The drug, a-methyl dopa is converted into a-methyl norepinephrine and substi-
. • . . I 
tutes· for norepinephrine at its storage 'site, whi~h causes. an el~va'tion of the 
. ' . ~ . ' . 
level of circulating norepinephrine~ These findings indicate that 
... . ·' 
, . . 
. ..: ' 
'• . 
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• . . 
. . 
release of norepinephrine in pheochromocytoma 
. . ' '/ . 
of oth~~~ompounds present in the ·circuiatory 
may be induced. by the metabolism 
system (Kopin and Gordon,. 1962; 
~-
Trendelenburg, 1963; Muscholl and Maitre, 1963). 
5. Steroids, electrolytes and experimental hypertension 
• l • · ,. . • 
The concept of the adrenal·being an important participant in the 
. 
. 
genesis of hypertension probably dates from Selye's hypothesis (Selye, 1946) 
- . 
. that an abnormal reaction of the adrenal cortex to stresses in the environment 
' 
could lead to hypertensive disease. While. evidence for a relationship between 
. ' . 
r;-
stress and the -development of hyperte~sion is circumstantial, the involvement 
of adrenocorticoids, ·particularly cortisol, aldosterone and deoxyco,rticosterone. 
in certain types of hyperten.sive disease has been well doc':'~ented, and several 
endoc~inopathies have been described where overproduction of endogenous ·steroids 
has be·en ac~ompanied by hypertension; such as cortisol in Cushing 1 s disease, 
aldosteron~ in primary aldosteronism, and androgens and deoxycorticosterone in 
congenital adrenal hyperplasia. The administration -of steroids to humans in 
' ' ' 
· exce~~ive amounts has' also been shown to prod'uce hY,pertension among o~her 
-effects ·-(~iglieri et al ,. 1968, 1970; Perera et ·at, 1944, 194 7) • Howeve'Dtt" 
... . 
~tudi~s on the development of exper~~ntal hypertension have been exclusively 
. . 
·confined to·animals. for obvious reasons. 
The adrenal cortex has received particular attention in the 
experimental development of hypertension. When regeneration of enucleated 
.rat adrenals was deaayed or prevented, the hypertension that normally"accompanied 
\ . 
· this process was also delayed or preven.ted. (Chappel et al, 1958; · Skelton ~t al, 
1956); and rats t~eated wit~ androgens failed to become ~pertensive if they 
.. 
had been previously adrenalectoinised (Salgado and Selye, ' 1954). ·. 
:1-' :r . ' 
,. .· .· 









The ' literature on experimental hypertension is particularly 
. . . 
. -..{ : 
extens~ve, but basically falls into the following five c~tegories which will 
. . ' 
be discussed separately. 
(i) · Adrenal · :regeneration hypertension 
(ii) ~alt and deoxycort;t:costerone ~nduced hyper~ension 
(iii)· Androgen induced hyp~rtension · 
(iv) Spontaneous hypertension 
' (v) Renal artery constriction hypertension . 




TI:Je development of hypertension in rats bearing one kidney and .one 
regenerating adrenal was observed ·to re,quire the addition of 1% salt to their 
· drinking water (Skelton, 195.5'). 
. . 
Regeneration of the adrenal occurred after it 
Q ' 
had .been enucleated by slitting the capsule and gently · extruding the medulla 
and most' of the cortex. Th~  hypertension developed _in two weeks and was 
severe hy 5-6 weeks. Animals fe~ a normal diet ~ithout ad~ed salt ?_eveloped. 
norma1 regenerated adr,enate whe~eas those o~ salt diet had regenerated a_drenals 
with very thin zona glomeru).osa (Skelton, 1968). In both cases the adrenal 
medul1a was . absent • 
. The exact mechanism by which the regenerating adrenal initiates 
..;:. 
' . 
hypertension'.is not known~ . itypophys~cto~ and. administratipn of exogenous. 
corticost~rone blocked the . development of hypertension (Skelton, 1956, 1959). 
Endogenous •pldosterone'· or corticosterone could not be · implicated in the adrenal 
/ . ' . ' 
~egenerat~on hyperte!lsio~, . sinee secretion of these compounds was reduced . ~ 
.· (Brogie and Pellegrino, 1959) •.. Howe~er, Skelton (1959) _suggest~d ·that an . 
· ··· abnormai pattern of · st'eroids may be produced by the · rege~erating adrenal and 
. . . 
that these compounds . ~y have the minerai~corticoid activity that is 
•, . , . 
.4 












that the regenerating adrenal is deficient 1n. both llf3-hydroxylase' and ~ 
'· 
' . ' 
.11-hydroxylase enzyme systems which leads. to the excessive formation of deoxy':" 
cortices terone (Brownie & Skelton,' L9?5, 1968) ·, and lB"':'hydroxydeoxycorticosterone 
(Birmingham et al, 1965 ,' 1968; Rapp, 1970; Melby et al,_ 1972a) ~ It is likely 
_,}that these compounds are involved in the 'development o~ the hypertension .• 
' ' / 
·f 
I f, 
(ii) ·Salt and deoxycorticosterone induced hypertension 
~.. : 
Salt and ·hyPertension 
The induction of hypertension in rats by adding s-alt to their drinking . 
. ' 
~r -~ water or food was first observed by. Sapi~stein. et al -_(1950) and later_ con£i:ymed 
/ by oth~rs (Meneely et al, 1954; Meneely apd Dahl, 1961; D~hl and Schackow, 1964; "' 
! 
,r Hall and Hall, 1969). Rats given a 1% salt drinking solution started to develop 
.I 
~ ' hypertension by the third week, _and by the eighth week all animals had become 
' . I 
. . . 
hypertensive. 
- ' 
Dahl and Schackow (1964) observed that if salt t'eeding was ' 
. .' I • 
/ 
started early in the life of an animal, the severity of. hypertension was greater. 
Development· of -hypertension was faster in males than in females, and the longer 
the period of salt intake, the greater tpe severity- of the ·hyper'tension. 
Histological changes were also found- in the heart and kidney, and the renal 
· tubules were ·ailated. 
Deoxycorticosterone and hypertension 
.... __ _ 
Selye (1951) demonstrated that the"administr~tion of deoxycorticosterone 
. . 
acetate alone to rats with one kidney remove_d produced hypertension~ Implantation 
. . 
of deoxycorticosterone acetate pellets into rats on normal diets also produced 
an elevation in blood pressure (Eades et al, ·1965; Hall and Hall, 1969) • 
·-salt-deoxycorticosterone and hypertension 
.With, the simultaneous ad!Jlinistration1_of salt .and deoxycorticosterone 
acetate, hypertension de~eloped much faster than with salt or deoxycort~-
... 
·costerone alone.;, The hypertension usually starts to develop by the 18th- day," 
. ~ ,.. ' . -· . 
• 'fir • ... • It . 
and by the 4th -~~ek all the animals are hypertensive (Knowlton et al, 1952; · 




- . ', 
. ' ' 







) . 23. 
The mechanism by which salt and deoxycorticosterope induce hyper-
tension -is not known • . It fa speculated that sodium and ~ater retenti.on 
incr~ase the extracell~lar ~luid and that changes in renal function· ar~ in-
valved. Champlain (1969) reported that high salt intake 'reduced the norepi-
nephrine storage capacity at the nerve endings and results in increased 
amounts of physiologlcally active norepinephrine being released into the 
circu_lation, which contributes to the -developme'?t of the hypert.ension:. Recent-
. ly ·Belin and Ziaka (1972) reported that high salt and deoxycorticosterone 
· administrati.on resulted in a thickening of the arteriolar walls which led to 
an increjsed peripheral resistance to the , blood flow and was associated with 
hypertension. 
-
Salt susceptible(S) and resistant(R) rats 
During experiments on salt .induced hypertensi~n, Dahl et. a1 (1962a,b~ 
~bserved that some rats developed a permanent hypertension in two weeks and • 
,. 
- ' 
others in 1-2 .months, while some never became hypertensive. '!his rai.sed the 
. I 
I ' • I ' • ' • ' • ' possibility that these variations in sensitivity to salt were controlled by · 
I o ' • 
genetic factor(s_) and that two stra,ins of rat COUfd ~e . develQped by selective 
inbreeding. The most sensitive(S) and most resistat.'t(R) animals with the 
. " 
highest and lowest blo~d pressures respectively from the .first generation were 
therefore bred. ' . -By the . tl!ird generation the response _of the two ~trai.ns to salt 
was significantly dtfferent~ and ·was most niark{!d by the fifth gener~t:l.on. The R 
i' 
rats when fed a hi.gh salt .di~t di~ not. aeve1op hyp~rtension, while the S rats · : 
on a low salt diet e?sily developed' hypertension. ~ When salt and cieoxycorticoste- ,. 
rone acetate were administ:ered simultaneously to the S and R rats, it was · 
observed that Jlypertens:i.on started to develop by ·the · third ~week 'in the S group., · 
l 
and by the e~ghtb week JJaS SO severe that all the animals died. The ~blood 
pressure of the resistant rats started to rise by the fourt~ w~ek and was only 













.. Rapp_ and Dahi (1971) ail,d Dahi et al Jl972~- hay~ found ~rkedly 
~ • · 
-high 18-hydroxydeoxycorticosterone but reduced corticosterone secretion by the 
,.:' 
:.::::.::~:::;d::;::.: :::::i:d .::~ :::::::>::::y::~l~::· .::::::. ' .. /
..,. _ 
This difference was attributed to one or more' genetic control :factor(s). ./~ 
Iwai et al (1970, 1972) L"eported that a low salt die't increased . the 
. ·• 
sensit:J.vity of the S rats to angiotensin and decreased their sensitivity to 
· renin in· relat~on tp· blood pressure. In the same group of animals, high salt 
. ' 
diet increased the response to renin and angiotensin, and bilateral nep~rec~oiny 
~ . . 
caused an :J.ncreased resp-~nse to· renin but a decreased responE!e to angi-o_tens;in. 
The R rats did not exhibit anyu of the!3e effects. In view of these findings 
they pr<?P~osed that . a . renm . inhibitor (a hypert_e~sionogenic fl.\itor)' may be 
invo\vfJ' in : the development of hypertension by -increa~ing ~he sens~tivity of 
• J 
I ... 
the~' S- rat~: to .angiotensin. 
"" 
. . . l_ ' 
'(if ~dr~ induced byP~rte~~ion 
· · I~ 1953 Skelton reported that admin!l.s'tration of methyl androstenediol . ; ~ 
. . .. , I . . 
to uninephrectomised rats receiving _a 1% saline drinking solution produced 
: . . ' 
r .. 1: ,., ,. 
hypertension.) Subsequeliy;ly it was : show that both methyl testoeterone and 
. t' f ,· . -
·.J- ,. • 
testostero0:e.-were ~ffe~t:ive 
\. . .' :,__, 
1969, Coloy et al, l:-970). 
' · ·. 
i~ indu~ing hyp~rtEmsioB in ra~·s 
However, Salgado and Selye (1954) 
. ., 
(Skelton et .al, 
found that the 
hyPertension failed· to, de'velop when m~thyl androstepediol was given to 
adr~na'lectonrlsed ri t-s-. 
The androgen induced· hypertension is a1so associated wi th cardiac . 
and renal hypertrophy·, ~tlrenal· and 'pituitary atr()phy, and vascular lesions ~ 
' . 
.. 
. The kidneys of testosterone treated animals contained tubular casts and .9" ... 
. . 
. ~ ·-
...... · showed degeneration in the - tubular 'epithelium (Skelton, 
· . ~ . 
1969; Col b¥, 1970). 
. ' . 




.. . ' 
' .. .. 
- .' 
' d . .. 
~~· -. 
. . . . ~ . 
I" •,• 
' \ 
: \ .. · . 
. . . ~ 















. 25 •. 
· Incubation of progesterone with adrenal homogenates from r~t~ 
'! 
• • .. Q. ' ' • • • 
treated with methyl androstenediol gave deoJcycorticosterone ~s ~he major · 
'. 
product (BroWn.ie and Skelton,· 1968)·. :further. in vitro · ~tudi.es with adrenal · 
& . 
homogenates ~rom androgen treat~d rata and elect;ron microscopic studlef\J have 
..(.' . ' . 
revealed a .low level of: cytochrome P450 and a deficiency in both llf3- "'and 
.. . . . . . 
,, 





suggest that the hypertension induced in these animals by androgen admi~fstra~ ,, 
i . . ' t. ,• • 
' tion results from an:-inadequacy of ~ertain a'drenal corticaL enzymes resultlng 
--·--in an excessive · secretion of deoxycorticosterone, which· to~ether with . the 
inge~tion of _salt:, leads ta the development of the hypertensive state •• 
(iv) Spontaneous hypertension I 
. . . 
Essential hypertensi-on in the human is not associated w:l.th ·any 
' ' 
\ . 
obvious defect which may be said to itY-tiate the hi~h b-lood pressu_re. A. model· 
~nimal strain has. been developed for the study of e~sential hypertension where ·· 
.... . 
. . 
the elevation in blood pressure also. develop~ spontaneously without apparent 
cause. 
:P. 
Hypertensive Wis~ar rats have been selectively bred to the twenty-. 
ft • • 
first generat:lo~ to obtain a genetic stra:in of spontaneously hypertensi:ve rat 
,. ... ,., , . . . 
_. • - I ~ 
.(SHR) (Okamoto· & Aoki·, 196'3). , Hypertensive cardiovascu~ar disease co~on1y · ·. ( > 
. . _,. 
occurs at an a~v~~ed .stag~ ~f the. hy~~rtensio~ and these -animals also ;'xhilrl.-t· 
• 0 \ 
. , 
.low plasma renin activity, ad\7nal hype~lasia ~d hypokalemia (Sokabe• 19.66) • . . 
Louis ft al . (1969) studi ed the ~ffect of administration ·of. salt on • . ·· ..... 
. 
. ' 
. the . blo~d ·pressure of the SHR and concl~ded that these rats .were insenst tii.re . ~to 
. . . 
high salt · inta}<e. ·The plas~a- potassium l~v~ls. of th~ SHR w~re f .ound to be 10% 
' . . 
' ' • ~ • • ' 0 . /} 
lower than the controls, ·and sodium depletion .fo.r 4 weeks did not reduce the 
I " ' • • • 
blo.od pressure (Baer et a1, 1972). ~-. Adininistration of. exogenous corticost~ro~e 
... . -- . . 
. . . 
for 8 weeks deiayed the. de;ve_lqpment · of "the hypertension but dl Cl pot preve~t 'i.t • 
. ·~ 
• 0 . ·~ 
\ 
:._ -·--
. ..... . 















T?tal adrenalectomy also .failed to prevent_ th~ developme~t~of~ the hypertension. 
.. . .. 
These findings suggest ,that· the sodium balance and adrenal corte~ were not· 
< of primary. importance in the .development of · hype~tension i~ thEf) SHR. In 
addition~ the levels. of '18.-hydroXydeoxyco~tic,osterone, deoxycorticosterone and 
• •• ... 0 
..,. 
al4osterone in the~adrenal venous blood of ~he SHR were not altered (Melby etLaf, 
-l,972b). 
(v) 
. IJ' .' ~,., 1 
-;.)'>,~ 
~ . ., ·~ 
•' 
Renai ·arte;y constriction hypertension 
0 ,_ • • 
Attempts have been made to reproduce hypertension in:~nimals by 
0 . 
·'. 
damaging the kidney ·or by obstructtng its blood' supply. Goldblat>t (1934) in 
the f:!rst c~~ssical 'experim~nt showed tha't constriction of a renal artery in . 
. the dog leaving the other k:!'dney intact, produced hypertension, A' silver clip . 
l appli.ed . to t~e - ren~· artery ca~~~d the blood press~re to ·~ise: within 24~ 72 ;h~urs 
- .. \ 
and gradually reach a plateau by 1-2 months.- A s~milar observation was made on 
. . . 
rabbits ··(Pickering and Prinzmetal, 1938), and rats (Wilson and Byrom, 1939). 
- . . 
In the do_g, the hypertension pers'isted for several years after the renal 
0 , , art~ry was cdnstricted •• However, if both renal arteries are con~tricted,. or 
• • ' ' ';. ' \ o 
' ( ' " 
one is constricted and th~ other rem?ved, a severe permanent hypertension is 
preduced. 
The hypertension that is caused by renal artery constriction can be 
relieved by removing the clip an~ restoring the blood flo~ or by removing the 
affected. kidney (Goldb;at~,. ~8; ~ickering, 194_5). These early observa tiona 
"' . ' - ' 
) 
indi~ated that hypertension induced by renal artery constriction .was .due to an 
iri~~ea~ed peripheral resistance • . McCubbin ef al (1956). showed that the ' caroti~ 
,. .' ' \ . . 
-. 
-baroreceptors become· res.et at a ... new level of arterial pressure in this si.tuatioh. 
~. • • d ',.,.: • • : • ' ' ...;; .. 
Electrolyte estimations in .renal artery cons-triction hype!tens~on, - ----:-· 
revealed that the le~e~s · of sodium and 
'1956; Phelan and Wong, ' 1968), . arteries 
.. 
' \ 





. . . 
potassium. wer~high·in- the-~~rta (Tobian, 
,·. ;' ' ' ~ .... , 
• 0 ... - , ,., . ' . , .. ~ 
'(Koletsky et'al, ·1959) 'and arterioles '! 
• 0 ~ ,f' \ . . . 
. . 
. •, . r. . 
,'/ 
. ' 
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Studies on the· involve~nt · of the 'renin-angiotensin system, 
f 
S!-~ggested that: it was not directly ·responsible for the elevation in blood 
pressure, sin~e no chang~s in plasma. renin ac~ivi~y occurred in.the· dog 
(Fasciolo et al, 1964), she~p (Blair-West et al, 1968)", rat (Gross et al, 
196·~b), or rabbit (Peart· et al, 1961)". 
Ayers et al (1969) studied the effect of vasodepre~sor and vaso-
dilator drugs on plasma renin activity in renal artery constriction hyper-
tension. They !ound that the plasma renin activity •was markedly !~creased 
. . '- " . 
with vasode~!essor drugs, such as reserpine. In control animals, .the plasma 
ren~n activity was initially elevated ~ut decreased w~~h increasing blood 
pressure.~ It was suggeated that· renal constriction· causes vasodilation which 
releases tqe renin, and is followed by vas!)co.p.striction which inhibits ' 
further release. · 
6. Estrogen, progestogens and · hyPertension . 
Hypertension, which may occur as a complication of pregnancy"is 
I 
usually associated with. sodium and water retention. Although , the plasma 
level and urinary excretion of aldosterone ~re increased (Jones et al, 1959; 
... 
Vande Wiele et. al, 1960; Layne et al, 1962; Sims et al, 1964), the level of 
physiologically active aldosterone is not significantly .altered becaus~ the 
majority is bound to pr,.otein~ .This may be the result of ~he stimulation of . 
protein synthesis by estrogens. (Layne et al, · 1962; Kean et al, 1969; and 
Horne et al, 1970). 
. . 
Pregnancy is also associate4. with consistantly marked increased pro-
·duction ·of ·"re_nin .substrat~, but with ·inconsistant increases in plasma renin 
activity ,or c_oncentration . (Newton et al, 1968;· Skinner et al,· 1969;' 
\ 
Wie~berger et al, 1969; Nasjletti et al, l970). In this respect the source 
I . 
of renin is of ~ome interest, ~inc~ renin-like activity.h~s been found in · 











(Gros·s, 1964a) and the pig. (Gould, 1964). 
. ' 
It is not clear whether the ~igh levels of progesterone that are pro-
duced ·during pregnancy have any definite relationsh~p with. the ·increas,ed -bio.:..: 
. . 
synthesis and secretion of aldosterone in this sit~ation (Lar'agh et al, 1964). 
HowJCer,.it is known that progest~ro~e and aldosterone have opposing action ·on 
7 
the renal excretion of sodium. Progesterone reduces the tubulat 'reabsorption 
of sodium and stimulates its excret.ion by couipeting ·with aldosterone for bind-
ing sites in the kidney (Land~u et al·, 1955; Landau and Lugibihl, 1958, : 1961) • 
. . ' , . . •. 
Recently this theo.ry lias baen supported by · Laidlaw (1973) .. in relation to the . 
effect of aldactone on aldo~terone pr9duction • . 
Hypertension'has also been found to occur in a small proportion of the 
populat'io~ taking oral confraceptives. These preparations contain various 
'. 
. \ 
estrogen and progesterone ana~ogs, which probably are responsible for the hyper-
tension, as well as for other chan~es ~hat are' normally · a~sociated with p~e~an­
cy: such as · elevated plasma Jevels of renin-substrate and ''renin. It has been 
shown in humans that pr~gesterone alone h~s very little ' effect ·on renin-sub-
strate concentration (Newton et al, 1968), but estrogen markedly .increases i~. 
Laragh (1972) , has .. proposed that at extre~ly high· levels of renin-substrate 
' 
there may b&'a failure · or i~adequate suppression -of the s~cretion of renin. 
Solne patients taking e'strogen contraceptives also have· markedly elevat;ed plasma 
renin. activities, and a direct stimulatory effect of>'estrogen on the secr-etion 
. 
of renin has been proposed: It seems likely, therefore, that the estrogen com-
• ' I • 
ponent of oral contrace·ptives DJay be the potent; stimulator of the renin-sub:.. 
strate levels (W~ir et al, ~970). 
... 
'Estrogen, and estrogen-progest~rone combinationsy have been shown to 
' incr~ase cortisol .binding pro.tein, aldosterone binding protein and ~-macro-
, . ' 
,globul:ln .. (l.ayne. et ···al, 1962; Kean et al, 1969; 'Horne et al, 1970.). Since· angie;.. 
tensinogen (renin-subst~ate) ~sin the ~~!~?bulin fracti?n, it . see~ p~ssible ' 
' ' I ~ I 
that the increased concentratio~ of this substrate is associated with ' the ' 
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7. Steroid metabolism and Essential Hypertension: 
' / 
Background to thesis 
There is considerable evidence to support th~ · involvement of the 
adrenal cortex in the etiology of hypertension. Although the association of 
bypertension 'with aldosterone and cortisol in primarY aidosteronism. and 
Cu'shing's syndl;'ome respectively, .is fairly well understood, as discusse~ 
previously, the relationship between al~erat-ions in the peripheral metab'ctlism 
.. 
- ' 
of steroids and benign essential hypert~nsion remains obscure. · ' 
Several. reports have indicat~d that the urinary excretion rate of .a 
variety of steroids may be altered in patients with essential, malignant and 
. 
·t 
renal hypertension. Thus, the urinary excretion of pregnanediol (Vermeulen and · · 
5 . . . 
Vander Straeten, 1963), pregnanetriol and~ -pregnentriol (Vermeulen a~d 
. . ' "' 
I • .. • I 
. . . 
Van _der Straeten, 1963; Nowaczynski ·et al, 1960, 1964);· and dehydroeplandros~-
. . 
erone :sulfate (Nowaczyns~i et ·al, f968; Dey et al, 1972) i~ signif~can.tly 
reduced in essential hypertensi-y.~s as camp_~~~ _normotensive subject_s. By 
·· contras·t, ·the secretion rate of DHEA and DHEA-sulfate is 5 ·and 6 times greater 
-
respectively in hypertensive patien~s (Shao et al, 1970), and the lev~l of ·pro-
gestero~e - in the plasma ·is ·more than doubled (Sasaki et al, -1972, Genest et al, 
1972). /' 
: 
Consideratiop of these findings has led Nowaczynski et al (1968) to 
. ' 
conclude that the differences observed . between the groups of no'~l individuals 
. - . 
. and. hypertensives ·are more pronounced a~ter 17~hydroxylation t~an before~ In : 
the following diagram whi_ch is modified from that of Nowaczynski et al (:1!968) · 
' 
. ' 
and incorporates seyeral other ~orJter' s findings, gives · ~he biosynthetic· and_ :-· : . 
~ . . ·,J .<,' • • • 
metabolic pathways of several adrenal ~teroids ·and the ~rences found in the 
.. ..., I • 
hypertensive patients. . Other workers have also sugges.t'ed that tl)ere may be a 
- . . 
l7Ck-hydr?qlati'on ·defici~ncy _ip t~; adrenai cortex of 'hypertensive pafie~ts 
. . . . •r .. . . . . 
from consideration of the iall ~n tfie hydrocortisone-c9rticosterone ratio ~ich 
' ; ' . • • • ' • I • ' ' • ·: • • 
·was : obse~ed with, !~creasing. _severity of hyp.~rtension · (Cooper .et al, 19S8) ~ · 
' -
• I • ' ' 4, ... . . ,.· 
. . 
. . . . . 




Biglier~ et al (1966) have described a patient w~th 17a-hydroxylation 
deficikncy who produced excess corticosterone and deoxycorticosterone, and 
had hypertension an~ hypokalemic alkalosis. 
The excretion of DHEA-sulfate in tpe urine of .essential hyper-
. tensives has been found to be 'highly pigniffcarttly ~educed from a mean of 
. -
3.32mg/24hr in · the; normal-·subjects, to 0,16tng/24hr in the hypertensives 
... . ·. 
_(Nowaczynski et ·al, 1968). ~ot~ DHEA ~nd DHEA-sulfate ar~reted primarily 
~ . 
. 
by _the adrenal (Baulieu et al, 1965; Wieland, 1965; Weinheimer et .al, 1966; 
. ' . . 
Gandy ·. and Peterson, 1968'; Nieschl~g et al, 1973) an:d ' Sh~o et al- (1970). have 
• 'f 
given the secretion rate of DHEA and DHEA-sulfate~in normal subjects ps 9.8 
. . . . . 
. . 
and ~0.7mg/day ' respectively. Although, DHEA has been isolated from the testis 
in very limited quantity (Neher and Wet:tstein~ 1960; Axelrotft-196~; Gandy .. and 
. . ., . . 
Peterson, 1968), there is ·agreell}ent that' t:he -normal testis d~es not secret~ · .. ' 
DHEA-sulfate (DeMoor and Heyne, 1966; Laatikainen et al, 1971; Nieschlag· et al, 
1973) • Ovarian secretion of DHEA has been sugges_ted (Aakvaag and Fylling, · 1968) 
. . r. 
but' sever~! studies have refuted this clail!i (Kalliala ,et al, 1970; Nl~schlag 
, . 
et al, 1~73) • . DHEA-sulfate may undergo .direct metabolism without cleavage of 
<. j • . • . 
. ! 
the conjugate or indirect metabolism following removal of the sulfate. In the' 
·latter case the two major metabolites are· androsterone and etioeholanolone. 
In addition, DHEA-occupies an unique P9Sition .as a · precursor of other androge~s,· 
. . 4 
since ~t · can undergo transformation into 4 -androstenedione and then to 
• J. 
. . 
testosterone in the testis. Both of these two steroids are further metabolized 
- ' 
to androsterone and etiocholanol'one ~nd their "dials" (Dorfman .and '{!nger, ' 1965). 
~ increased excretion of i:mEA has also be'en found to be · as~ociated 
. . 
. , . ' 
with oliguria and hypertension. (B~s~oe et al,".; 1965), and Sonka et a1 (1965) . -
-----I - . , 
have shown that the total excretion -of DHEA (glu~uronide ~nd sulfate) is 
I r • • •' • 
• -.1 - ' • -
increased in uncomp.iicated. obesity; in CC?.ntrast to obesil:y comp,licated_ by . 
f ' , .. r 
diabetes and· hypeJjtension where it .was. rfopnd 
\ 
. . I . I . t~ be- sh~i-ply de.creased. However .. -
- ' 
- \· .. -· r!" l 
o f \. I I 
:,• I • { 
' o ~ ' • I I ~-.. ~ 0 o ' 
,• . 
. .. ... 
J . , • ' 
. •· . 
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neither DHEA or DHEA-su1fate showed any activity when administered to humans 
by-continuous intravenous infusion (Lipsett et a1, 196~). 
The metaboiism of corticosteroids in essential hyPertension has ' 
been most extensively studied by Kornel and his associates who fractionated 
' ·- ' ·' , . D ~ 
the metabolites into s~v~ral groups (Kernel & Motohashi, 1965; Kernel and · 
_,.! ' I _.,. ,-
< f/' - -- . -- . 
Takeda, 1967; Kornelj et a1, 1969). The fol!owing .statistically significant 
. • / ~ . 
-differences w~r~ ~he nqJ:"mal and essential h~pertens~ve groups: 
(lY-intlle"'!reea;teroid fraction, e:x:cretion of.- cortisol and cortisone was-
" ,, 
higher in hype~tensives~ (2) in the ·glucuronide conjugated fraction, excretion . 
' '· . 
. i ' ' ' ' ' . 
of tetrahydro fcort·isol, tetrahydro cortisone, tetrahydro corticosterone and 
~ .. ' . .. 
10 • I 
tetrahydro-11-dehydro corticosterone was lower in the hypertensivee, (3)·in the 
' . 
sulfate fraction,~ excretion of the most polar steroids, 6a.- and 6e-hydroxy· 
cortisol, was 4iglier in the hypertensi vee. Consideration of. these findings 
I 
that patients with ~ssential ~yPertension, exhibit a I •. led tornel to propose j 
defrct in the steroid ring-A reducfng _enz}rm~ .systems (Kornel et ·al: 1969).. · 
In "this context it is of interest to ~ote that s~'i_Ab et a1 (1970a,b) 
h~' rece~tly demonstrated an increased reduction, of the r.ing-A system of 
l ) ,·. 
·boih cortisol and corticosterone when ·livers from hyp~rtensive ' rats were 
" . ,· ' ' f/ . 
~ncubated in vitro. It has furthermore' been postulated that high b~ood pressure, 
or one or more causative factors, may in some way affect .the enzymatic activ~ty . 
invol_yed in the metabol~c trans-formation of corucostex:oids by the liver • 
' . 
t~ I, ' t 
/ 
' ' 
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'* An outline of stieroid biospthesis· .. and metabolism involved in essential: hyPertension 
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Objectives of thesis 
/. . 
In Niew of reports that the excretion of DHEA~sulfate in the urine 
L of essential hypert~nsive patients· was markedly reduced (Nowaczynski et al, 
. ' 
I I 
1968), ~hereas ~he secretion rate of this compound was considerably elevated 
(Shao et al, ~970~, it was of interest to determine whether this was the 
0 
result of further metabolism. Conceivably these metabolites might have some 
. rot~· 'in, the etiology of the hypertension. The -excretion of the major 
metabolites of DHEA, namely: androsterone and etiocholanolone, are th~refore 
com~ared in the urine of hypertensive and normal subj~cts, together Witb the 
. ' 4 . 
-intermediate compound ~ -androstenedio~e. In addition the spectra of 
metabolites are examined· by._gas chromatography in order to determine whether 
different metabolit~s are excreted by the hypertensive and normal groups. 
The estimation of androsterone ·and etiocholanolone also provides information 
' 
on the relative 5a- .and se-reductases that a~e involved in the metabolism of 
the · c19o2-17~ketoster~ids. The influence of the 11-oxygen function on the 
relative Sa- and 5S-reductase activities is examined by estimating four 
. . 
major c19o3-17-ke~osteroids, name1y 11a-hydroxy and 11-keto androsterone ·~d 
etiocho1anolone. The proportions of the 11-oxy~enated metabolites are also 
compared in order to determine the relative 11-oxygenation activi~ies in the 
two groups. 
The fin~l - section of the ~ thesis compares the influence of the 
~17-cortic~id sfde chain'on the Sa- a~d . ?e•re~uctase e~zyme activities in 
' ' . . . 
the normal and hypertensive groqp~. Conversi~n of these compounds to ~ 
~7~ket~genic steroids allows a further measure of the 11-oxygenation index 
. . 
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' (a) Solvents 
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1. ,. MATERIALS 
A. Source of Materials 
.. ...... .. ....... ..... 




' E~hyl:ene chloride, methylene ch'!oride, n-propanol, benzene, . 
cyclohexane, !so-octane, ethylene glycol~ t-butanol, pyridin~, ethyl acetate, 
I 
toluene, dioxane, diethyl etner, ·acetone, tetrahydrofuran, methyl alcQhol, 




.Chloroform was 'purchased fro~· Canadian Laboratory Supplies, 
,. 
• • • (! 
0 Can·ada; ligro~n, B. P. 35-60 C from Eastman Organic Chemicals , U.S. A. ; 
hexane, sequan~l grade, from · Pierce Chemicals, U.S. A~ ; and dietbylalnine 
'from Aldrich Chemicals, U.S .A. 




Sodium hydroxide, sodium sulfate, sodium acetate, sodium chloride, 
I 
sodium borohydride-, sodium periodate, pota!3~ium hydroxide', m-dinitro.benzene · 
granulated zinc, ·blue tetrazolium, acetic anhydride·, concentrated hydro- , 
chloric and s~lfuric acids, and glacial acetic acid.were purchased from 
Fisher Scientific co., · Canada. 
............ 
I • • 
Picric acid, B.P. ,was obtained from General Chemicals, U.s:A.; 
crea.tinine zinc chlt>ride and tetramethyl a..~onium hydroxide, A~R. from 
' ~ ' . 
·., 
Eastman organic. Che~cals, .u.s.A.; phenylhydrazi~e Hci · fro~ British Drug 
Houses, · Can~aa·; and hexamethyl disilazane, trimethyl chlorosi.l'ane, cliloro-
. • ' .. • ,..... I ' • 
.. ~ethyl d~methyl _chlor.os~lane, ~'DMF-~il-~~ep- 'K:tt_ ~nd_ sili_c~i.zed glass:;/ 
wool fr~ Ap.pli~d Sci~ce, U.S~A. ,_" , . . , .· . · . .. .. /. .. ·· 
' . .. ~ 
0 




. _: ·. ·. ·.·/ 
.... / .<·- - ~ -· ,.. f•t • · - .. ,.,·:· 
. . /. .. . " ' 
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, ., 11 · -
.. '· -~! ,. ':: r' · / : :-:· 
.· 
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. /' . r. Silica ~el, GF 254 and Whatma.n chromatography. papers, number 1, 2 
. ' 
·and 3mm (57 em length) were purchased. from ',C_!inadian Laborat<acy Supp~ies, . 
Canada; silica gel, grade 9~0, 60-200 mesh, from Fisher Scientific. eo., 
Canada; silica gel, 100-200 mesh, from N~triti~nal Bioc~emicals, U.S.A.; 
) ' . 
and Amber1ite XAD~2 r~si~ from ~hm and Haas, u.s.A. 
. 
Gas liquid .. chromatography (GLC) columns (6 '.-U-type, gl'Bss, 4mm 
·O.D., and'l2'- coiled~ glass, 4mm O.D.); GLC column packings precoated with 
3% XE-60; 3%.SE-30, 3% Hi-eff-BBP, 3% QF-1, 1% SE-30 on 100-200,.si1inized 
1-
, 
GCQ;' ·septuuis·, "O"-rings and , hardwares were purchased from _Applied Science, ' · · 
, 0 n,l 
· , \, 
u.s.A. 2% XE~60 on ·100-120 Supelcoport was supplied by Supel~o, U.S.A. · 
Nitt:'ogen, hydrogen and ail:' wer~ obtained from Canadian Liquid Air ·; canada • 
. 
(d) Enzymes . 
• I 
~-glucuronidase (Ketodase, beef liver, 5000 FishmAn units/ml) 
I 
. . 
t " • • 
was purchased from Warner Ch.ilcot~~. U.S.A.; and qlusulase (containing 
100,000 units f3-glucuronidase and 50,000 units sulfatase per ml) f .rom Endo 
Laboratories , U.S. A. · -.-~ 
~ I 
(e) -Steroids .· 
,( 
All . steroids were pur~hased from Sigma Chemical co., u.s.A., 
4 
/except dihyd~otestosterone, se-andr~stan-3~o1-11-one, ~-androstan-Ja-ol-
.. 
· 17-one, 5a-artdrostan-3f3,11f3-diol-17:_bne and 5-andr.osten.;.3a-ol-17-one, which 
~ . (7 • t•' : . • • 
_were' purchased from Steraloids, ·u.s.A.· .; . 
. . I . 
·(f).;· Isotopically labelled steroids and· chemicals 
. / . 4-1~C-p.-Ald:cJ~t-;:one, 30-S.Om.Ci/~; . 4-14c.;dehyd~qepiandropte~;ne, 
, . .. ' 
50mCi/mM; 1,2~3n-efiocholanolone, 30C~; 1,2-3n~A4~androstene-3,17-dione, 
3 . . . . ' .. ' 
50CfmM; .7- lf.:dehydroepiandrosterone ·sulfate, ammonium salt, ·SCi/mM; and 
. ' 3 . . . - ' . ' 
· 1,2- H-tetrahydrocortisone, 20Ci/mM Pwere purchased from N~ _England Nuclear~. · 
3 . 
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. 35 • 
' . 
PPO, P6POP and low potahsium gla,ss counting- vials we.re purchase&t • 
from _Packard instruments.., U •. s. A~ 
" (h) . Special glassware · 
. ~ ' ~ . 
..-.t .). ·- ._.,., : ' 
/Coleman .eel is, ·(round, 
.,...., 
25xl05mm; icm square) ; glass-s_toppered 
tubes (2 ~ 5~) ; ~{ititered .tunnels (~edium) and centrifuge tul:ies, (pyrex, i~m1, 
- ,- ' .. 
. . . . · ~ - . 
conical) were pu~chased from Canadian Laboratoxy Supplies, Canada; and 
. . . 
-silylation tubes, "mini-aktors" (l.Sml) ·, and Hamilton syringe_s from-Applied 
. ' . 
I 
Scie~ce, U.S.A. · .. ": 
·. 
0 
· ) • \ t.' 




r , . . 
Ethylene ·chloride and methylene chloride w~re dist~lled once 
_rejecting the first- and last 10% disti).iate • . -:"Benzene•, cyc1ohexane · a;d · 
. ..,;: ' . 
I ' .-• 
isooctane were distilled twice rejecting 10% of the d~st~llate as above. 
. ;. . : - . ~ . 
.' ' 
Methyl ~lcoh~l, absolu~e and '95% ethy~ alcoh~l 'were'refluxed 
. . 
with 6g granulated zinc and lOg KOH per litre of alcohol for lhr. Each 
was· redistilled . twi~e collecting the mid.dle fraction and discarding the · · -
first and ~ast ~~tillate. 
Pyridine was refluxed over KOH pellets for 6h~ and disti1led 
. r . . . 
three times. _/ . 
· Ethyl ace_tate was washed wi.l=h 2N-sodium carllonat~ · ·solutrio'n and 
. . \,' . . .- . . . ' ' . . ·_: . /. . 
'dr;t.ed over anhydrous sodium sulfate and distilled··oJlce (Sarda ·et al, water, 
~· ... - . 
-. 1968) • . ... 
.. Tetraliyd'ro~uran was re~lu~e~ · ~e~ KOH foi . 24~ -an~ dist.i lied .. ~ '· . . 
~ . . :
• ,_\ 0 
The · distillat~was percola~ed ' through a 'silica · g~l colUdn and ~tored 
, ~ (, - . 
· -in, an.amber bottle ·in a : desiccator: :(France· et al, 1965). ' This sol,;_~nt was 
, • • ' • ~ ~ • - ' ' • I ... , ' 
fres~ly purified.e~ch week • .. ·. ' 
, . ' .. 
,· 
' . 
II • 6 I > 
• · . 
; · . ' 
. ~ . . . . . 
~ . . . :. 
. . ' . . 
•, • •• , W • ·_ • ' • , , 
:• 1 
• . y ,' 
.. , , ... , 
·. •, ~ 
• 
0, : • '', ',, L I ' t, ~.: ~ 
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Chloroform was distilleg f~om anhydrous potassium carbonate 
. . . 
and 1% purified etqyl alcoho~ (v/v) was added., to ·prevent ' the fo~tion· of . 
. . ' 
phosgene during storage 'in an amber bottle. 
. ' • ~' 
Small :volumes ·of diethyl_andne were distilled over KOH pellets 




0 0 (b) ·Reagents 
M-OinitroQenzene was recrystailise(i twice1 from 95% ethyl' .. 
'alcohol, dried and s_tored in an amber bottle. 
··.Phenylhydrazine H~l (lOOg) was diss~lved in 500ml hot absolute 
·e~hyl ·alcohol~ · filte~ed hot . ~hrough Whatman ,No •. i filte~ ; paper· an~ 
. .. 
. • . Q . • 
, · ::::::::e:~ t:c::be~:o:::: \ls wefe washed • with cold ~lcohol ~ dried, 
Picric ac.id w~~ cryst~lis~d~. froni·.~ethyl ··alcohol, dried and ' 
... 
-' 
stored in an amber bottle. 
c 
· Acet~c anhyfiride w~s refluxed ov~r calcium carbide1 for. ,4hrs 
, . 
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2 • METHODOLOGY · 
'-.• . 
•. 1 • . 
. "! 
J 




. . I ' ' 
Urinary creatin+~e. was assayed as d~scribed by' Lambert (1945) and 
,. 
Anker '(1954), The' ~rine kas diluted 1 :l5 . or 1:25 depen,ding .on ,its volup1e! 
I .· . • ' ' / 
Picric .acid .(2ml, f-'1:5~) and so~ium hydroxitie·· (0.15ml, .2.5N) were added to 
one ml of the diluted urine, standards and wate~ blank. The reactants were 
'mixed, and after 20min at ·room temp_erature, diluted to 15ml with water. 
Optical densities ·were read at 520mu with· a Coleinal) Spectropbot.om~ter, Jr. : II. 
~ - . . 
,. 




. A stock sta~~ard, prepared. by dissolv.ing creatinin~ zinc chloride 
. , I /9 I / 
(400.5mg) ·in .HCl (500ml, O.lN) was stored in an ambe~ bottle with -a few .drops 
of chloroform as preservrtive. Working standar4s were prepared by pip~tti~g 
1,1 ,3 and, 4ml of the sto.ck standard . and dilutit:lg each · to 20ml with water. 
. ~ 






1 ' . ' 
, ~ -Standard x Experiment x J?ilution . x .TC(tal Urine '• 
, (mg) · '\co 0. D. · f ac'tor - vol. · ./" 
.
C. reatinine (mg/24hr)a ---------~--=---=--=-~--------.. -- .. ~.· " 
· Standard O.D. . 
-· p 
Urine dilution factor: · 15 for 1:15 dilution 
' ' ' 
•, I • 
• . •• t · 
. . , : . ' ... 








t' ~ •• 
;. ~ .. . ' 
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B. Colorimetric assax of tqtal 17-ketosteroids 
Procedure I 
<?· 
-Total urinary 17-ketosteroids were assayed by a colorimetric . ·" 
.. . 
method as described by Ware (1959). Urin~ (lOml) was hydrolysed in 
f 0 duplicate with c~nc. HCl (3ml) in a boiling water bath at 95 C for 
15 min. ·After ·cooling,' the hydrolysate was extracted w~th ' ethylene . 
. . ' . 
. r 
chloride (l_Oml) and centrifuged (5min' 2000 rpm)... The ethylene chloride 
extract was shaken with 10-12 pellets of sodium hydroxide, centrifuged, 
-,!I 
··and the clear extract (Sml) t~ans~erred to a 15ml centrifuge tube and 
evapora_!:ed • . 
· Zimmerman color chromogens . were developed by ad4ing an alcoholic 
solution of m-dinitrobenzene (0.2ml, 2%-w/v) and freshly -prepared alcoholic 
KqH :(0.2ml, 2.5N) to the dried extracts, standards 'and blank •• The reactants 
. . 
were ~d and alLowed to stand for 30 min ~n the dark. Propanol (~ml, 40%-
. . 
v/v) and methylene chloride (3ml):were added ~o each tube, shaken well and . 
. ' 
centrifuged (5min, 2000 rpm). The optical densities were- read at 520mu. 
. . 
_Fig. 1 gives a typical calibration curye. 
Standards 
. A stock standard was prepared by dissolving.DHEA in absolute 
ethanol (lug/ul). The ,working standards for the calibration curve ~ontained 
5,10,15,20,30 and SOug D~EA. 
Blank 
2%. alcoh~lic so1.utfon of m-dinitrobenzerie (0. 2mi) and . alcoho_li~ 
t<qH (0.2ml) •· 
I . 
. · Calculation 
.· 
. Standard x Experiment x 'l;otal .. Urine 
{mg) 0.1). : vol. 
Total 17-KS (mg/24h~-----------------
·/ . . . . r . Standard O.D. x urine volume extract~d 
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The total ·urinary'l7-hydroxyeorticosteroids w~re estimated by a · 
colorimetric method taken from Sunderman (1960). Duplicate aliquots ·of 
urine (lOml), a water blank (l<hnl:) and <1 standard cor.tisol solution 
. . " . (SOug in lOml) were pipetted into separate measuring cylinders (~SOml, 
glass stoppered), All -eamples· were adjusted to pHS with acetic acid .. 
' . 
(5%-v/v) or NaOH (4%-w/v) as required, and ineubated. with Ketodase (0.2ml) . 
. . ,. . . 
. . 
·and acet.ate buffer (2ml, pHS, . lM) with chloroform (O.lml) ad.ded as pre-
.. ' • l 
servative. 0 , After incubation at 37.C for 24hr, the hydrolysate was extract~d 
with. chloroform (lOOm!) and the extract washed ·with NaOH. (lOml, O.lN) 
'followed by water (lOml)'. , 
. . 
Duplicate aliquot_s (40ml)' of the clear extracts were transferred 
• 11. 




· Standa~d phenyl: 
T~st/lank: 
Tesb phenyl: 
. . l ,~...., - • 
40ml blank ext'ract and Sml alcoholic 'sulfur.ic acid 
40ml blank .extract ·and smi p~nyl hydrazine 
40ml standard extract and 5ml ~lcoholic sulfuric acid 
'40ml 'standard extract and ~ml phenylhydrazine . 
40ml . test extract and Sml alcoholic' sulfuric acid 
. 40ml t~st extract and Sml phenyl hydrazlne . 
.&lc'bholic sulfuric add: :sulfuric· acid (64%-v/v) - absolute -ethanol ·. 
• (10-5 (v/v)) 
Ph~nyl · hydrazine: recrysta~lised phenylhydrazine HCl in absolute -ethanol 
f • f: • " • • 
(lmg/ml) 
· The contents of each tube were mixed · and allowed to · stand ·for 20min. · An 
• ' • • • .. ' • t ~ 
,, ... . 
. . ~ . . 
aliquote (2.5ml) ~~s , t~~nsferred from each tube to.a corre~pondi~gly labelled 
. .. ' ' 
·. 









Coleman· Cell, and after1injubation · for 30min~t 60°C the optical densities 
were read .at 410mU~ 
· Standards ...... 
. - .• f \ 
A stock standar1:.Was prepared by dissolving cortisol.-in absolute ; 
.ethanol (lOOug/ml). · A working s~andard (5ug(ml) was prepared by diluting ~ml 
of the stock standard to -lOOml with water • 
'Blank: lOml w~ter . l .. , 
Calculation: 
Tdtal 17-hydroxycor~~costeroid (mg/24~r) 
,, 
) Total urine '.'• .. 
""-.(=0-=. D=-·--=T=-e_s;...t ':'"P_h-:e:-n-y':""l_) _.:..-::-:-c_o __ •_0
7
• =-T~e~s-t-:::---L~-=-=~:~t-=----·-·_-_v':""ol=---- x 0 • 05 
(O.D. Standard phenyl) (O.D. Sta~dard blank 10 
., 
I I' • ', . , 
D. Colorimetric: assay ·o£, totai 17-ketogenic ste-roids 
. ~ _!.\ ~:, ~, ,~ ' 
! ' 
Procedure · '' '· · 
· 17-ketogenic steroids [~e mea~ur•d in the urine by an assay · 
procedure based on ~he ~.thodSJ}o·f Few . (196i) ;· RJ:i:herford and Nelson (1963) and 
Wilson and Lipsett (1963). u/ine (lOml) was_ taken in duplicate in 50m1 :tubes 
and' tested for the presenc~ :of glucose with ''Clinitest" tablets. 
If glucose .was present, the urine (lomt) was .diiuted to 25ml with 
• 1._ f ' I ~ Cl • f 0 
' . . . " . 
water, ammonium: sulfate _(12 .Sgm) added and the mixture extracted (3 x l'?m_l): 
with eth'anoh·ether (1-3). The combined extracts were evaporated anq dissolved 
itt ::.urea solution (lOml, 0. 2%) ; 
. I 
The·urine -was adjusted to pH7, and reduc~d with sodium botohydride 
.(lml, 10% in (>.lN NaOH). After t~r at ro-om temp~rat.ur~, acetic acid (0,5~~ · 
' " 
25%-v/v) was· added and the frothing checked by addition ·of ether. The pH · 
·was .readj~sted " to 7 after st~~ding 15ndn at room · temp,erature~ and the reaction 
,. . . 
. ,. 
mixture oxidiseq ~ith sodium~eriodate (4ml, 10%) and NaOH (O.Bml, 4%). 
After in~ubation · at .37°C . for lhr, NaOH (0.25ml, 40%) was' ada'ed and . incubation 
continued for a further ismin. The reaction tnixture was cooled,· extracted 
. ' 
with ethylene chloride (LOuti) .and the extrac.t ·washed .sequentially .with 
' 
r 






·H2so4 (2 •. 5ml, 5%-v/v), water (2~5ml), sodium hydrosulfite . (2.5ml,: 5% in · ' 
. 2.5N NaOH) and water (2 x 2.5ml) ~ The extract was dried over anhydrous 
. . _sodium sulfate (lgm)' transferred ' (5ml) to ·a 15ml_ centrifuge tube_' and 
evaporated. The' ~otal 17-ketogenic sterpids were quantitated by the 
Zimmerman Cqlor reaction as described for the total 17-ketosteroids. 




Standard x Experiment x Total urine voL 
_: ·-.. . · .. ·.: (mg) o .. n. 
Total 17-ketogenic steroids (mg/24hr)= 
Stand~rd ·o.D. x voL urine extracted . 
. . 
E.- /Double -isotope derivative assay of· urinary ,aldosterone 
f 
I 
/ A. doub~e isotope derivative assay of aldosterone was developed 
that 
I - · 3 . - . -
involved ~cetylation with H-acetic anhydride of low specif~c activitY-
and a m~difi~d combination of the chromatographic proce_~ures given by 
. - ' 
Kliman and ·P~terson (1960) and Nowac~ynski et. al (1967). The .methodology . 
~as . been ~eported (Dey et al~- 1972). I~ SummarY an acc~rate ~ount ,of 
14 . . -
C-aldosterone was added to the urine and the extracted· steroid was . 
. ; . 3 . . 
acetylated with H-acetic . anhydride • . The rea~tipn product, aldosterone-18·;21-
diacetate, was purified in several chrdmatographic systems until'a constant 
• • ~ " t • • ' • .. • 
3 /14 . . - . . . . 
H C isotopfc ratio .was obtaine4. ·The quantity of aldo~erone was calcu- · 
' . . . . 
; lated from the. final. 3n-count, the percentage recovecy of 14c-, and· the~ 
3 . . 
specifi c activity of the H-acetic ·anhyd~ide. 
•'' 
. ··' •: 
' ' 
(1) Chromatography .system& (all proportion~-are by volum~): . ' . 
· System • I 
(i) Th~n layer: chloroform~acetone (3-2) ' 
(ii) Thin_ layer: · toluene-ethanol (90-10) · -~ 



















. . . 
. ' 
'• , 
.. - •'- ..... _.., ---:-
0 
(iv) Paper: ethyleneglycol/isoocta~e-to~uene (7-3) 16hr 
.(v) Paper: isooctane-t-butanol-water· (5-1-5} 6hr 
., ., ,. . 
(vi) Paper: Benzene-cyclohexane-methanol-water (6-4-2-1) 
... 
6hr 
(vii) Paper: isoo·~tane-benzene-methanol-w-.ater (6-4-8-2} 6hr 
.. 
. (viii)Paper: · .petroleum ether-benzene-methanol-water- (33-17-40.:. 3hr 
. 10) . 
Solv~nt systems (iv), (v) and (vi) were taken from the r~ports of 
42. ~ 
Nowaczynski et al (1967); systems '(ii), (iii) and (vi) from Kliman 'and 
":Pe.terson · (1960) and sys'tem (viii) from Bush (1961) • 
. (2) Chromatography procedures: 
·: 
Extreme prec'autions were . taken du.ring the handling of all 
' chro~tographic systems an~ · chromatograms to avoid radioactive contamination. 
Thin. layer chromatograpy· (TLC): 
Glass plates (20 x 20cm) were toated with silica gel GF254 
(0.25nun thickness) and. ~ried at 110°~ for lhr •. The ·plates ¥er~ washed by · 
ascending chromatography with ether an'd methanol and then reactivated at 
. 0 . 
110 C and s~ored in a desiccator over "Drierite". 
The dried samples were dissolved ·in a few drops of benzene~methanoi 
(1-l:v/v) and carefully transferred to TLC plates with fire-polish~d . . . 
' 
dis'posable glas.s capillary pipettes. , Th~ee subsequent r;nses assured quanti- · 
. ' 
tative transfer. Ascendi~g ~C w~s run at room temperature in paper lined . 
tanks 'after equilibration: with freshly mixed so1v~nts (total' volume 10Dn11'. 
' .. 
· . Steroids were removed from TLC. plate~ by scraping the silica gel into medium 
. . . . 
scintered ' funn~ls ana· then .eluted wit~_ methanol-methylene 'chloride (10-90: 
v/-v) • 
· . 
. Paper·· chromatography~ 
. . 
Whatman papers were. washed by descending chromatography with 
. , . . . . 
methanol .for 4Sh~ and d.ri~d be.fore. use. 
.... ·.~ 
Papers were impregnated .with · 
. . . 
, .. 
I . 
. ethylene g~ycpl m~thanol (1~35) for system (iv)~ · System (iv) was run' on 
•• 
'. ., 
· . . 
_ .. . : • ', I I t , •• I,: 
, 
·-· 





Whatman II?, paper ·and .all other ~ys tems on Whatman Ill paper. Th~ paper 
. ' 
. . 
cht;omat'ograms were develop~d by descending chromatography at 28-32°C and 
the steroids located under u.v. The appropriate zones were cut out, 
attach~d to a hypodermic syringe and eluted with methanol (lOml), 
(3) Radioact-ivity counting and scanning procedure: : 
Ra~ioactivity was. ~ocated .on paper and thin layer plates ·with a 
Packard Radiochromatogram scanner (model 7210). 
3 14 ' H and C were· counted in a Packard · Tri-Carb Liquid Scintillation 
Spectro~~ter (tDPdel 3364) ~kh appropr~ate .double labei settings, Th~ 
I 
counting efficiencies were determined with an automatic external standard 
and quench _correction curves, Counting efficiency for 3n was 38-40.-5%· 
' ' -
(mean 39%) and for 14c, 62-64% .(mean 63%). Co,):'rections -were applied for the 
overlap of counts between 3~ and 14c channels; the ;atio for 3n/~c being 
' 14 /3 0.0015 and· for · C. H, 0. 29. Background counts were . also subtracted .• 
' 14 ' . . (4) Purification of C-d-Aldosterone: ' 
14 '. . . .. ' 
.4- C-d-Aldos~erone was chromatographed in systems (v) and (iii) 
~d then dissolved in· benzene-methanol (1-::l:v/v) to give approximately . 
4QOOcpm/ml prior · to storage at 4°c. The purity was checked periodically in 
the same systems. 




The speci~ic . a~tivity of 3n-acetic anhydrid;-- (SOOmC:L/mM) was· ; 
diluted to approxitnately lmCi/mM with . purified acetic anhydride according to 
; . .. .. . 
t . ' - . , 
the formiJla given by · the . Radiochemical Centre bulletin · (~9~1): W·l;fa· (1/A-~/A) 
·where, ·w(mg) ""weight of carrier compound added~ M · ... molecular weight of 
. . ~ . . . . . . . .. . 
compoti~d, a(~Ci) = total activity in the ampoule,- A(mCi/mM) = JllOlar specific 
activity of tri'e compound .and A(mC~/mM) .. molar ~pecific activ:L·ty of the 
'' " ' ' 
' ' . 
. · . •' . 
' ' ' • I 














The diluted . H-acetic anhydride was· distilied twice 
under reduced pres_sure (10-15mm Hg) and st01;ed under nitrogen at -17°C. 
. 3 
'The specific activity of the diluted H-acetic . anhydride was 
' ' ' . . . 3 . 
· determined by acety.lation of .cortisol. · Purified H-acetic anhydride (SOul) , 
and pyridine ,.. (20ul) were added to 'c .ortisol (200ug) ·and the reagents mixed in 
I . 
a tube that/ was tightly closed with a glass stopper mois~e~ed :with a drop of 
.·pyridine and incubated at room temperature overnight. Following acetylation, 
- ' 
40% ethanol (lml) was added and ·.the mixture extracted with methylene chloride 
. ' 
(Sml) • . The extract was washed with water (2mlf • dried ove.r anhydrous sodium 
' . 
sulfate and evaporated :1J;J: a ro~ary-evapo-mix (Buchler. Instruments). The 
prodJct, .cortisol-21-acetate, w~~ purified ·by chromatog~aphy in systemS (v), . 
• I ~ r '' • 
. (vii) an~iii) and its concentration determined by t~e blue-tetr~z~li.um : 
reaction as described ,'by Kliman and Peterson (1960) and Nowaczynski et al 
(1967.). Briefly, the blank, standards and extracts were treated with blue-
• ) .1 ' ' 
tetrazoiiu~ (O.lml, '50mg/1Gml abs~lute etha~ol) and tetramethyl ammonium 
. / . . 
hydroxide (0. 2ml, ·lO~g/iOml ab.solute ethanol) , and eacl;t. was diluted to 4ml 
with abs~1ute ethanol. After mixing well, 'the reactants were kep·t ·for lhr 
. . . . 
at room temperatur~ 1:n the dark-, and the opticai densities were · measur~d at 
. i 
525mu ~ith a .Unicam spectrophotometer (model SP-500). An aliquot was also 
• I 
. - ; : ·. ' . '3 . . 
taken for counting and the radioac;tivity expressed as dpm H/ug c,ortisoL 
The result was multiplied by 2, since aldosterone fo~ a diacetate and 
) cortisol a _ monacetate, . 
.. 
. ' 
(6} Assay of urinary ·aldosterone 
" (i) Hydrofysis and extraction 
Dupli-cate aliquots (25ml) qf· urine were adjusted to. pHl and an 
. . . . 14 . . . ' . . . . 
known amaurtt of · C~a1dosterone. {approximately 'Z500dpm) was added. 
- • ' ~ ~ 0 • 
accurately 
The urines were incubated at room temperature for Z4hr and the hydrolysates 
. . . / ., 
e~tracted with ~ethylene chloiide (3 x 2vol) ,· The extracts were combin~d and 
' 
I · , 





washed with ice-cold NaOH. (O.lN, 1/lOvol) and water (l;/lOvol) . ' After 
· drying over anhydrous sodium ~ulfate, the extracts were evaporat,ed under 
reduced pressure and the residues transferred with benzene-methanol (1-1) 
I -
into tubes and evap~rated'. 
. ~ 
_, ~-
The dry extract was chromatographed ·in systetn. (i) with aldosterone 
and -cortisol as markers. The area corresponding to algosteron~ was eluted., 
~vaporated in a . rotary-evapo-mix and dried compl~tely in vacuum desiccator. 
(ii) Acetylation 
The dry residue was dissolved in pyridine (20ul) and reacted with 
3 . ) H-acetic anhydride (20ul • ~e tubes. were closed with stoppers moistened 
0 . 
with a drop of pyridine, and incubated at 37 C for 24hr in a -desiccator 
cont~ining cone. H2so4 and solid KOH. Aldosterone-18-21-diacetate (30ug) 
and 40% ethanol (lml) were added to each tube -and the ~-cetates ~xtr·acted 
.. 
' 
with m~thylene chloride (2 x Sml~. The extract was washed with water ·(2 x lml), 
, . 
dried over anhydrous sodium sulfate · and evaporated. 
(iii) Purification of aldosterone diacetate .-
·. 
.. 
. . . 
The aldosterone-18,21-diacetate was purified sequantially by 
chromatography. in systems (iV) ~ (ii), (v) ,! (vi) .and (vil) · . . After the 
~ ' 
final 
. . '· 
chro~tography, the. U..tV band was eluted directly into · a counting vial and · 
evaporated. A distilled· water blank (25ml) was include'd with each gro~p of 
10 samples. and carried through the complete procedure. 
j. . 
f' ' 
• (iv) Measurement of radioactivity 
The dry residue was dissolved in lOml ~oluene based· scintillator 
~ . ' . . 
(4gm PPO and lOOmg l'OPOP/liter toluene) and counted· with the appr'opriate d~tlble 
label settings. . The count~ng efficiencies were determined as desc-ribe·c'i. above . 
' . 
• I ~' 
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ng aldost~rone/25~1 urine . , 
3 a . . • 
. H cpm x . % Efficiency x % 14 / . C Recover'y 
=·--------------------~------~· --\~---· 
activity of 3H-acetic anh)4ride . · -:specific 
'1, · -
/ 
. ' · 
. ' 
Corre~t~d ng., aldost~rone/25ml urine · '· 
' ' . 
. ' 
• . . 
/ 46. / 
. . . " 14 . . 
• · (ng ald~~t-erone/25~ urine) (ng C-aldosterone + water blarik) 
•ug aldosterone/25hr urine 
Corrected ng. aldosterone/25m! urine x total urine vol. 
# - ""'\ • • 
= --------~------------------------------------~ 
· I 
1000 X 25 
(v) Assessment . of methodology 
(a) Precision and reproducibility 
The precision ·and reproducibility pf·. the methodology were, 
. 
determinied by 'several estimations of aldo.sterone in the· urine of two -normai · 
subjects. 9ne urine assayed six times gave.· a mean of 14.3 :t 0.'35 .(S.D.) ug 
. . 
·aldosterone/24hr (coeffi.cient of var~ation (CV) 2.6%. The second urine, 
'assayed ' n:l.ne times, gave a mean of 9.33 ± 0.45 (S.D.) ug aldoster0It'e/24hr 
(C. V. 5. 2%) • ': . 
(b) ·Specificity 
The specificity· of · th~· method was assessed by .determining the 
. . 
,' 
I .... , 
., .... 
: . 
•' . 3 14 . ' . . . . . H/ . C rat:l.o after each chromatography unt_il a constant ratio was ootained. -
.One urine _ gave the 'rat.ios l.lt 0.51, _0.38, ·0.35, 0.34 and ·a.34' ,;ln systems 
- p 
(1), (iv), . (H), (v) ,· (vi) and (vii) respe.ctively.- · A further chrottlatography , 
. ' . , . . 
in system (viii) did not alter •'the rat:l.o Qf ··o.34. Since a constant 3nl4c 
• • 1 • 
ratio was obtained after system ('!), samples were ·routinei! chromatographed 
in sys,t.em8 . (1)' (iv)' (ii), (v) and (v:l.). 
" 
' . ,, 
' . .. 
. . ' 
· ..•.. f • 
. , ' . ' 
. · t . • 
', 'I f 
' . '. 
•• ~ l . ,, 
• I 
, _. ' 
.. !i . . 
·.~ . . 0., 
'I o ' 
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. . · ' 
... ' ·.~ . . . ' 
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- ~~~ · · Aldos.~ero9e (0. 2 2~0ug) was' added to water (SOml) and to urine 
' ·~ . -
o' 
· (50ml) from an ~~renalect~mised patient. l'he'·samples were assayed · as. · • 
·.. ~ . . . . . 
. . ~- /- . 
· described above, an~ .. the recovery of aldosterone ~s . gi yen in Table 1• The · 
. . ·.. , - ~ 
mean recovery ·from "b~d1· .. water and urine was 10+. 2% . The mean recovery of 
' ·.. . . ' . 
14
c-d-aldosterone ·in 123 ~ir.ines from .notmal and hypertensive subjects was 
9.3% ± 1. 81 (S.p. )_. 
(d) . Sensitivity '--·-·········· -- -- -- .. 
>, 
Aldosterone equivalents obtained with · the non-specif:tc· water 
, ' ( ' ' . 
b1ank aqd urine fr_om an adrenalectomised patient were n9t · significant~y 
different·. The water-blank gave a value of ·14.0ng/25m1,' (n .. l7, ra~ge . 8-25ng) . 
·and the urine, from the adrenal~ctom~s~d patient i2 . 5ng/25ml compa.red ~~th a . 
range of 183-472ng/25ml urine for normal subje~ts. The valu~s o~tained f<,>r 
the water blank and t~e adrenalectomised paden t '~- urine represent the l ower 
. \ r J 
limit of set1sltivity _of· the method. 
" F. GLC . Methodology. 
) . • 
(1) . Equipment 
,.;.GLC was carried out on a~ Hewlett Packard High efficiency. Dual 
r , , . . 
column gas chromatograph : (1nodel ~02), e~uipped w.ith two ~y.drogen fl_ame 
.;_, 
ionization detectors ·and ·a Hewlett' Packard strip chart record~r (10","' 
- . ' 
model 71271). · U-shap'ed (6' x 4mm) glass columits were . packed with 100/120 
. ' - - 0 ' • .. . • ' . ~ ' • ' • 
GCQ precoated with the liquid . p~~ 3~ OV:-1," 3% SE-30; 3% ·XE- 60, 2% XE- 60 ' . - · 
• • J -
and '3% Hi-eff~ _SBP .' Acoi~ed (12', x 4mm) foass · column wa~ ~acked ~ith • 
• I ". , . ·• • ' ../1-,: , • • ' • J • , 
1% SE-30 on' 100/1:20 .~CQ. The column supports and J~sswoo~ were all 
' . 
s ili.nized'. . 
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TABLE 1 , 
. l ,· . .. 
' . 
. Recovery "of aldosterone from.water and urine . in the double isoto~e 
.. 
) . derivative, assay 
. .. 
1 Sample Aldosterone added 
(ug) 
Aldosterone % Recovery 
· recoyered · ·(ug) . ' ' ~ -
• 
0.2 0~211 105.5 
"' 0.5 o.sog' ~OL7 · 
Water ~ 1.0 0.981 98.1 




.. Mean 101.2 
0.198 99~0 
o:s 0.510 102.0 
1.011 I ; 1~_1, 1 
"· 
Adrertalecto~sed 1.0' 
patient's urine' 2.0 2.051 102.6 
;Mean ' 101.2 
. ' 
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(2) · Conditions for GLC 
. · All packed co~unms were conditioned with the. detector det~.ched, · 
.. . .. . . 
with' a 
'{, . ' ,, ... \. 
, . . . 0 ' 
w thout a carr:$r gas flow, ·arid then at 23Q C fo(r , 48-72hr 
. . ~ )· 
!· ""' flaw. · Before running th~ ~-~amples, the columnf! were . 
.. 
primed with a mixture of t}W . TMS~ derivatives of/the c~mp6unds under study. 
. . } . 
·.The running conditions for each stationary phase is given in Table 2. 
, . i 
' Purity of £teroid standards . . · 
··. 
The a~t.hentici.ty ·of steroid· standards w~re checked . by comp~r~~g 
' 
""" 
melting points' and .chromatograp~ic PTOperties (T~C- and GLC) with the 
·literature values . (.Table 3)-. 
- . (4) Internal standard and relative retention time . •. 
' 
The retent~on time .of a' co~pound on a gas chromategram is determined 
. I 
by the distanc~ of the apex of . . from the point of ' injection·. 
I 




· Sih.c~ th~s value is subject to variation with fluctuations in • 
~... . . , .. ' , .. ' . . .. _·. 
running condition, ~he GLC. data may be expressed more mean~ngfully in 
I 








RT (em) of compound 
RRT= ------~------~------~----
RT. (cm) .of internal stapd~rd 
, -. 
The intern~! standard · chos~n sho~ld ideally have a retention time closely 
related ·to the compound(s) under study, but adequately separated to allow· 
·quantitation· of the co1npound(s). 
• " I 
I 
is commonly used, 
although otli.er methods . of ·characterizat:l:on of compounds on GLC, such as . 
.. . . ' . 
. - . 
• s~·roid nu~~and , methylene uni~~, li~ve ·~ls·o· ·b.e~n w~dely·, used· (Wot~z ·_and 
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· ~ . 
. .. 
· . · ;Table 2 
Running conditions for GLC under ·isothermal operation (6' U ~haped columns) ' 
I • 
Conditions 
Oven ·0 temp. · ( C) 
. . 0 
Flash heater ·( C) 
'Detector (oC) 
' 
. · ~it.rogen (ml/min) 
. ·. Hydrogen (ml/tnin) 
Air · (ml. min) 
I ... 
StationarY. Phases-
* 3% XE-60 3% Hi-eff~ · 3% SE-30 3% OV-1 2% XE~60 1% SE-30 
. 8~P 
.$' 
210 240 220 220 200 200 
240 260 240 250 240 240 
240' 260 . . -~ 2~0 25Q 240 240 
I . .. 
40 40 ·so 50 ·so 50 




300 300 300 300 
.. Chart .(inch/min) 0.25. .0.25 ·0.25 · o·.25 0.25 0~25 
.. 
* . 12 1 -c9i-led column. ' ~ · 
. . 
': . . . ' 
., 
.. 
. ·, . ' 
. 
. . ' 
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'"' M1> (oC) · . , ** . Compound GLC RRT TLC Rf. 
6 
\ •' Found Lit.· Found Lit". 
. . 
~~ . ) . 
L Androsterone . · 182-185 . 0.61 b.60 . · 0.61 .0.63 ~ -
w ' 
-2. · Etiocho1ano1one '. 152-155 a·. 11· 0.71 0.55 0.53. 
. 3. DHEA 150-151 0~'83 0.84 ' 0.63 0.60 
·.-.""! 
" . '4 ~ ·11-keto androsterone 155-158 --- t' 1.32 1.26 0.44. 0.40 
, . 
' 
( '·5. ,11-keto ed.ocholar101one · 189-190 . 1.53 1.47-. 0.35 0.33 . 
I • 
~ 
6. 1W-hyd roxy and,ros.terone 200-201 1. 78 1'.73 0.37 0.39 -.. 
. . 
234-237 7 •·. 1113.:.hydroxyetiocho1an- Q.19 2.12 0.31 0.34 
. _ ' 
o1one 
·! 
' . ' 
I· 
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(5) Derivative forma·tion ....... . 
. .· 
\ 
Urinary e~tracts and standacd steroids were taken in silylati~n 
tubes 'C'mi~ia''Ktor") and thoroughly dried .in a desicca~o~ be.fo.(,~. adding tl{J. ,-
,. 
following rea~nts. 
. ' . 
Trimethyl silyle~her (TMSE) 
_ The ll~deoxy-17-KS . were reacted with pyrid~ne (0.75ml); hexamethyl-
. . 
d:f:.silazane (0. 2ml) and t~rimethylchlorosilane (10-15 drops). The ·117-oxy-17-KS 
and 17-k~togenic s .teroids were, reacted with "DMF-sil-Pre.p" (0. 2ml). All 
reacti.~nr:rw~re carri~d .out overnight ·at room-temperature, and then the 
. · ' 
· · . reactants were evapora~ed under a stream of nitrogen in a heating block at 
40°C. The· dried. react·ion products w~re dissolved in te'trahydr~furan (Q.lm1) , . 
-. 
.. . . 
centrifug¢d and 1. Sul injected into the gas c~romatograph;· ; 
' • . 
'(6). Identifica-tion of GLC peaks ·from urine 
' 
.· Sey~al steroid peaks were observed in the GLC chromatogt~ms of . 
- --·:--' ... / 
. . . 
urinary extracts frou,i. normal and hypertensive subJects. The identity-of each 
' ' 
0 
. ' . 
peak was established by comparing ·the relative ret~ntion time with a k~~wn 
•. ' 
standard (Table 4). ·on two .. d:tfferent GLC. phases. I~ addition, further 
. . . ~ : 
evidence of identity was ol?tained b.y admixing the .. kriown standard steroid 
With the urinary•· extracts' and observing an increase in the- peak area and 
. ' . 





(7) guantitation of GLC peaks (' !·, ·,. . . 
A progres~io~ curve was prepared ' with the _TMSE deriva;~~;s ·of 
· authentic steroids under study at con~:ntrations appi~ximati~g as closely 
The peak a~~a . ~;~ \c .... alculated from p~ak ' . . as possible thos,e of the s~tttples. 
.. - ~ 
height~x width ~t hal{height, and the concentrat!ioi:l"'of\each steroid ' was ' 
,. / ' . . . \ 
~hen· ~ead d~y from .t~e ·pr~~re~sion curve. The 
was ad.apt~d: from the re~o-rts of C~w~ey et al, .1967, 
" 7. . and Goldzither, ,l97~). 
"I 
' \ -follo~ing cal~ulati~n 















Table 4 .._. 
. I 
R~lative retention times of standard"17-ketosteroids and urinary steroids after-ad4ition of authentic 
standards 
- Normal. subjec~s .· Hypertensive subject s , . 
. Standard Steroids 2% XE-60 3% Rl-eff-8Bi 2% XE-60 3% H±-eff-8BP 
Std. Uri.ne Urine Std. Urine Urine Urine Urine Urine Urine 
·+ .. + + + ' ~ 
"I Std. Std. Std. Std: 
* ' Androsterone 0.60 0.6~ 0.60 0.56 ·o.56 0.56 0.6Q 0.6.0 0.57 0.57 
* 
; . 
·0. 71·. o:12 o. 76 o·. 7L.-<h 12 
-~ ..... 
Etiocholano1one 0. 72 Q.76 0.76 0.76 0.76 
. . >- ... 
..-----: 
' ------- ' nehydro~pia~d~terone* o.84 0.84 0.84 : 0,90 0.90 ~90 0.85 0.85 0.90 .0.90 
* 
. . ,_ ' · .. ' 
11-ketoandrosterone 1.32 1.33 1.32 "1.29 1.29 1.29 . 1.33 1.33 1.29 1.30 
. 
* \ ·~ · ~1-ketoet~ocholapolone 1~55 1.54 . 1.55 1. 70 1.69 1.69 < 1.54 L54 "1.68 1.68 
* 
-:-"\ 




* i.62 . lla-hydroxy etiocholanolone 2.19. 2.20 2.20 2.61 2.61 ~~62 2.20 2.20 2.65 
·. ' ' -£1 




Androstenedione Q •. 65 0.65 0.65 ( . 0:66 0.66 o:66-. 0.65 0.65 0'.65 . 0 .•. 65 
* Dihydrotestosterone as ·rntern.al ** standard; Testosterone aeetate as internal standara 
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1000 - . . 
s = ug steroid calcul_ated. from 'peak area an4 progression curve 
F = vol .of sample TMSE (ul) 
vol injected ( ul) 
100 ' 
R = ----------------------~·~· 
. % recovery of radioactivity 
' .· 
G. GLC estimation of 11-deoxy-17':"ketosteroids'· (c19o2-KS) 
. . . 
~ . 
The' conjugated 11-deo'Xy-17-:-ketosteroids in the' urine we~e 
J . . 
determined by GLC of their TMSE de~.ivatives on 3% XE - 60, and involved a 
modification of the methods of Rive'ra et al _(1967,), ru.v'arola .and oMigeon (1~66) 
. . 
and Bardin . ana Lipsett (1967). 
(1) ·Purification of .iab~lled steroids 
. 3 . . 14 b . 
_'1,2- H-etiocholano1one and 4- .C-DHEA .were purified y paper 
. . 
. chroniato_graphy in tlie syste~ · ligro:in-methanol-watet' (100.:.96-4:v/v/v) 
. . 
. ' . . 
-·followed by 'TLC. in the system to:iue~e~methano_l (97-? :v/v). · The purif).ed 
. . . ~ 
compounds were dissolved iri . benzene-methanol (1-1) to give a solution. 
. . - ' . . 14 . 4.. ' 3 . 
approximately 5000cpm of C-DHEA and to 15000cpm of l{-etiocholanolone 
. . .. ~ . 




(2) . Ketoda urine ~- ~ 
. ' / . 
o · Duplicate aliquots (1/20) · of 24~r ~rines. a~~ of a water .blank _were 
treated .with 1ml o'f 14c-DHEA (500_0~pm) and' '"H-:-et:iochola~olone (lSOOOcpm)and - ~-
,.~ ... 
~he pH adjusted to 5. Acetate .buffer ·. (5ml,' pHS, 2M) a:nd I<etodase (800 units/ml) . -
' ' 
- . . 0 / . ' 
were added, and· the mixture incubated at 37 C for· 24hr. The hydrolysate was 
. ' ~ 
extracted with methylene ch~oride (3 x .equal vol), and the combined -organic 
·' . 
· · phase ~ashe~ with NaOH\ (2 ~ 1/lOvol:, -_ lN) . followed by - ~ater (3 x 1/10 'Vol). · . 
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. 
The alkaline and aqueous phas~s were combined and sa"'led for solvolysis, and o(P' 
. ' ' 
the cl~an extract dried over anhydrous sodium sulfate and evaporated under 
~· 
re'duced pressure!" This fraction contai.ned the steroids liberated from the 
. glucuronide co~jugates. · 
(3) Solvolysis 
Sulfate conjugates were ·aolvolysed by the method of Burstein and 
. l 
Lieberman (1958). The pH of the combined aqueous phas~ ·was ~djusted to 1 
wi ~h H2SO4 (20% ~ v /v) after addition of. sodiu~. chloride (20gm/100ml) , and to 
. u 3 . . . 
. each .was added . C-DHEA (SOOOcpm)_ and · H-etiocholano1one (15000cpm) •. After . 
extraction with ethyl acetate. (3 -x, ~o1) ,.·the co~b:i.ned extract was incubated 
\' ~t 37°C -for . 24hr ,' the solvolysate concentrated under pressure, 'and washed 
with NaOHt (3 x 1/lOv.ol, lN) and water (3 x 1/10vol). The -' aqueous phases 
' 
we~e , pooled. and extracted ' once ~ith ethyl, ac~tate, and the extract washed 
- . 
with water (2 x 1/lOvol)~ The combined .extract was dried over anhydrous · 
'sodium sulfate and ~vaporated under reduced pressure to give the sulfate 
conjugate "fract,ion • 
. (4) · ~f~ct ·of K~todase hy;Cirolysis on . DREA-su~fat~· 
The .possibility that hydrolysis of DHEA-sulfate mdght .occur during· 
. . 
incubation ··with Ketodase, was invest~gated. 3 . ·. H-DHEA-s~lfate was added to 
triplica~e aliqu·o'ts of urine, the urine extract~d with methylene chloride 
(2 x equal · vol) and the extrac,t washed with water (2 ·x 1/lOvol), dried ov~r 
. . 
anhy~_ro~odiu~ sul~at.~' and evaporat~d. 
sequentially hydrolysed with ~etodase and 
The combined aqueous pha~e wa~ 
solvolysed in the usual manner~ ' 
Aiiquots of the corresponding hydrolysed fractions were counted • . Only a -
. . 
small frac~ion (4.9%) ~f DHEA-sulfate ~as hydrolysed hy Ketoda~.;,...the res~lts 
. . . ' 
~~£ . the hy~r~l~se.s 'were therefore ~ot · co~~ec~e~ .f~:~ thii~uant~ty~ The . recovery 
of .radioactivity in each fraction is given in 'l'able 5.1 -
·j v 
r .,.., 
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''(5) Silica gel chromatography 
,. ., 
·7· The glucu~onide and sulfate fractions were purified and resolved 
further on silica gel (60-200mesh, lgm). The silica gel was slurried in 
,, 
benzene and packe~ in glass col~mns (20 x 0.4cm)! Dri~d extracts were 
applied in a few drops. of benzene. Table 6 gives the ~lution sequence and 
. 14 . 3 . . 
recovery of C-DHEA and H-etiocholartolone after silica gel chromatography •.. · 
I . 
. These labelled steroids were added to all urine~' as tracer markers, and the 
second silica gel fraction was taken fo.r GLC analysis of . the 11-deoxy-17_::-
ketosteroids. 
(6) GLC estimation of androsterone, etiocholanolone and DHEA. 
. . \ . . 
Androsterone, etiocholanolone and 1DHEA in the glucuronide and 
sulfate fractions were · resolved as their TMSE derivfitives on a 3% XE-60 · 
· col~mn. · The relative r~tention times with r~spec;t to the inter~~! standard, 
> 
choiesterol. TMSE were/ 0.33, 0.38 and 0.45 respectively. · . 
- , • t' 
Fig. 2 illustrhtes the resolution of the TMSE derivatives of 
- J \ 
. J'\ '• I ., ' 
stand~rd androstero1e; tiochola~oione, DHEA and cholesterol on 3% X~~60, 
. • • . \ ~- I 
· and ~~g. 3 ~he . pr~g\~ sian . \urves. for each: compo'll;nd in t~e range 0-2ug. 
Further chromatograp a 3% Hi-eff-8BP cqlumn indicated the absence of 
impur·i ties. 
14 . h . 3 . !. . d ' The recovery of C~DH~A and H-etiocho1anolone was etermined 
for · each experiment· bY. counting !! suitable ali<tuot before gas chromatography •. ·. 
i4 . . .. j . . . 
Table 7 gives the overall mean recovery of c-DHEA and H-etiocholanolone 
-
in the sul~ate /a~d glucuronide-fract i ons from 37 urines. Since labelled 
· . androsterone 'was not available commerdal·ly<, its recovery wa.s estimated 
. . . 
. 3 . . 14 .. . . 
from the ftVerage r~covery of H-etiocg~lanolone and C-DHEA in e~ch ·sample. 




' ' ... 
'. ·Table 5 





· FJ:'action ~ean :Range 
~ 
Free 12 •. 1 11.5-13.3 
' ' 
0 . ;. 
•v' Ketodase 4.9 4;8:-5.1 
'-
. ' 
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Table 6 - j :· . 
,_ 
. 3 . . . 14 -
Elution ·.and recovery of H-etiocho1ano1one and . C-DHEA on · 
. ·;-· i· }'/ . 
~ilica gel chromatog~aphy 
Jr 
Solvent , .~ -
~ 
; . 0 
(i) 10% ethyl acetate 
· in benzene 
(ii) 15% ethyl acetafe 
-in benzene 
(iii) 15% ~thyl acetate 
.. in benz~ne 
*' 
- Fraction collected 
. .. 
'• ' 
} . ' 
. . . . 
.. -
,. 
... . . .. · .. ·. 
.I ~ 
. . , 
. _, 








1 _(l~ml) 0.3 0-0.3 -
2 (25m1)93'. 7 * 90-95 
' j (10ml)0.55 0.4-0.6 
'~ 
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nine' times for DHEA ·and :tiocho}"anolono/·~n the sulfat.i., _and glucuronide 
. '. ! 
fract.i'ons. Table 8 giv~s the standard deviation atitl coeffic::f,ent· ~f variati~_n 
for these estimations, 
'(7) GLC estimation of 4-imdrostene-3 ,17-dione 
(i) · Purifi~tion 9~ i ~ 2-3H-androsten.eCi~~me 
. l : 3 . . . 1\ - ' : •· _)1~2- H-androstenedione wa! purified by paper chromatogfaphy in the 
J . -
· sy_stem hex~me-metlianol-water (100-~0-lO. :v/v/v), fol_low~d by' the thin. layer 
. ;• 
system benzene-e~byl acetate (60-40%v!v) • . The purified co~pound was dissolved 
in benzene-methanol (1-1) and diluted .. to· approximately 5000cpm/ml. 
j) 
(ii) Estimation-of androstenedione 
<!I ' 
I• • 
An aliquot of a 24hr .urine ' (200ml) was extracted with diethyl · 
e.ther-chloroforni· (3 x equal .vol~ J;..l .. :v/v).: The com~ined extract was conce~tr~ted 
• D "' ; • • ,. 
, ·under reduced ·p~~s~ure and ~ashkd ·with ~aOH ({x .1/l~ol, lN) and water 
' . . 
(3 x 1/lOvol)_ ~o .give a clean _extract :that was dried· over anhydrous sodium .. 
• 4 
. : sulf~te and , evap?':~t~d • . Th'e r_e~idti,. was ~urifi~d consecutively by -p~per 
" • • • " • > • - • • • • 
chromatography iQ the .system hexane;..~ethanol-wat~~ (100-90-lO:y/v/v), followed 
..... . . . . . . 
. ,. ' ,. . 
:· · by 'FLC in sy'atems benzene-methanol (85-ts :v/v) and benze~e-ethyl acetate 
~ . -
(60-40:v/v). 
. . 4' -. . . ' . 
. The area corresponding to A -~~as eluted from the 
0 " . • . • l . ;. . . 
chroma~o'gram,,· dried th9roughly' . dissolved . in tetrahyd~ofuran 
final ; 
, t I 
(~5ul) ~apd. an~· .. · ' . . 
aliquot taken to determine the recoverY of radio~c~ivity~ Fig. 4 ·give~ 'the 
• -gas . 'chromatogram of standard andr-ostenedione on 3% SE-30. Ftl{ther ch~oma-
' ' .· t~graphy .On ~% 0V'-1 COnfirme~ the, purity of the c_ci'mpound. The CC?nce-p_tratio~ 
of ';-t~r~id in each peak was calculated from a pr~gr~ssion_ ~u~e (0._05-lug) .. \ 
,. 
of standard androstenedione (Fi~ 3). A4-A had an RRT o£.0.64 ~th respect / . 
..., .. . 
to the interna~ _ standard testoste~one &~etate. ,T9~ mean overall recovery· of 
.3 . ·. . . , . F : . . . . 
H-and~os tenedione in the urine· was 5S. 6%. -~ . . ; " •.~ . ~ , . . ·. 
f 
. . ' I 
. . 
. ::;~ .~ 
. ' : 
' : . 
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% O-lean). ··Recovery. of radioactivit:y: 
** .A 3H-E · l 4c.,.DHEA· 
T • 
.. Sulfate , '57 .o 57.5 56.5 
.. 
Glucuronide . 58.9 58.6 5Q .• 3 
* ~ 17 normal and . 20 ~ypertensive .s~bjects 
** . . . 3 . 14 . 
. Est~mated from·mean recovery of . H-E .and c-~HEA 
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:Reproducibility of the GLC estim&tion of er.iocholanolon~ . and-.pH_EA · · 
' * in· a repr~sentat!ve urine .• 
II 
. ,, 
DHEA (lllg/24hr) Et'iocholanor'one. (~g/24h1:·) 
Sulfate 
, 
Glucuronide Sulfate · 
f \ .• • • • 
.. - . Gl_u~·u~tii~e 
' \ 
......_ . 
·~·-;: . ' 
.t . ' .1. ~-2 ~O? .2.0 
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' l ~ 
- A spect~um of urinary 11-deoxy and 11-oxygenated 17-ketosteroias ~ .. 
• - ~ 0 . 
~ .was resolved by GLC of -their TMSE derivatives ,pn. 2% .xE-60 ·with a procedure 
: ,------- . . 














Goldzieher (1971) • .. 
,; • I 
(1) Purification of labelled steroids 
, . 
• · r · 14 ~~ ' · · ~ 
. Th~ purif'icat:Con of · ~ . C-DHEA w~s ·carried out as previqur1y: 
. . 3 . . . ' . . . \ 
described. ,l,2- H~tetr~hydroco~l was purified by paper chro~tography 
. ,~· . . . . . . . ' ' 
in . the systems.benzerte~hexa~~ (1-l:v/v)-formamide and benzene-methanol-
water (4-2-l:v/v) and then oissolved in ethanol to · giv~ approximately 
.¥ .. 
. .~ . '\ 
10, OOO~pmhnl. 
. . 3 . . . . 
'reparation of . H-llf3-hydroxy-etio~holanolo'ne (2) 
... 
. S~nce label~d 11J3-hydroxy-etiochola~olon.e was not . available. 
-- . - - - 3 . . . . . 
oommerically, it .was synthesi'sed from 1,2- H-tetra}lydrocortisoL. Tetrahydro-
• f ' I t ; ' 
.. 3 . . 
cort'isol (200~~) was -mixed W'ith H-tetrahydrocortisol (30Ci/mM) and oxidj.sed 
~ - . q , " 
. with periodic acid a~ d~scrib~d by B~sh (196~)~ Briefly, the steroid ~as 
.. t . < 
·· dissolved in me~hanol (O.Sml). and "reacted with perioai;c acid solution · , 
11 
~5ml, 4gm/100ml o( o. 2N ~2~~4 ). . The reactants were incubated in the dark at 
.lfoo~ .tempe~~ture for lBhr, and t;:he produ~.t "~xtra.cted w.ith eth~nol (i' x 'Zml) 
aft·e~ the. addfd.o.n ~f cone. · a~6ni,um hydroxide ~.-lml). :: 'i'he su~etnatant · . ' 
' I ' ' - , J I ... ' 
• . , . I ' .. . • • ' - . t , · • • .. 
obtained by· centrifugation w~s evaporated and pur~fied in ~everal . chromato~ 
. . . . . . !. 
. . . 1. , . ........ 
graphic systems as indicated· d.n ·Table 9· •. ·TLC plates were develQped in system 
If) : •' • • . . • . • .. .. . ' •, ' 
•' 
(a) and after <;Irying, re-r.ut'l •in ' th~ - s~me direc'tion 'i~ - sy~tem (b). Staridard ·a· 
~ 
~ ~ . . .. . 
llf37hydroxy etiocholanolone and tetrahydrocortisol were also run as markers 
' • I • p • • • ' ' , ' I ' • , ' # " ' .' ~ J • • 
- ~d ~isua~is~d with iodin~ · vapo~r, ~nd · t~e ~orr~sponding. llf3~hydroxy . 
• • - ' ' 
1 
• • • t till • , , . I 
etiocholar:tolone J:>and was furt'he~ · p·urif ied in syste~pS ·{c.;.:e)'. a fter remova l 
) .. ' . 
. •. 
' , .~ ~ • I 
.. 
" I 
. . . 
~ 
'. ~ .. 
• l 
C-9 .. ··-~ 
. - . 
; ' 1 ., . 
I 
'I 
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, . 
·from th~1 ~C-p1a'tes. e concentration a:!;. the pr·oa~ct. wa.s .. de;ei-mii).e~;by 
· .the Zimm~rman reaction· a·· previous!; d~s~ribed for. the co1o~imetr~~~ ~sti~tion ~ 
of total 17-ketosteroids an ·ali'quot wc:rB coun~ed for radioact~yi ty. The 
r 
specific act:!-vity of. the product was lO,OlOdpm/n~>'· · o&. 
·(3) Amherlite XAD-2 :resi 
. . 
· Amberlite XAD-2. {lOgm)' was washed _three t:l,mes with distill~d· 
water until the an chloride ions were removed. The resin 4 • • 
Was packed as a slurr'y in glass col, mns (150 X 9mm) to give · a flo~ rate 'of 
~ . . . 
. . . . -- - 14 . . 3 , . 
3-4~/min-. One 'ml of· C-DHEA (SOOOc ni) , H-1113-hydroxy etiocholanolone 
. . . ,. . . . . . 
. . J '3 . ' .. 
· ... (SO~.Ocpm) and H-THF. (10 ,OOOcpm) stand rd so1uq.ons· were combined and 
· concentra~.[d ~efore · addition to an a~iq ·.;/""uri':'~ (16ml), . . ~\~~~~~~ 'was 
percolated through the Amberlite .resin, shed, ~ith water (50ml) ·ana ~e 
, . .. 
steroid conjugate fiact.i.op eluted with me hano~ (50ml) 'and evaporate(\. under : 
1:. ' - :· 16 
reduced pressur~. T~b1e 10 giv.es the elution seq1:1ence and r~covery of 
' r "":J, 
radioactivity. · .· 
. i 
.(4_); H)T.drolysis ·of urine 
. . ... . • l 
• The methanol eluate from the Anihl'!rl;i_te col~mn was _.ev~porated and 
th~ · resid~e dissol~~} in acetat.e buf.f'er (lSml, ~H~, 2M) and hydrolysed wit~ 
. 
g~usu:\;ase .(,!).ltta/lOm.l urine) for 48hr at 37°C. The hydrolysate ~as extracted 
. . 
with methylene chlor.ide. (3. :>e~equal. val) and the Gombined extracts washed. with 
.; ~ . - . . • .. ~...-~l 
\llaOH (1 x 1/!0v~l, .O.'!N) -and ~at'er (2 x 1-/lOvo;L). Th,eltext;act. wa~ d~fed .over 
\ ' 
anhydrous s·odium ·sulf.ate an''d evapora.ted under -reduced pressure. 
. " ' 
(5) -. ~ilica gel 'chromatography , j • • 
.. 
· . . Silica gel (2g, 100-200m~sh) was slurried' in 20% etliyl acetate in 
. . . . . . 
. . . 
ligroin and 'packed i~ giass columns (18'~ 0.7~m). -The dr~ residue·r:om the 
hydro'lysate extraa>t was applied to the- column in a few drops of· the same · 
.. • I ~ ' ' . ' 
· solvent. ~nd elutipri car~ied ·out as giv:en in .Table 11. .'The mean rec<>Veries 
I 
\ 
. . ; ... · ('Ql ' ' . 
( .. 
. ~. , 
.  ' . ' 
. -~ 
. . I' 
,p-- . . 
.. . ~ 
., } ' 
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. 3 . ' ' 
Purification of synthesised H-ll~hydroxyetiochdlanolone 
,. 
Syste~ . _Running time 
(a) 
(b) * . TLC: 
. '** 
.(c) Paper: 
** (d) · P~per: 
. ft** (e) TLC: 
Chlor~forni-ether (4-:-l:v/v) .. 
· I . • . 
Ethyl acetate-benzene (2-l:v/v) 
Benzene-methanol~water (2-l-l:v/v/v)· · 
. . 
' . ~ .. Heptane-toluene-methanol w~ter 
(2-l-2,55-0.45:v/v/v/v) , ,. 
' · 
Benzene-ethyl acetate (40-60:v/v} 
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Tab-le 10 
• I .. ,t I} • 14 . 3 ' . 
Elution and.recovert of · C-DHEA, H-etiochelanolone and 
. ' . . . ' . . 
3 . . . . 





Water (5Vmi) · 
. . l 
Methanol (SOml), / : · 











3 3 ·. 
· H-E +. H..,.THF 
me~~l · range : 
2.2 
2 .0-3~0· 
*· * 90.4 '86.3-95.0 9.1.2 ·88-.8-03.8 
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of .the three major steroid fractions, c19o2 ._ a~~ ci9~.3 me'tabolites·.·.a.nd the 
~orticoste~oid's (c21) are abo_ ~iven.· Fractions (ii) . and (iii) wer~- combined 
and the components .. es'timated a,s their TMSE derivatives. FraGtion (iy) was 
.. converted to '17-ket_ogenic ster'oids before GLC (see Later) . 
/ 
(6) GLC estimat~on of 11-deo~ and 11-oxy-17-ketos;eroid fractions 
Several chromatographic systems were investigated in order- to ebtain· ' 
• • 0 • . " • • • 
• I • 
. the best conditions f£lr . the chromatograp~y of the TMSE deriva_tives of th~ 
' ' 
_c1?.o2\artd c19o3 s~eroids.~ Th'e best resolution ·was effecte,d, on a 2% ·XE - 60 ; ' 
· column under isothermal conditidns. 
\' Fig, 5 gives the reS~lution of the ~e:ivati~e~ of, the · .·· 
_. • r I . . ' . . . " , 
~t.andi\:ds, · androst~ro~e, -~tiocho~an.olon~, . _4eh~~r<?~pia'?dro_s terotu~ ~ d~~ydro-
testJt~rone, 11-keto androste·rorie, 11-keto · etiocholanolone, 11!3-hydroxy·· . 
• 0 • 
androsterone, and llS~hydroxy etiocholanolone. - The RRT for each compound 
.. 
. . , . I . 
'with respect tp di~ydrot~stosterone ·(internal standard) fs given. in Table 12. 
This ·,~a j, le (iso gives the RRT ' s, of the. five commercial! y airailab le c. 3 epi~rs · 
c:>f A, E, nlru, · KA .and HA; namely .iii oandro~eY one, . 313-hYd roxyetiOC holanolone , · · 
~androsten~~7'ol~.l7:-one., i;-1-<~~~~B,Qa~drost~~ and ll~-:hydr_~~s~~ndros~er~ne 
r_esiectively. 




_Fig. ·6 gives the p~ogressi~n ·cury~ pl~tted for each standard it( the 
range o.i .. '":' 2-~0ug. ' : ·. · .·. -.- .. 
- . ~~ .. 
~e mea~ recoveries of c1992 . ~nd ~~903 compounds, determineG from 
. · . . 14 '3 . . · . . .. . . . 
the recovery _of g-DHEA and H-1113-hydroxy etio_C!~p~anolone,- ·were·· 76.8% 
......... . . . . . ' . . . . 
• ~~ · ' • , · • • • : ... I ' • • 
and ,77 ~ ~% iesp~tiyely. · . ··. · • . .. 
\ 
. . ' • · • . 1. · GLC est:~tiof of 17•ketogenic ste~oi~s ) 
In order . to facilitate the GLC analys is or the corticost~oid 
r • • . 
' . . 
1 • 
·f~ac tiona they· wet;e conve'd~:ed . to .. 17'-ke-tos'~eroids. 
' . . 
These compound's were then 
I 
. . ,p 
t 'ermed- 17-ketogenfc steroids. · 
. . 
., I . 
. .. 
' I •. • , 
f . I :· · 
1'. 
. .. 
.: . . 
• • ( . ~·~ J I . • iJ ' . 
. . I , .: , 
. _, 
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· . ·Table ll 
..... 
Eiution and recovery of 17-ketosteroids · 
and· cortices teroids from sili~a gel coluni):ls· · 







(i)' 20 _e.thyl acetate,. 
in ligroi~ (20ml) 
(ii) !'; 40% ethyl aceMte 
· in ligrQin (25ml) 
.... . 
. (iii) '60% etliyl acetate . 
, in 'ligro;ln (25ml)' 
... . 
(i;v~ ' ·· 100% ·ethyl acetate ; · .. -
(25ml) 











' ** . ... 3 . Recovery, of H-llf3-hycftoxy_etiocjlolanolone 
*** . 3 . Reeovery of H-tetrahydrocortisol · · 
****' . . . . . 




.· I . .--·· -· · 





% Recovery of radio~ctivity 






0,. 71-~.0' 0.12 . tl~_0.24 . 
88.9-:-102_. __ 1.2 0.56-1.9 
j • • 
. 
**** 1.2-1.6 • 87.1 82.2-96. 3, . 
. 
1.5-3.1 6. 2· c 5. 8-6.9 
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Table 12· 
Relative . retention times of . s~an<~ard 11-deoxy 'anq ll~oxy..:.l;-7-k~tosteroids 
· I 





RRT w:i.th respect to dihydrotestostero.ne · 






11-keto-androsterone · · 




. ' ' 
'Isoandros terone. 
• " J/1 • 
313~hydroxyetiocholanolone 
' ' 5-androsten-~-61-17-one 
' ., 
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_(1) Steroid ,. side chain· cleavage and extraction 
.' 
The corticost~roid _fract-Ion · (C2~) isolated by silica -gel : column : ' I' . . . 
chr~~t.ography\ was ~e-duced ~ith sodium borohydride and O?t~dised with sodium_ 
" perioda.te to give the 17-ketogeni~ . fraction essentially as 'described by 
"' . . ' . . . . . 
' . () , . ' ' 
Edwards (1964) and Makin (1970). Briefly,- the frac.tion . was dissolved in a 
- f 
few· ~rope of ethanol, ,..,diluted .with · water (Sml) ~nd the . pH adjusted ·to 7. 
. . . . ... ., 
'Sod~um borohydr:ide (2ml, 10% s~lution in o ·."OlN NaOH) 'was · added .and the -
. .. ~ . . . 
mixture i~cubated'' at 50°C for ' ·24m'in·~ . An a~id-acetbne· mt~tu~e (2ml, ·glacial. 
I ' II • 
. , ; . 
. . . . \. . 
acetic· acid-acetone-water: l-l-2:v/v/v) was· added and the mixture again 
. . 0 
_incubated fol=' .20min at 50 : c. Ether was added as.·· required . to avoid fro~hing; 
and the pH readjusted t;o 7 be_fore the ~ddition of an aqueous solu.tion of .. 
. . "' .. 
a·pd~um period ate ~Bint, lP%).~- The · mixture was incubated, further for 40min · 
. 0 ' r • ' ' l 
~~ 50 C, cooled, . and ext:racted .with methylene _chloride _. (3 ~- 20inl_). The \ .. 
- c:o~d 'roethy~e~e chio-~ide e~tract .-was washed -~th NaOH _.(i ~ 1/l~ol, . ~-~iN) 
• I 
and ·water \(2 x 1/lOvol), d~ied over anhydrous soddum sulfate a_nd ·evaporated 




under · re,du~ed, pressure. The reaction p~oduct contained three major 17-k'eto-
. .,. . . , . 
a steroids derived · from · the c21-steroids . .as given in Table 13. d· 
.. -
. . .: . - . ~ . . . ' . . 





· 1113-hydro~. etiocholanolone 
...... 
These three comp~unds were estimated 'as th~i't: TMSE derivatives 
&:· 
on 2% . XE - 60. The res~l~t:i.on, RRT and the progre~sion curve of these'. steroid 
. . . . 
standards .haya. been descri?ed previously. (Table .12i F'igs. 5 and 6) 
~ J • , • ·_ •• ' : s. . 
The m~an recovery of the ·corticosteroids (17.-ketogenic . steroids) ·, 
• ' ' I I • • , ... ') 
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All hypertens;ve. ~_ubjects studied were inhabitants' of f9ur 
Newfoundland communities,· '(Fogo·, .Rame·a, Badger and Bay d:e Verde) . who took 
part · in a b~<?od ' pressu're survey in this province (Abbott et · al, (1971), _a .,b). 
·-
The normal subjects stu~~ed ~or ·11-deoxy-17-ketosteroids were also . 
fr.om the same 
' I ' • • •• • ;;l? I , . · . . 
four ,Newfoundland ·conununities, whereas: for the .~1-oxy-17-keto- · 
. . 








. . . 















. Th; hypertensf.v~ and normal subj ec.ts in ~he NewfoundlanCI 
. . - ) . . . . . 
communities chosen for urinary studies were examined to exclude secondary 
• ' .I ~ 
. 
. 
I • • • • 
. . causes. of hypertension.·' Briefly; they had a. casual dias tol:l,.c pr.essure greater . 
• • • • • • - • if" • • 
· I 
·. ·, ... than ·9o!IIIli' of Jn.ercury, a findi~g which · .~as co~firm.ed on subsequent clinical · · 
. ' 
. 
. reassessment. )J~ wer~ examined iri their communiti~s· with SJ>ecial att~ntio~. 
paid,· to family history o~ hypertension, 'ocular fundi, heart, per:ipheral · 
' . . 
.. 
pulses, abdominal bruits and for clues i~d_i.cat~ng the pr~sence · of coa~ctation 
. . . . 
. of . th~ ~orta, Cushing's Syndrome a~d plieo~hromocytoma • . The cardiac·, rena( ' . . 
~ 
. ' . , 
<i'nd cerebrovascular+ ~ystems were assessed for evidence of deterf:oration due 
No subjects had thyr-otoxicosis,, diabetes. mel!.itus,. or were 
. . .~ .... 
t~ · hyp~rtens ion. 
.. . . . . 
kt{own .t:o•have 8· carcinoma',- and' all. wer~ untreated , arid on unres.tricted qietq. 
• • ' • I ' .. " • • I ' 
. Labora.fory tests were perfo'r.ined ·on ~he urines from all s~}?jects at., 
.· .' 
. . 
. ~· . ·. · . 
'P 
I . • . 
~h~ ~'neral,. Hospital, ft. John:' s,- · The· urinaly~is, sodium, po~assiul!l, an~ . . 
,~ I . , ' . , ,. 
· vani~lyl w;"nd~l:l,c' .aci{ (YMA) were ;ithin_. normal limits except f~r ~h~ . . . 
: following i~siividua'ls: . FB (N) ha'd ·a~ . albu~ri va_iu~ of 2+/ F6·2 :: (H) had ~ 
.. 
, . · sugar ' ,o~ "H···, ·'and. t~~ VMA .values. for F~ (N}; F66 (H;, F64 (H)·, F69. (H);. ~nd . .'· I ' 
: .. ·· ) ; , 
, , ..J . 
. . 
' I ' 
,, . 
.. ~~ "(n), w·~e 9~9· , : 16 .• 9, i 3 .3, ·.li.S, and ;l<J.-9mg/24hr .. re~pectively. ··:I'he. vMA 
• fl • ~ • ' • ',. ~ • ' -' ' • ' \ • r 
• • • , ( • 1 ,· ~ • • .. • • • .. ~. • • - • .. • I' ' • 
values for . those·· subJects. wete, above the upper 1imit of . the assay' (normal 
"'· I ' I •] ~ • 1' : ~ · '", ' J , '• • " • • .\., {' / ~ .. 
.:• . 
' 
•' • I <'',. I r 
. , , .. .. 
. (' • . 
' 'o ~ • I ' j ~ I • 
' ; • n ~·' , •*' '(. I ' D 
. . ' \ ~ ... ,. 
. . 
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/ ; .. .., ( · .. ·' ' ' -.... Table 13 .. · .. . . . 
, / .. 
Possible .c;>rigin -of 17-ketosteroi ds obtai ned 
by reduc~ion-qxidation of . 921- _steroid :frac~ion ' . .. 
, J 
,. .. I 
I 
c2{_-steroid - .17~ketos te~oid . produc~d' . o.f ·• 
. • 
..,. 
" 0 Pregnanetri o1 ' • Etiocho lano1one I 
-· II Tetrahydro-11-deo~cortisol .. " 
. . ~ .. 
. . . .. . . 
. . 
'l'et rahydrocort i~one 
. ,. -
Tetrahydrocortiso1 
513:-cortol .. 1Ia-hydr~xyetiochol~nol9ne 
513:..cor to lone ' . •' . -
I • 
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.. . . 1-
values ran_ge up to 9mg/24hr)", b'ut since the' subje~ts were on unrestricted 
~ ~ 
diets,' the signif~cance of these results is uncertain. . • 
, Si~gle . 24~r urines wer~ collected from both groups i n 
po~yethylene ~ottles without. preservativ~ and stored. fro~en .at -?O~C. until 
processed. 
.. 
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Classifi~ation ·of subjects general laboratory investiga:tions 
(i) Classi~icatiori blood pressure 
The -blood pr~ssures of ~5 individuals · in the four Newfoundland 
. w-- ' 
communities of Fogo, Ramea, Badger and Bay de Verde and 15 normal laboratory 
personnel were measured with'. a sphygmomanometer (London Scho<:>l of Hygiene and 
~ . 
Trppical Medicine). Subjects were . de~ign'ated h~ertensi:Ve .or normal on ' the 
basis of their bloo~ pressure togeth'er witp other medical considerations,, 
. * including. family history.,. medical history, age, etc. · . The subjects in each 
community were -designated by· a number and the code F, .R, B or V to represent 
I . I • 
their community as ·mentioned above~ The normal laboraeory personnel wet~ 
' . 
. ' . 
designated as Ml.:. 7 and Fl-8 for ~I:es and· females 'resp'ectively. 
I 
Table · 14 ·indicates that all norm~l subj_ects ·had a diastolic. ·. · 
... l . 
·pressur7 ~elow 8~mm Hg (range 65-86}. The systoli~ . ~·r_essure ·of these subject's 
ranged from 108-178mm Hg wi~h 26 subje9~s having -values ~elow 137. In the . ·. 
! 
__ ..., ___ 
. hyperten~ive group (Table 15) 36 ·subjeits nad ·a diastolic pressure above 90 
- • r, • • 
.; 
with one ._at 8? (;ange s9-i28) • . Sy.st~:ii~ pressures ranged from 127-:224mm Hg 
. : . 
with 32· subjects· above 140 and 5 below. 
"(ii) Age and sex of _.gubjects . 
~enty.:..eiglt females and 9 males wer~ included in the hypertensive · 
group, and 20 f emales and 13 males in· t~e group of s~bjects ~th .~ormal . 
' blood pre!.~!!!'es. · .. The normal subjects ranged in a~e from 21-78 years w.ith· 
.. ' 
. I . . , 
28 subjects under 60 years ·and 5 over. · Among the normal male and female 
· subjects, · two· males and three ·femal es we~e over 60 years. 
'' 
* I am indebted to Dr. E.C. Abbott for' the blood pressure measurement s and · 
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. The as,e.s of. the hypertendve sub.jecbs ranged from 25-69 yea~s . I' 
with 32 subject~ under 60 years and 5 over. In this group two ~1~ and 
I - ,.. 
three female .'6u_bjects .we~e o~r 60 yea;-s. 
. . 
(i~i) Urine volume and creatinine excretion 
Compi~te col~ection of 24hr urines was assumed ·from· both the total 
• (} . • 1 
. . 
volume of urine voided and the creatinine excretion. Table~ . l4 and 15 
. indicate that the normal subjects had ·a towe~ mean creatinine excretion 
. , . \. . "' 
I 
(L lg/24~) th~n the h~pertensiye sub.jects (L 24g/24hr); hqwever, the 
. difference -was not· statistically significant. Several of. the normal and 
hypertensive subje·cts excreted low .. levels of creatinine,'Whicli may indicate 
differences iri the body mass or a• failure' to collect all the urine voided. 
However, no significant difference was evidept. in the_ mean volume of rurine 
r 
voided ~y the two groups. 
(iv) Aldosterone excretion \ 
. . 
;The ·excreti6n of afdosterone · wa~ e~timated i"n the 24hr. ~rines by . 
) 
• f/ ' 
a double js~tope derivative assaj·m~thod. 'All .the subjects were on ~restricted 
. : . 
diets and freely, ambulatory • . Tabl~ 16 giVes the results of ~ndividual norrlial 
· ). ., 
. .: ... I 
. -·(' f- 1 
' 
-.-~;o::>'JJ . • I . , . 
ana-hypertensive ~ubjects. The range of aldosterone excret~on in the gr~up of 
I. 
normal subjects was 1.1 -- 20 •. 4ug/24hr (mean 10.14ug)_. and . in.tr,.the group of 
.; 
hypertensive s-ubjects, 2.6 - _18. 7ug/24hr (mean 9.6)ug), .. . There w~s n~ 
' .,...;_ · 4 
significant difference between the two gtoups in .t~e· mean excretion of aldo-
. . . • ! I ,,.. 
steron~, whether expressed as ug/24hr urine .or 
1
ug/ g creatinine. These 
·.· ' 
I 
results ruled o~t the possibility of primary_ aldos~eronism in the subJects 
studied. 
. '. .• 
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Code : _Biood - ' Age 
Pressure 
Males 
. . F7 134/79 .39 
Fl4 - 147/75 ' .. 59 
F41 . 126/8o-.. · 25 . 
B45 137/65 - 32 
V46 .. 178/83 73 
F5i 170/81 68 
, MI. 
- - 190/80 33 













Wt. Urine vol. Creatinine · Code 
(g/24hr) 


























Pressure lbs. (ml/24hr) (g/24hr) · 
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120· · 74s o.6a··---
. 1.53 6.8t\ 1.34/ 
1.47 680 0.51\-
92 12 0.80 
115 700 0.80 
145 1330 . 1 .06 
.. 
- M3 1:24/84 .28 . 143 






















126 -_ 1710 .1.47~ -
143 1050 - 0.92 -- ~ 














125 , ~ 780 . 1.25_. 
' 120 1320 1. 29-
F3 108/74 +27 760 0.83 
F4 122/75 140 -· 7.30- -1 ·.24 
CREATININE EXCRETION F5 l24/80 13o 1o6o · 1.1e ., · 
- ' 
.·, . (Total Population) 
. ' "' ' 
Mean . 1.27 
SB± 0.45 
SE:t - 0.08 
'P*'!r -N.S.*** 
·* - ·- ' -
F6 128/78 
F7 124/76 






120 740 0.89 
98 1100 0. 60'' 
125 1880'- ' ' 1.12 
ll8 1090 0.51 
·----.. __ ' 
-~ormal laboratory peTsonnel _ -
. ' ** - . ** . - ' .. _ . . 
:· . _ . Studen~ 't,' test, P · : Differences between the total popula~ion of Normal and ' Hypertens'ive subjects 
. - *** - - ·,- ' . - ' - . - . -- . 
- · · _ .NqL§J.gnif~~ant where P -iS greater than 0.05 .l' · . . :· .. 
(1\ •• 
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Table ; 15 - · · ·:·-
'Classi~icatio~ of IIYPEriENSIVE ~ub~-ec-ts\•L~n~ - t~e - exc~edon of ~rin~ ~d creatin·i~~ · -. -
.• 
.. 
,· Blood Age Wt. Urine Vol. Creatinine' a..S Code 
Pressure. lbs. (ml/24hr) (g/24hr)_ 
. . ' 
Blood Age Wt. Urine Vol:, Creatinine 
Pressure lbs. (mli24hr) {g/24hr)· · 
Males ~ . ;! Females 
~ 
117/94 68 ' 18L 1690 L84 V57 _139/91 54 '164 
213/101 57 194 800 2.10 V27 176/102 50 146 
-
"152/98 . 43 135 1660 1.59 Fl 186/107 -39 . 177 
146/97 36 207 1340 2.39 B25 224/126 Lrl' 222 
- '135/96 40 179 770 2.23 V31 194h12· 53 149 
.154/95 50 135 -1700 0.39 . B61 163/95 52 . . 1.80. 
157/90 32 136 1230 1.94 ·F68 216/114 54 118 
. 171/92 4l 170 . 2020 0.70 R78 141/91 ·57 150 
214/107 63 108 1590 0.55 V47 - . 219/128 60 150 
F28 167/107 42 199 
F22 "146/96 39 155 
. ' F47 · 157/93 41 106 
B38- 185/105 ' 64 . 174 
Rl2 149/114 42 . 144 
. CREATININE EXCRETION R52 ' 137794 47 2f0 
(TotaL Population) . B12 210/110 54 106 
. Mean ' 1.24 . · B59 150/95 50 216 · B64 . '166/98 .. : 52 207 SD± 0.57 F61 136/93" 43 .. 168 SE± 0.09 
p** N.S. F62 171/99 47,- 194 F63 159/96 53 198 
• 
F64 194/92 42 130 
-F69 171/89 25 217 
R72 127/94 33 1176 
.. V32 214/UO 53 ~ 160 
V42 140/96 52. 180 
.. · V59 . 187/97 62 148 
, . i . ' . ft. : • • R54 . 201/124 69 153 
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Section II 
Studies ·on .the 11-d.eoxy-17-ketosteroids excreted as sulfate and 
" 
. . 
glucuronide conjugates in the urine of NORMAL. and HYPERTENSIVE 
. subjects 
{ 
' (i) GLC resolution ,of the 11-deoxy-17-ket~steroid spectrum 
' -
. The 11-deGxr-17-ketosteroid fractions ~ere isolated from · the 
urines of norma~, and hypex:tensive s_ubj~cts as des~ribed in the Methodol-
ogy section. 
. ,...).. . . . . . ~ 
The component~ of the glucuronide and sulfate cohjugate 
fractidps were extracted after hydrolysis and resolved as their TMSE 
• ' .I ,, ,r 
. - ~ ' 
derivative~ by GLC. Fig. 7 compares the resolution of the . three . major 
11-deoxy-17-ketosterolds, · androsterone (A) , etiochol~n~lone (E) , and ,. "' ' .. 
, '• • ' · {j • • • • ~ 
, • • l • • 
dehydroepiandrosterone (DHEA) in the two conjugate fraction~ isolated ' 
• I ' • • • ' ' ' I • 
from ' the urine of ·normal and hyp_erten'sive subjects. 'The spectra illustrate . 
' 
:, I 
a sadsfactocy res~lution of the st~roids with negligible overlap Of · pea~s~ 
' in particular there is an ab_se~~e of peaks. that would interfere with the 
• quantitation of_ th'e ·steroids. under :_ study. 
. . ;; . . 
(1!) Excretion ·of the individual 11-deo!Y~17-ketosteroids in the 
conjugate· fractions 
·Tables 17 and' 18· give the individual values for the excretio~ of 
. . . . ' ' • . -:;. - , r ' I • . A, E and DHE~ in the . glucuronide and .sulfate fractions isolated from the 
' . . . . • . :! 
urine of · normal and bypertensive s~bjects. The total_excretiqn of 'these 
co~o~n~a is also . given by the summation of the ~o conjugate fract~ons. 
The gr~up ~f. i7-ketosteroids as measured colorimetricaily, -is . compar~d with 
' .. 
. . . 
the summations of A+E+DHEA measured ·by GLC. 
. . ~ . . .. . . ; ' r : 
' ' 
-. 
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.· !!'able 16/ 
·-Excretion of ald~·sterone in the urine of NoRMAL and HYPERTENSivE . stibj~ct~ · 
· • . I . 
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. I . . ~ · Total Population . 
ug/24hr. ug/g cree1:tinine: 
.. . · , 
; I ~ ' 
·' 
Mean 10.14 9.77 
±SD 4.17 4.30 
±SE 0.74. 1.11 
. .. 
. ' · '· • .. 
. . . . _ .. 
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,. Code. _· 
V57 18.2-
V27 14.8 





R78 3 :5. 
V47 4.8 
F28 '5.8 
F;22 2.6 · 




in2 · 8 . 6 · 
B59 7.8 
. · B64 10.9 
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(iii) • \, • r ' Comparison of differences ·in·the excretion of the 11-deoxy-
17-ketosteroids in'the urine of normal and .hypertensive subjects 
' 
. Table 19 gives ·the mean excretion of the three major 
.•.. / 
) ~ -ketosteroid• 
urine of normal 
in the sulfate and ' glucuronid~ fractiorts isoiated .fr~m the 
~~·\~ ~:j 
and hypertensive subjects and ~~i.\ sign~fi~ance of the 
' ~ differences between the two groups. In Table 20 the significance of the 
' . 
'differences .in the, exc.retion of the' n~deoxy-17-ketosteroids when ,expressed 
.~·,\0-~~~f) <7 .; 
as mg/24hr and as mg/g creatinine d.a ~i.v~~·f The latter we.'s included to 
ensure that 'the steroid values given. in mg/24h~ were related to ·coroplete and 
•· 
accurate collections of 24hr urines. 
The' results of the ex_cretion of the three major steroids may be 
• I 
. ' 
summarised as follows: 
Dehydroep{androste~one 
The level of · DHEA-S was highly signific~ntly reduced in the· urine 
.of the hypert~nsive subjects .(Pc::O·. OOl), and although the excretion of DHEA-G 
·~as . ~ot altered, the 'total quantity of 'DHEA'(G+S) excreted was signi~icantly 
' 
reduced (P(O.OOl) · due to the effect of DHEA-~. 
Et:l:ocholanolone 
The excretion of E-G in th~ · urine of the hyper.tensive population 
.. · , . 
was markedly reduced (P(O.OOl), but no signi~ant differ~nce was fou~d· f?r 
. . 
E-S. The total excretion of E. (G+S) was also .markedly reduced in the. hyper-
tens1ve group (P<O. 001) and reflects · the reduced "excreti'on of E in the 
glucuroni de fraction. 
Androsterone 
The mean excretion of A-G was ~ound to be significantly increased-
(PiO.Ol) in .the' urine of the hypertensive subjects ~hen the val~es were . 
"' .. . ' . . 
n l:c , , · 
expressed as . mg/24hr, but no significant differ~ce was evident when .the 
.· 
I • .. ' ~ ... ' 
~esu1ts were .give~· as .mgfg c'reatinine. Furthermore• no difference was , found ·. · · · ·. 
I I ' ) ' I ')• : • ' / i . .. < ~ • oi 'V '<)' f~ G._..,'";~ \ : • 
• I · ., ' • • • • ' • 
. in the excret~on -of A-S i-q. the total amo,unt : of A·· (G+~) • . , .. ·· 
,·, 
·. 
\ ~ '. ': 
' ~. . ~. . 
.. ·· · • I : .. .. ·r 
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. Fig.. 7 · GLC r~_ol~tion of the 11-d~xy-17-~ketosteroids _in the ·conjug~te fractions 
iso-lated from the urine of NORMAL and HYPERTENS I'VE subjects , · 
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~ - · .:rab1e 17 
:· Excretlon of total 17:_ketoste-roids and the giucuronide (G) and .sulfate., (S) conjugates of androsterone, 
- · . ·. et.ioGhor~C>lbne and DHEA • (mg/24hr) in the urine o_£ NORMAL subjects 
!·. 
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Code G. s . 
>Males 
· F7 0~2.3 2.10,.. 
F14 0~14 1.58 
_F41 0.72 1.25 
B45- 0.40 1.95 
· V46 0.25 ~.37 
F53 1.10 0.75 
Females 
Vl7 ~ 0.81 1.66 
V39 0.56 . 1. 78 
B32 0:15 ·2.09 
V3 0.16 • 1.95 
. V14 0.-61 ·1.58 
B1 · o.21 1.58 
<.l V7 0.76 1.92 
FlO 0.63 2;33 
·~ B50 0~26. 2.18 
VB 0.91 i.98 -
B52 . · o. 71 · 1.5~ · 
··-=-:::-- - =- - .- · .. -* . . 
-=---. - - ·eo1·ori~tric assay 
. . • 
... 
• 
:: . .- ~ --::- " 
:: ::·:.:.·: ':; -·.' : - : 
:_ ._.. I 
·E 
G+S G s .. 
2.33 - 1.51 0.14 
1.72 2.10 - 0.12 
1.9t 1. 75 0.18 
2.35 1.20 0.12 
1.67 1. 73 o:o9 
1.85 2.55 0.11 
. 
2.47 ' 1.56 . 0.21 
2.~4 ~ .· ~. ·, 0.91 0.09' 
'2::·24 . .. ·"··'-:1. 80 0.15 
2.11>" -~ 'Q~54 0.05 
' >i 
2.19 1.'97 0.20 
' 
. ~ 
'1.85 ·.,; ·.53 0 • .09 
2.68 . ~ ' ·0.14 .... 0.88 
2.96' 1~oo 0.08 
2.44 0.4·1 0,06 
2.89 1.40 0.10 
2.29 1.78 0.12 
1, 
. :- --==-- -::-~--~- -- ... __ -- :: ·~- -
Q • 
,. 
* DHEA Total Tota.l 
-
G+S) . -G < s . G+s A+E A+E+DHEA 17;._KS · 
1.,..65 0.25 1.97 2.22 3.-98,. 6.20 4."60 
2.22 0.31 . 2.58 2.89 3.94 · . 6.-83 
1.93 0.16 4.92 5.08 "'3.90 '. 8.98· 10.7 
1.32 0-.11 1.38 1.49 _;3.67 5.16 7.4 
1.82 0.27 2.94: 3":21 3.44 6.65 4.2 
2.66 . 0.-28 . 3.50 3.78 ~4.~1 8.29 10.7 .. 
1.77 0.31 3.00 · 3.31 4.24 7.55 4~ 1' 
1.00 0.11 5.11 5.22 '· 3~34 ·. 8.56 4'.0 I 
4.4 1.95 . . 0."60 4.52 5.12 4.19 9.31 < 
0.59 0 .• 06 3.74 3.80. 2.79 6.50 8.7 
2.17 0~27 3.18 3.45 4.36 1 .~n · 12.3 
.2. 62 0.33 .2. 50 .. 2.83 4.47 7.30 · . ·3.8 
1.02 . -.e..19 3.0 3.19 3.71 6.89 1.0.5 
:1.68 0.21 2.20 2.41 4.64 7.05 12.0 :., 
0.53 ' 0 .. 06 3.50 3.56 2.97 6.53 · "'B. 7 . 
1.50 0.09 1.58 . 1.68 4.39 6.07 3;8 
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I o : '•· .. iJ' i"! _::or- ,;''!vJo..f'~• I Table 18 
-~ 
'J : 
Jf ~-~;t" ·1: 
Excretion of. to~al· 17-ket~t~ro~s and · glu~uronide (G) a~d sulfate (S) ' conjugates of androsterone, 
etiocholano'lcme and DHEA (mg/24hr) in the urine of HYP~TENSI~ subJects 
. -: . . ~ Code 
( ' 
. . 
















. V1.7 • 
·Fl 
" ., B25 
V31 
.. . B61 . · 










































0.13 0.55 . 0~~0 
0.13 . 0.61 0.22 
o.39 ·o.6o · .O.?l 
0.23 1.01 . . o. 70 












O. i_4 · ~.,99 2. 73 1.20 0.18, 1.38 o ~ L~O 1.39 
o.55 1.-33. • ~;·8·8 . o.68 . · 0.11 . o.85 o:3~~3.38 3'.65 
0.67 1.35 2.0'2 " 0.20 0.99 1.'19. 0.25 .0.01 0.34 
, 1.20 2.02 3.22 0.38 0.13 0~51 0.19 0~12 0~31 
. . l5 8~ · 1.34 · 3.19 0.3& · 0.11 0.47 0.43 0.09 · 0.52 
·.-' '0'.47 . 1.()5 2.12' 0.44 0.11 0.55'' Ct.--25 0.10 0.35 
1.42 . 1.55 .. 2.97 •' 0.33 0.21 . 0.54 . 0.08 0.18 0.26 
0.36 .1.55 1.91 0.05 0.25 0.30 0.17 0.16 0.33 
1.4~ 3.06 4~48 -1.92 0.~6 1.58 0.18 . 0.22 0.40 
·- 0..81 ·2.'33 . ·-3.14 O.Z,2 · ... 0.09 0.31 0.19 . 0.17 0.36 · 
. ' . 0,;; ~9 . 1. 25 1. 84 0. 9'2 0.12 1. 04 0 .15 . 0 .18 0. 33 
· o~ 9o . · ·1. 81 2.11 !.5o · o.2d 1.10 o.2o · o.12 o;32 
·1.46 - 1".48 2.94. o.56· o.26 o·.82 o.3o o.o8 . o.38 . 
, . 1.87 .. 1.52 . .. 3,.39 ·. 0.32 . 0.30 Q..62 0~16 0._22 0.38 
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\ . ~ .... ' 
Ratio of ~/5@ compounds ' .· ' . 
''· 0 • •' 
: · . . · ·The "A/E ratio, which gives. S: measur~ of the relative .5a/5t3 
t • . . • · • 0 • 
reductase $~~ivity in the . metabolism of rhe" 11-deoxy-17-ketosterotdfwas 
... • 1' ' 1 
' . .... ,. 
. '\ .,.J . 
, determined in the glucuronide, .. sulfate and total "·fractions. . A s~8#~ficantly 
. ·. ~ . . ; ,..-;'~~ " 
' <' 
increa~ed ratio was founa~for the hypertensive· population in both ~he 
,_ 
I. . -... . . " . 
glucuronide aD:d glucuronide plus sulfate fractions (:acO.OOl) as a result of 
' . 
, ~- ma:ked reduction in the exctetion of ·?tioch~lanotol:le~. In the sulfate · ~ 
' ' 
' I . " 
' frac~ion, by contrast- an· increased ratio was found in the normal group 
' G '(~ 0. 02); however both hypert~sive and normal subject;.s excreted low levels . F. 
. . ... 





. (A), as sulfate conjugat~. ...- . 
' j 
Total 1'7-ketosteroids · · . . 
' j n / , 
No significant difference. was :. found in the excretion of the total · 
i7.-k~~~st~roid~, ~s ~ured. colori~etjically, in the two groups of subjec~s 
~ 
studied. I~ addition, .. the values fo'r the mean excretion of total 17""keto":" 
"' 
' 
.. steroids failed to .correlate well with A+E+DHEA (G+S) .measured· by GLC. ·_ The 
lafter was hig~ly . sl~ificantly ·reduced in the. hype,rtensive grc:>up (P< 0. OQl). 
'iy) . Releativ~ Sa- ~nd sa-reductase activitY 
So fiir the excretion. of the ~-(androsterone) ~~ '513-reduced 
' (etiocholanolone) steroids by the hypertensive and normal subjects have been 
- - • f • • 
• 'I • • ~1DPar~d. In Table 21_. the· rel_~tiv~ proportions of thee~ metabolites have . . 
been compared withirr the norwal group ·anq also within the ·hypertensive group 
I • ~ • . ~ •· , . 'l 
to obtain an indication of the .relative steroid reductase 'activities in·'eacl,l. 
. group. The results may be sut!IIIUlrised as follows : 
·' 
; Norinal subjects 
. \ . The ~ormal subjects exerete~ more etiocholanolone than androst~rone 
· in the gluc~n;~nide . fract:!o~ (in the proportion~ -~f. 3 :1) ~ which · sugges~s · a · · 
· great~r S~~~~t~se activi~y. 
l • .. \ 
." 
.. 
~ . . •,l 
'. -·. 
. . . ... { ... 
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- j . A N 0.51 
H . 0.9-3 . 
.. E N 1.49 
* 
H 0.66 
DHEA N - 0.22 -
H 0.38 
sulfates 
A N., ·1. 74. 
H 1.~74 
E N . · 0.12 
.li 0.22 
DHEA* N 3.07 
·n 0.46 
0 
·' Table 19 
' 
Differences in the excretion of conjugated ll-deoxy-17~KS 
(mg/24hr) in the urine of NORMAL and HYPERTENSI~ subjects 
Total EoEu1ation ..... ~ Males .. 
±SD :!:SE P value Me'an ·. :!;SD ±SE · P value 
I 
!} -
0.29 0.07 0.47 . 0.33 0.08 
0.50 0.11 < 0.01 .... . 
' 
0.69 0.51 0.25 N.S. 
0.61 0.15 1.81 0.42 . • 0.20 
0.48 0.11 < 0.001 0.57 0.27 0.14 < 0.001 
0.13 0.03 0.23 0.08 0.03 
·0.49 o:o4 N.S. .· 0'.43 0.24 0.1-? N.S. 
' 0.38' 0.09, 
' 
1.50 0.45 0.16 
0.48' 0.11' N.S. 1.~9 0.44 0.;22 N.S. 
0.04 ~.01 . 0.13 \1.03 0.01 
0.19 0.04 N.S. o:21. o.d9 0.05 . N.S. 
1.04 0.26 .... 2'.88 J-.13 0 .• 44 
· 0.85 0.20 < 0.001 - .. 0.13 0.03 0.01 < 0.001 • 
Glucuronides Elus'sulfates 'A-
A N •. 2.25 0.37 0.09 1.97 0.28 0.17 
' H 2.97 _,·0.71 0'.16 N.S. · 2.58 0~68 0~34 · N. S. 
- E N· L67 0.60 0.15 1.93 0.42 - -0.20 
* 
H 0.89 0.47 0.11< 0.001 0.79 0.25 0.12 < 0.001 
.. DHEA N 3.29 1.07 0.27 3.11' 1'.14 _0.43 
H 0.74 0.86 0.20< 0.001 ·o.56 0.25 0.12 < 0.001 
.. A+E N-. 3.92 0.52 0.13 '· -· 3.91 0.33 0.19 
· H 3~56 o.Bv.' o.2o N.S. . 3.37 0.75 0.38 N.S. 
.· A+E+DHEA N_. 7.21 1.06, 0.~6 7.03 1.27 0.43 




Females - · ., 
,. 
p ·value Mean ±SD ±SE 
0.54 0.26 0.10 
1.01 0.47 0.13 <. 0.05 
1.40 0.61 0.21-
0.69 0.52 o.-14 < 0~'01 
0.21 o-.15 0.05 
0.36 0.55 0.02 N.S. 
1.87 0.25 0.12 
L~9 _. g._4_8~-~ ~0.~3 . N.S. 
0.12 ·. ·o.os·, -- o-:m..:;-_-: 
' - 'l ,.. 0.23 0.21 .·0.05 ·· · -·- N.S. 
3.18 0.97 0.32 . 
0.57 0.96 0;26 < 0.001 
2.14 o.33 o·.1o 
2.70 o. 72 <-·i>-.1.?_ ~--· N.S. 
1.52 0.63 0.2Z _· 7 
0.92 0.52 \ 0.14 < 0.05 
3.39 1.01 ·0.34 
0.79 0.97 0.26 < 0.001 3.93 0.61 0.18 
' 3.62 0,88 0.23 =.- N. S. · 
7.32 0.91 0.31 
4.45 1.24 0.33 < ~ 0.001 ~~, .. · . 
.... ~· -*Level qf . significanc_e did not alter · after correcting resu1t~Jor the mean 4. 9% DHEA-S estimated to be 
•••• 2t ..... -~, . 
.. ~ ...... " .... ~~ : hydrolys~d by Ketodase hydrolysis (cfp-51) . . .. 
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' \ 
I_: 
I . . 
• • • • • • T~ble 19 
I' I ' 
Total population 
; ..... . .~isteroids ,_ 
1 • • • 
Mean ±SD ·±SE P value 
·.· t 
.. 
. . -.. -. . * 
,::.' ·· A/E Ratios ._ 
Sulfates 
. : G+S . 






H f 3.94 
N . 7 .• 11 
H .- 5.91 
. ' 
.. ., ' 
0.22 0.04 
2.03 0.45 ' ~ 0.001 
9.53 2.31 . 
5.86 1.31 ~ 0.02 
1.07 0.26 " . 
· 2.35 . o.si < o.oo1 
-3.29 . 0.84 
1..92 0.44 N~S. 
*" . ' . . ' 
. · Mean values calculated from individual ratios I' ' : , , 
·** . . Colorimetric aa·say 
·· . . . ·. 
~.. . . 
.. 
~ - . - . 
:-r·:_ .':·.: ; ·- :..··-· . 
. .. 
·, • I • ..... ~ t ': • · , • 
. , . . 
. ~ . . 
. . ·: . - . . 
•, o , 
- ~ . ... 
• l) - . 
.: .· 
•. 









_--Mean ±SD ±SE P value ~ 
. 0.35 0.19 0.08 
1.43 1.23 0.55 < 0.01 
. 12.23 4.2l 1.74 -
10.24 4.89 2.19 N.S. 
1.10 0.42 . 0.1.7· 
' " ' 3.55 1.50 · 0~67 ( 0.01 
3.15 7.52 5.00 
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Table 20 · 
Level of significance of d£fferences* in the excre~~~n __ of conj&gated 17-ketosteroids expres~ed as 
** ,, . •• . ..,. .. ... -~~ ..j. 
mg/g creatirlne . , and as mg/24hr, in the urine of NORMAL··;ftd HYPERTENSIVE subjects 
-· 
I-
Total population Males . I Females 
-











' ' . 
" . 
:·: ,· Glucuronides plus sulfates 









** Total 17-KS. . ~ .· 
. . ' .. ~ 
:· · .. '\. 
. * . 
.. . S~udent 't' te~t' P <. 
'. ** ' . 
. · · · Colorimetric assay 
'c 
-,.. .. 
··. · ... 
.. · .... ... : 
. I, ' 




N. S .. 
N.S • . 
0.001 
N .. S. 
0 . 001 













































N.S . . 
. . , .. 
~ N. S. 0.05 
"f 
0.01 0.01 
N. s. N.S. 
N.S. . N.S. 
.N .S. 
·N .S. 
· 0.001 0.001 
•• 
N. S. N.S. 
. 0.01 "" 0 0.05 . 
0.001 0,.001 




N .S. N·. S • 
. ' . 
' 
. \ · 
. · 
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By · cont~ast, signifieantly less etiocholanolone than andro~terone was 
excrete'd · in the sulfate fraction (1:4), suggesting that the 5~-·reductase 
activity is less important than the Sa-reductase activity. ·As ·a- result 




higher than E (G+S) and the difference was not st~tistically significant. I · 
Hypertensive subjects 
The hypertensive subjects excreted less etiocholanolone than .· 
androsterone in both glucuronide and sulfate fractions, 
..... '< sign~ficantly Jifferent. 
; "/ 
but only the · 
excretion of E-S was 
1 
Comparison of the ·proportions. of A and E excreted in the urine of 
the normal subjects studied and in the urine of the hypertensive subjects, 
revealed that similar proportions were excreted by both groups. after sulfate 
formation. However, 'W'hereas more of' the 5~-compound, etiocholanol'one, was 
~·----- ··~·--·- - - . 
excreted as a glucuronidetthan androstero~e by the. norma~ subjects,. the 
reverse ~~s true for the hypertensives._ Since the excretion of E-S was 
,. 
markedly .~rt:!duced in the hypertensive group the total excret;~on, E (G+-J) was 
. ' ' 
also s'l.griificantly l~ss. 
(v) Excretion of androstenedione 
Al\drostened~one, which is .. an intermediate in the formation of 
A and E, was measured in order td determine whether· alterations in the 
' . . . . 4 
excretion of these latter compounds was 'related to the met~bolism of· A -A. 
' . 4 ---· 




Fig. 8 gives the gas chromatogram of this compound 
rom the urine of a normal and a hypertensive subject. 
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Differen~es in the mean excretion of Sa- and 56- reduced 17-ketosteroidsl 




TP.ta.i EOEulation . Males Females 
·:Mean ±SD ±SE P value · Mean ±SD :f'SE p value Mean ±SD 
0',51 :0.29 0.07 0.47 0.33 0.15 0.53 0.26 
1.54 Q.58 0.14 < 0.001· 1 •. 80 -'0.43 0.19 <' 0.001 1.40 0.61 
1.74 -0.38 0.09 · 1.50 0.45 0.
0
20 1.87 0.25' 
0.12 0.03 0 < 0.001 0.12 () 12 0 "< 0.001 0.11 0.04 
·,~ . 
±SE 




Glucuronides plus- sulfates ~ ·~ . ..,_ 
0.09 A 2.25 0.37 1.97 : 0.28 0.12 2.40 0.31 -·:0.10 
· E 1.66 0.60 0.15 N.S.I 1.93 0.42 0.19 N •. s. 1.52 0.63 , .. 'o. 20 
. . -~[ Hypertensive subjects 
G1ucuronides 
.A 0.93 0.50 0.11 .0.69 0.51 0.25_ 1.01 ' 0.4T 0.12 
' E 0.66 ,p.48 0.11' · N,S. 0.57 0.27 0.13 N. S. 0.69 0.53 0.14 
'· "' ' a' 
-
--sulfates 
A 1. 74 0.48 0.11 1.88 0.44 0.22 1.69 0.48 0.12 
E 0.22 . o,.19 o:o3 < o:oo1 0.21 0.09 0.04 < 0,001 0.23 0.21 - 0.05 < 
Glucuronides plus sulf.ates 
A 2.67 . o. 71 0.17 It 2.58 0.68 0.34 - 2 .• 70 0.72 0.19 -
E 0.89 0.-47 0.10 < 0.001 ~ o. 7-8 0.25 0.12 < 0.001 0.92 0.31 0.14 < ~ 
. · .. :. 
-' 
.... 
. . , 
I -
P value 















• n • 
" 66. 
Individual ll4.-A are given in Table 22. · The mean excretion of !J.4-A 
expressed as ug/24lir u_rine a~d ug/g creatinine ' was highe~ in. .. the hypertensive 
· group·, but only the results expressed as ug/.24hr urine were statistically 
• • f ... ... 
. . 
significant (P<O.Ol). Females predominated in both groups, and ~o attempt 
was made to analyse the res~lts of males and females separately. 
' 
(vi) Effect 'of age on the excretion of 11-deoxy-17-ketosteroids 
The effect of age on the excretion _of A, E and DHEA (G+S) in the 
'urine o~rmal and h~pe~tensive sub~_ects is illustrated_ in Fig. 9. In each 
case a regression curve is.drawn from the scatter plot. It is eviden~ 
from this that no signific,ant decline occurred in the subjects investigated 
in the present study. Neither did b,lood pressure have a significant · 
,. 
influence on the values. DHEA and E, which were excreted at low levels by 
..... 
the hy~rtensive' subjec~s, remained consist~ntly low between the ages of 
1' 25-6·9 : . ·, . ' I 
~.i 
(vii) -Effect of blood pressure on the excretion of 11-deoxy-17-ketosteroids 
I , 
The effects of_ increasing blood pressure on the· excretion of th~ 
~1-deoxy-17-ketosteroids, wa's examined by plotting the individual ·steroid· 
.values.agains~ in~~easing 'blood pressure. Fig. 10 gives the relationship 
be~een the diastolic and Fig. 11 the systo~ic blood·pressure and the 
\. 
'excretion of DHEA, .A and E by normal and hypertensive subje&t:s. 
No , de_finite ~·orr_elation between these pa'l;'ameters was evident 
apart from DHEA. The majority of the subjects with diastolic pressures . 
'I 
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···· . · ~~l'? ' 
Excreti~~ of ' ·and.roste~edione (ug/-24h.r) in the uz:ine o'f NORMAL and 
HYPERTENSIVE subjects 
* Normal subjects 
Code A4-A 






B32 . 0.23 
V3 2.3 




B32 L2 ,. 
To·tal· Population 
. ug/24hr ug/g Creatinine 
Mean · 2.26 2.07 
~J ±SD 1.37 1.09 
±SE 0.39 0.31 -~ 
•I 
·* . 3 males and 10 ·females · 






,  ( . 
.. 
I • , . 
: J • • 




BlS ' 8.2 
F6 ; 5.1 
F59 4.8 
B38 1..7 . 
R12 2.4 
R52 7.3 
VS7 ' 4.3 
V27 ~.-. J .... . ,' 7.6 
Fl 6.3 
B25 4.8 
IV31 4.8 " 
B61 -1.3 
F68 1.5 
R78 · 2.7 
Total Population · ~ . 
· • ug/24hr · ug/ g· Creatinine 
• • C I 
. Mean 4.16.' ·2.90 
· . . ' ±SD 2.27 1.84 
±SE . 0~58 0.49 
P < ·0.01 ·.N.S. 
·. 
' 
. \ . : 
\ . 
\ 
~ . . 
.  ' , ·· 
· . . '· 
' . . ' , . 
' - : . ~ I > ~ ; '• 
. . · ' .: . . ·. ~ . . .. \ .. ' j. o • I .. 
. - . · ' , . ..... _ . .· . . 
. . ' ._ ,_:  ·. :>.· .  -~-~- ~·._.:.: 
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Fig.- 9. Excretion of ll-deoxy-17~ketoste,roids In the urine of. NORMAL and · 
HYPERTENSIVE subje~s with increasing age . . 
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Fig. 10 ":~cretion of 11-deoxy- 17-ketosteroids in the 4rin~ of -NQRMAL and HY~ERTENSIVE 
. ' ! -
1< fUbj~s with increasing diastolic blood pressure ~ 
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. Fig.· II Excretio.n of 11-cteoxy-17-ketosteroids in the _urine of NORMAL and . 
· . . .. HYPERTENSIVE subjects with increasing~ sY5tol ic blood pressu~e 
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. " ·~ . 
Section III 
J • 
0 • • 
< • 
. Studies on the 11-deoxy and i1-oxy-17-k~tosteroids ·excreted· 







The 11-oxy-17-ketosteroids (c19o3) were analysed in ·the urines 
. ' 0 
o~ a separate group of normal and ·hypertensive subjects to that studied 
' .,' 
0 
·in the previous section. In order to cotppare _these ,. two ·sets of subjects · 
t~e 11-~·eoxy-17-ketosteroid~ (Ci_9o2) w~re also chr·omatogrjlphed.. Fig. -12 
• • ' • • • •• • • ' p • • .... 
~ives the resolution of the severi major metabolites quantitated in the 
cl902 _and cl903 steroid fractions isolated from the urine of &hypertensive 
' and. normal subject'. 
The spectra illustrate a ·satisfactor-Y resolution of th~ s.t::ero.ids 
and the abs~nc~~ of other peaks ~hich '·interfere with -4:he· quantitation of the 
steroids under study. · 
o\ • • • • 
• > 
(ii) Exc,retion of the .~ndividual 11-.,deoxy- and 11-oxy-17:.ket.osteroids 
Tables 23 a~d 24 g~ve the individu~!values for the excretion 
~ 
of A, E and ~HEA in the c19o2 fra~tion and KA,· ~' HA.,"' HE ·in .~he c19o3 
. ' 
' . fraction isolated from -the urine Gf normal and hyperten~ive subjects •. 
. ~ . , 
·The total excretion of A+E+DHEA and of KA+KE+HA+HE is also given. The t 
group~lysis of-17~ketost~r~ids is compared ' with the ~ot~l values of 
c1902 a~~ ~19o3-Ks as '111-easur~d by GLC. . . . . s . 
I . 
' (iii) Comparison of the dif.ferences · in the excretion of ll~deoxy- and 
., 
.. . 11-oxy-17-ketosteroids in the urine of normal . and ' bypertensiv~ subjict~ ·~ 
, ; . 
Tablel125 compares the mean excretion of· the seven ~j'or · · 
. ,( t 
17- ketosterQids. iso~ated ·from ~he, u.rine ot nbrmal and hypert.e~~:ve .• · 
subjects and the signif~cance of the differences between the two g~oup~ • 
. ,. 
. ' 
·. ·. , j .. · ( . 











' ' . 
'' 
r I 68 •. 
. ' 
The difference found in the ·excretion of A, . E and DHEA ·confirmed the-
·' A' y / •' 
- ? ·. ;.-
--~ ... - -. . "' ' 
• -results ·•in th~ P.~e'{!_ous"_~ect-ion. 
- - -· ~---·- ' . 
1 
0 
r. ~ · ...l ...! ,. 
. . . 
. ~ 
1 The results of the etcretion of the 11-oxy-,17-ketosteroid~ wer~· as·. _ ·· 
.. tJ ....., ·~" 
· follows: /) 
11-ketoandrosterone 
. ~ . . I 
The-excretion Qf KA was higher (1.61mg~ ·in the hyp~rtensive 
.. 
. . 
• I , • ' ' .. o ' ~ ..... 





~' : . 
.. . 
e , --- . • 
, · · . . . ' 
I • • • t'-', I ' 
' ... . f •• • 
I 
significant (Pc: 0. 01) ~ 
. , . . , • . ". I 
11-ket'oet.iocholanolone, llfl-hydroxyandros,terone and llfl~ hydroxy- ) · . ... 
etiocho'lanolone ·\ ' · 
j' The excretion of these 'three ~o~o~nd~ wa~- again in_cre~.sed in the ... 
hypertensive group., .but the'differences w~r~ not. ,st~tistically ~ignifican~t. 
• . 0 
. , , 
• 
Summation 
' ' Table 26 compares t~e summation of several steroids in . the 
in, the ~19o3 groups. In · the c19o2 group, the.· total excreti'on of 
. . 
'D 
A was . .again markedly ~~duced ~n the hJp~rtensive .. su~jects · .(~ 0.01), _ ·
iirmed the findi~g in the p~evio~·~ atu~y. . · · "~ · . · . · . ·. , ~ · 
'. ' . ..... 
a,nd c 
: , In -the c~9o3 group, "' the excretion_ of the Sa- reduead"C~mpounds, . ' 
' -
KA+HA, was highly,increased in th; hypertensive subjects (P<O.Ol). The · 
\, • .. • • ~ ' • "C'£) 
excretion of sf}...:. reduce.d co~ounds, KE-:1-HE, was. "only slightly increased i~ ... --~~ 
_;--- ~·--_. 'J 
.. ---
_the -hypertensive group but· the· diff~rence . was : ~t stat'~s-(fcaiiy signifi~ant. • 
. . Hewever;-· the total e~cretion of [U\+HA~+HE. was ~ign_ificantly increas~d,· 
{ I "b, o 0 '\ ') 
(P<Q.02) in the hyper.tertsive eubjec~s ~r~~lecti\1-g the . markedly !¥1~-~ated · 
~xcretion of ~-~uc~d co~~o~ds in. the · same g~otiJ? .- ·. ·· · 
., ... : • • • • .. ' • • • • • p ~ - - '. ' . .. . 
There ~as no _sign~fica.pt differtnce in ·tlt~ excretimi-of.- total~·!~ ___ ; __ _ 
~ • ... • • • • • ' • • ~---~'· l • ·:-.:.<L. , . 
ketosteroldi, as measured colorimetrically, in . the tw~ ... groups .of subje~ta · .:;·~ · .. 
' 'I Is, ' • I • • , .. l ~ , ~. • • .. t ... : • • o • ' • • (;:r.' 
(Table 26). In addition, . ~he co!otlmetric· va1ues did not c~r~~~~te.well - 1 
, \ l 6 , • 1 • 
' wi~h ~he c19,~2 and C~903~KS 88. me~ure~ b~ ~ (Ta~:r: "\ . ·: . . : . . '•:} < 
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GLC r~ciluli~~ otthe 11-dilo~~ari~ ll~oxy~i7~ket~stti~ok~ i~~la.t8d ;;::{, 
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· Table 23 
Excreti~n of individual 11-deoxy- and 11-oxy-17-ketosteroitls * 
· (mg/.24hr) in the urine of NORMAL subjects " .. . 




c19o2-:-KS -c1903-KS . . . ' " 
Code A E · DHEA · A+E A+E KA KE. 1IA HE KA+ ··KE+ t KA+KE 
.. 
DREA . . HA HE' . RA+HE 
. 
. . . 
. · Mal~s ~ 
,, . M1 1.20 ' 0.54 ". ---4.00 1.77 ·5. 11 1.10 '1.20 0.71 0.68. 1.81 1.85 3.65· 
·M2 1 ... 11 ' . 2.50 1.00 3'.61 4.61 0.35 0.:22~ 0.13 0.49 0 . 48 o:11 1.19 
M3 3.00 0~87 0.42 3)i4 4.29 0.09 .0.74 0.20 0.31· 0.29 1.05 1.34 
M4 1.04 2r4o 3.16 2.12 6.60 1.60 1.69 . -3.27 .-1.~9 4.87 3.58 8.45 
M5 1.54 0.58 . 6.88 2.23 9.00 1.82 0.66 1.17 0.~3 2.99 0.99 3 .. 98 
M6 · 1 .. 62 1."17 1.'35 2.79 4.14 1.10 . 0.20 ' 1.30 0.22 2.40 0.42 2.82-
M7 2.22 3.06 2.68 5.24 7 .96' 0.50 1.07 1.20 ,0. 7 _ 6 1. 70 , )..83 3-.53 I 
F~~s . I I - ... 
:Fl. 1.30 . 1.80 1.4(\ ~.10 4.50. o.so· 0.20 0.40 0.50 0.90 0.10 1.60 
. ( F2 2.00 2.60 1.00' . 4.60 · 5.60 0.27 D-.50 0.05 0.25 ·. 0.32_ 0.75 1.07 
F3 2.70 2.80 1.60 5.~ 7.10 0.62' 0.38 0.25 0.78 0.87 1.16 ~.03 
F4 ~ 0.50 4.97 5.47 . 1.01·:·' . 3.20 1. 77 0.53 0.30 -. 0.39 0.71 . 0.92 ·1.93 . . 
F5 0.95. I 1..08 7'.10 2.011 9.13 0.76 0.50 0.38 0.30 1.14 0 .. 80 "1. 94 
-F6 3.30 1.48 l:-.14 .4. 7& . 5.92 0.30 .0.52 0.80 0.42 1.10 0.94 2.04 
,F7 . 2. 70 Q.60 2.51 3.30 5.81 0.2-4' 0.53 0.71 0.30 0.95 0.83 1. 78 
F8 . . 1.64 3.61 1.36 5.25 6.61 0.20 . 1.69 a4.60 2.50 4.80 4.19 8.99 




. . G1ucuronides plus sulfates . 
"**" . Colorimetric assay I] 
I . . . 
l 
. \· : . . . • 
·V -.. ·-
~:~ .: • I ... _ - 1: ~ • • ' 
'" 
I 
. \ ... 
'** Total ... '1 
17-KS . 
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. Table 24 
. * Excretion of individual· 11-deoxy- and ll~oxy-17-ketosteroids . 
(mg/24hr) in the urine of HYPERTENSIVE subjects 
... 
, ' ~ ~ ? '.- - • - • 
. _ .. ..... -: . ' ·. 
'- . 
.. 













., HE ·N 









Differen~s in the. mean excr~tion of i~divi~ua1 ~1-deoxy- and. ~1-~xy-1~-keto·a·ter'~id~~ 
(mg/24hr) in the urine ·of NORMAL arl"d HYPERTENSIVE subj~c.ts 

















Total Population . 
±SD ~SE ' ' P value 
0.81 0.21 
1.20 o.3o N.-s~ · 
0.93 <0.21 
0.83 0.20 < 0.05 
2.06 0.53 
o.43 o-."lo .·· -~--o.-ol 
0.49 0.12 · : 
1.13 . 0.28 < 0.01 
0.47 0.12 
0.67 0.17 N.S. 
1:18 0.30· 
1.27 - · 0.32 N.S. 
0.61 0.15 
,-





. 1.67 0.65 
1~80~· 0.30 
1.59 ; p:96 
0.63- . 0.19 
2.78~. 2.04 
0.78 0.2'3 
0 .. 94 0.60 











0.11 < 0.05 
' 0.83 ·. 
0,13 '< 0.02 
0.24 




0. 84 ~ . 1.-N-:-s--.~~ 




















±SD ±SE P value 
0.87 0.31 
1.33 0 .• 38 - N.S. 
0.89 ·0;31 
' 0.90 0.26 < 0.05 
1.93 0.68 . 
0.47 0.13 < 0.01 
0.18 0.06 
1.13 0.32 ·< 0.01 
0.41 0.14 
0.65 6~19 N.·S • . 
1.32 0.46 
1.13 Ow32 N.S. 
0.66 0.23 
0.83 0.24 . N.S. 
~ ''*· . G1ucuronides p1ua~su1fates 
'' 
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-- Table 26 
~ . * Summation of the mean excretion of individual 11-deoxy- and 11-oxy-17-ketosteroids 
(mg/24hr) oin the .urine of NORMAt and HYPERTENSIVE subjects. · 
I ' • .. &-
Total' Population Males Females 
Mean· ±SE ' P value . ---------- ~an 
-------
~SD ±SE p value ±SD Mean ±SD ±SE P value 
'"' 
N t,. 3.56 1.27 · 0.33 . 3.03 1.19 0.45 3.98 1.24 0.44 
H 3.36 1.64 0~41 ~ N.S. .2. 23 0.18 0.10 N.S. 3.65 1.77 0.51 N.S. 
N 0 4.95 1. 70 0.44 6.05 .1. 75 0.71 5.81 1.65 6.-58 
H 4.02 1.82 0.45 < . 0.01 3. n · o. 78 . 0.45 . < 0.02 4.27 2.20 0.63 < 0.05 
N 1.68. 1.38 0.36 1.93 1.51 0.62 1.37 1.24 0.44 
H . 3•46 1.58 0.39, ·< 0.01 4.51 1.50 0.86 < 0.05 3.14 1-.45 0.42 < 0 .01 
'N · 1.37 1.02 0.26 1.49 0.98 0.40 
" 
-1.27 1.04 0 .. 37 
H 1. 79 1.31 0.3~ . N.S. 1.74 1.01 0.58 N.S. 1.80 1.39 0.40 .N.'S. 
N 3.04 2.30 0.59 2.24 0.91 3.64 2.27 0.80 
~ . ' H .5.25 2.66 0.66 < o.o~ 
3.57 




,, : _ .. ·_ 17-KS 
N 6.9i. . .3.51 
--. 
. .' 
H- .-: ·- ·4.58 . 3.41 
.'.:. _. .. /·~Gla~~ronides plus . su~fa:tes ~- ' ** . . 
.-. 1. · -: Colorimetric as_say 
.' ' . . l 
I ' • { 
· ' ·. ' 
- . / -= ~ . . 
. . '/ '~ ' 
(· 
' 
0.91 5.08 8.96 7.00 3.04 5.42 9.00 









. ··f · 
. . 
if. 
' . ~ 
compounds, excreted by normal and 
Steroid ratios 
The ratio of ~/5~-red~ced 
, . 
• 
hyperterisive subjects is given in Tab~e· 27. The ratio of A1E was 
. . ~ 
si~ificantly · increased in ~he.hypertensfve group (P 0.05), presumably 
due to decreased excretion of S~-reduced ·compound (E) ; and confirme.~ the 
finding in the previous ~tudy. 
69. 
The ratios of KA/KE, HA/HE, anc:~· KA+HE/KE+~E were also elevated 
markedly (P 0.05, 0.~5 and 0.01 respe~ttj.vely) in. the hypertensive group, 
. . 
and refl~cted the increased excretion of · ~-reduced compounds (KA and HA). ~ 
This suggested that in th~ for~tion of .c19o3-17-~etosteroids by the 
' hypertensive group, the Sa-reductase ac~ivity may be increased relative 
to ·the Sl3·. 
Table 28 gives the level of significance of the differences in 
D ' 
the excretiop. of c19o2- and c19o3-~ exp~essed as mg/24h~ urine~ . lhe . 
ratios in mg/g creatinine were _not calculat~d since they would be inde-
f 
pendent of ' the creatinine concentration. 
(iv) Relative Sa- and 513-reductase activity . ·· · 
:J ' . ~ 
The relative proportion of 5ar and se-redu~d c19o2 ' and Ci9o3 
steroids were compared between subjects with normal blood pres.sures.· and 
between the hypertensives. Table 29 tl8ives the mean excretion of the. 
individual Sa- and sa-reduced comp~unds and th~ ~tatistfcal_ significance 
, of the Clifferences in the:tr excretion. 
Normal subjects 
· The mean excretion of · the· Sa.- and sa-reduced compo"Qnds in the 
I 
' . ~ 
. ' 
c19o2 and c19o; groups were ~imilar . among: the normal 'subject·s • . However, 
. , . . . . . I , . 
, there was ~ tendency for the Sa-compounds~ · A,KA and .KA plus. HA to be 
incl:eased. but the differences' were not significant·. 
I ~ • ~. 
. ' ·.: · 
·' 
', . '( 
. . . ' ' .. . . 
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a · 2.32 
r . 
Table 27 
Ratios of 5a/5f3- reduce.d compounds in the 
·urine of NORMAL and HYPERTENSIVE subjects 
. . -... -~ -.. ...:.....: 
Total Po2ulatiori Males 
Mean :tSD :tSE P value 
. . 
P value :tSD ±SE 
·1.20 0.42 1.61 1.09 0.45 
3.09 0.89 < 0.05 " 3.29 1.57 0.91 < o.os 
· o.7Z.. 0.26 1.75 1.72 ·0. 70 
2.53 0.73 < {).05 .4 .06 2.91 1.68 N.S. 
0.73 0.26\ 
2.01 0.58 < o.os 
2.10 1. 83 0 0.75 
, 
2.48,. 4.80 4.30 N. S. 
0.2·9 0.10 t.S4 1.77 o:12 
' 1.12 0 • .32· ~ 0."01 3 .• 37' 1.88 1.09 N.S. 
Females 
Mean :tSJf :tSE P value . 
' 
1.52 1.26 0.30 ... ~ .~ 
2.95 2.82 0.10 < 0.05 
1.38 1.31 0.34 
3.08 2.68 0.67 '< 0.05 
1.60 0 . 40 0.36 
3.24 2.86 0.72 < 0.05 . ~ 
1.39 . 1.26 ·0.32 
-2.57 1.41 0.35 < 0.02 
' • ~ 1. . • 
. .. 
,. 
\ Table 28 
"'• ,. I 
* Significance of differences . ** in the excretion of 11-deoxy- .and ll-o~~l7-ketosteroids 
. . ,;. . . *** 
expressed_ as mg/ g creati¢-ne . . , **** . . .. . -. . . '· . as compared to mg/24hr in the .urine of NORMAL and HYPERTENSIVE 

















Ste~oid r~tios·. ( 
. A/E. . •. 
KA/KE 
HA/HE 
:·: · · ·. KA+HE/KE+BE . . 
. ~ ***· 
. Total 17-KS -:· 
• • 0 : · 
.. 
,• . 
Total . Population 







N.S. N.S •. 
· N.S. N.~. 
• o.oz 0.01 
0.01 0.01 








- *** **** omg/ g ·. . mg/24hr 
N.S. N.S. 
-'N. s.. 0.05 
0.05 0.02 
0.01 0.05 




N.S • Q.02 
0.05 - 0.05 
-
N.S •. N.S • . 






* . ** ·~ 
. · Student '"t' - te~t; . G1ucuroniaes pl':ls, su1fat~s; Colgr1:metric assay; P -·-' 
\'': 
f , · · • 
Females 



































Statistichl differen,.s were evident in the excretion o£ the 
5Q.- and se- pairs i~ both the, cl902 and cl903 groups by the hypertensives. 
-~ 
. In. all cases, the Sa-· compounds were ~xcreted in greater amounts than the 
~... . 
5f3. 'Among the c19o3 compounds the possible Sa- directing .influence of an 
\' ' ' 
ll~oxy-group was eviden~ in the excretion of KA and HA. 
Comparison of the levels of Sa.- and se- reduced compounds 
excreted. by the normal and hypertensive subjects indicates a relative 
\ 
deficiency of 513- reductase. activ;ity in the f~rmation of the ' c1902-17-:-keto-. 
. steroids in hypertension. By contrast, the Sa- reductase activity appears to 
be significantly increased in the reduction of th~ 11-ox:Y-17-ketosteroids by . 
the hypertensive g!oup. I I 
(v)· Effect excretion of 11-o (mated .17-ketosteroids 
e on the excretion o~ the c19o3-KS in the urine· of 
normal and hypertensive s bjects is illustrated in Fig. 13. The majority 
of the hypertensive subjec s exhibited higher levels of KA and HA than the 
normal subjects ,ole range of ages studied (21 - 69 years). 
. ' ' 
\ 
(vi) Effect of blood pressure on the excretion of 11-oxygenated 
· 17-ketosteroids 
The effect of inc 
' ' definite correlation betwee 
diastolic and s~stolic bloo~ p~es~ure yn. 
shown in Figs, 14 and 15 respectively·. No . 
th~se param~ters were observed except ~hat the 
' ' ' 
excretion of KA and HA appEfared ··to increase with diastol:f,c pressure over 90 
·and systolic pressure over· 140~ ' f , However, . several i ndividuals were atypical. 
. . - J 
I 
I ,. I . . 
I ·.. . . 
. , 
.· 
• • • \ • • 01 ·" 
. . : 
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~erences in the mean excretion of Sa- and 5~ reduced 17-ketost'e-roid.s__--~ . . . 
(mg/24hr) ~n ~he urine of NORMAL ahd of HYPERTENSIVE subjects · 




















' Total Population 
tSD ±SE, P value 
0.80 0.21 
·o.96 0.25 · N.S . 
0.50 0.13 
0.47 ' 0.12 N.S. 
1.18 0.30 
0.62 0.16 N.S. 
1~38 0.36' 
.-i:o2 0.26 N.S. 
., 
1.19 . 0.29 
o~ao 0~19 < 0 .• 02 
1.13 0.27 =· 
0.67 _ o:16 < o.os 
1. 27 0.30 
o. 74 o.1a < o.·o5 
1.60 0.39 




Mean ±SD ±SE · P -value 
1.67 0.65 0 0.26 
1-.59 0.96 . o.-39 N.S·. 
0.94 0-.60 0.24 
G •• 82 0.50 0.20 N.S. 
' 
1.14 0.97 0.39 
0.67 0.53 0 .-21 N.S. 
2-.08 ' 1.45' 0.59~ 















0.-18 < .0.01 
0.61 
0.42 < 0~05 
' .0 ~ 84 . 
. o.24 < ·o.os 
0;86 ... 




Mean ±SD ±SE P value 
2.09 0.82 0.31 
. 1.89 0.92 0.34 N.S. 
·o.4~ 0.19 0.07 
0.57 0.43 . 0.14 N. S •. 
0.94 1.32 0._46 
0.69 0.66 0.26 N.S. 
1.39' 1.24 .·0.44 
1.27 1.04 0.3.7 N.S. 
. • , 
, . 
-~ 
' 2.31 1.33 0.37 / 
1.34 . 0.88 o.24 < o.-os 
1.50 l.clJ 0.-~1 . 
0.84 . 0.63 0.17 < 0.05 
-1.64 1 .13 0.30 
0.96 0.83 . <Q •. 24 < o.n5 
3.14 1.46 0 .• 40 
































. ' II-ketoandrostero.ne 
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Fig. -14 Excretion qt 11-oxy-17-ketosteroids in the_ urine of NORMAL and HYP,ERTENS IVE. 
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Possible diagnostic value of <DHEA and · the ratio A+E/DHEA in 
es~ential · hypertensien~ 
.,, The excretihri 
; ,-I ,,J. ,,- of DHEA and the ratio o(A+E/DHEA i_n the · normal and 
. . 
: hyperteru3i,.Q'subjects · are illustrated in Fig. 16.· It was of interest to 
note that 82% of the\ nonit.al subject's excreted more than l.-2~g DHEA/24hr urin.e, 
whereas 90% of the hypertensive subjects excreted l~ss than 1.2mg/24hr~ 
For_ the ratio A+E/DHEA, ~t was found that' 85% of .the'normal 
~tibj:cts had,';~tios less than 4, ~hereas. 73% o~ ~e hype-~te:_~~-i)~u~j·~·c.ts 
. 1(h~d ratihs gr~ater · than 4. · . . ------ ---· 
' 
It would. seem, therefore, th~t there is a good correlation 
-e ' 
~ . . .-.... 
between the excretion of DHEA -or the ratio.of A+E/DHEA in the essential 
hY,Pertensive popUlation' studied, which could be pf value in suppleme~ting 
. ' . 
- . . 
~ 
the data from blood pres~ure me~surements. Whether it has any further . value 
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'Studies on 'the 17'-ketogenic steroids excreted . 
in the· urine of NORMAL and HYPERTENSIVE subjects 
• • , + 
(i) GLC resolution 
The c21-corticos~eroid fraction which was isolat~d from the urlne 
. . . 
of normal and hY.pertensiv~ subjects was measured indi~ectly as 17-ketogenic 
steroids by oxidation to 17-ketostero~ds.as described in the methodology 
· section. Each component of th.e 17-ketogenic steroid fraction was then 
' .I 
· resolved by GLC as its TMSE der~yatives. · Fig. 17 compares the resolution _' 
of et~ocholano!one, 11~-hydroxyandrosterone and ' lla-hydroxy etiocqolanolone, 
. ~ . ' . . 
which were derived from the corticosteroid fractions in the urines of a 
normal and a .hypertensive subject. The possible source of these steroids 
in the 17-ketogeni.c steroid fr~ction has be~h discussed in the methodolo· ~ 
' 0 • 
section. ·. The e;pectra illustrate ,a satisfactory resolution of the steroids 
·studied and the absenc~ of. ~nterfering peaks. 
(ii) /. _ . E~cr~tion of . indi~idua1 ~7-Ketosteroids derived 'from - t_h~ 
17-Ketogenlc steroids · 
.. 
I 
Table 30 gives the individual values for ·the excretion of the 
• I 
three major 17-ketosteroids in the urine··'of male and female "normal and 
. 
hypertensive subjects.- · The individual glucuronide and sulfa~e- conjugates 
-
were not analysed .in this study_.· 
. . 
(iii) Comparison of differences in the. excretion of 17-Ketosteroids and 
ll-deoxy-17'7ke.tosteroids derived from the 17-ketogenic steroids (Tables 31 
- V J 
· and 32 ! 
. . 
.. 
:Etiochol!inolon~ was found to be a.major .steroid metabolite that 
' . . . 
was·_ derived· from .the 11-deoxy-corticosteroids 'by the ketog.enic react±on • 
. . :, . ' ' ' - .. \ - - : . - - .. 
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\ Table 30 - r 
j · Excretion ot individual i7-ketoster~ids* (mg/24hr) derived from the . 
· i7-k~togenic steroids hxcreted in the urine of NORMAL and HYPERTENSIVE subjects 
Normal 
Code E HA HE -HA+ifE . ** E HA ... Total 
+HE KGS 
-Males·. 
Ml 0.41 :1.67 i.98 3.65 . 4-.06 -. 10.6 . 
Mi LlO 0.98 1.98 2. 96 .· 4.06 . 11.5 
M3 -,1.20. 1.68 z'.l4 . .3.82 .. 5.02 6-~s 
. M4 1.59 1.5'4 4.43,. . 5 •. 97 7.56 . 8.5 
M5 - . 1.20 1.70 1.90 . 3.60 4.80 7.0 
M6 . 0 1.30 2.03 2.16 4.19 5~49 27.6 
M7 ·. · 1. Oli -~ 0.88 2._44 3.32 4~36 7.7 
Females' -;., ~ ,J 
Fl - 0.65 1.90 1.60 ' 3.50 . I 4.15 6.5 
F2· 0.58 2.22 2.79 5.01 5.59 11.4 
F3 0.74 0.86 1..65 . 2.51 3.25 . 6.1 
F4 0.10 0~64 0.61 1.25 1.35 . 6.4 
F5 1.00 1.49 1.64 3·.13 .4".·13 10.9 
F6 0.58 1.73 1.36 3.09 3.67 10.5 
F7 1.90 2. 70_- .2.80 5.50 7.40 . ~-8 . 
F8 ' "1.07 2.;70 5.20 7.90 , /"' 8.97 '7.7 

























Code E- HA HE. HA+HE 
Males 
F6(). 3.80 2.50 2.40 4.90 . 
F65 1.11 6.31 7.07 13.38 
F66 1.80 4 .• 60 4.90 9.50 




B12 1.08 5.20 3.9D .9.10 
'B59 0.59 3.80 3·.80 ·6.60 
B64 0.71 1.01 2.89 3.90 
F61 2.~ 00 2 .·50 5.90 8.40 
F62 1.01 6.14 6.42 1f.56 . 
F63 L 70 3.50 6.50 10.00 
F64 1. 70 4. 70 4.70 9.40 
F69 0.54 1.13 1.47 2.60 
R72 - 1.14 2.32 1. 73 4.05 
V32 0.65 2.60 2.20 4.80 
V42 2.14 3.20 4.78 7.98 
V59 4.80 o·.69 0.95 1.64 . 
R54 .0.85 4.89 6~90 11.79 
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Table 31 
. . . ·. . . · .. * . '- . 
Differences in the excretion pf 17-ketqsteroids (mg/24hr) derived from the 17-ketogenic steroids 
·. excreted inr the urine of NORMAL and of HYPERTENSIVE subjects 
Total PoEulation Males Females 
., . 
Steroids Mean ±SD ±SE P fvalue Mean ±SD ±SE P value ,. Mean ±SD ±SE P value. 
.. .. Individual values \ :i ., E N ' 1.06 0.58 0.15 1.12 0.33 0.13 1.02 0.72 0.25 .. I• 
• 1.11 . 1.85 ·. ' . H 1.57 0•28' N.S. 1.19 0.69 N.S. 1.48. 1.08 . 0.31 N.S. 
' HA J.o2. · 0.34 1.47 N 1. 75 1.23 O·.Jf 1.50 0.83. f 1.95 0.51 
·u 3.22 . 2.07 0.52 3.56 2.35 1.35 N.S. 3,13 1.97 0~57 0.05 




.. HE N 2.46 0.71 0.18 : 2.43 0,38 0.15 2.48 0.83 0.29 
·' - H--- 3.97 ' 1. 7.6 . 0.44 q.o1 -· 3.83 2.07 1.20 N.S. 4.01 l.64 0.47 0.05 ... ~ 
·. Summation I . . .  HA+HE N 4.21 1.79 0.46 3.93 -0.90,: 0.37' 4~43 2.22 0.78 I 
.. H 7.20 -3.64 0.9·1 0.01 '7 .39. 4.42·· 2.55 N.S • 7.14 3.36 0.97 0.05 
.... 
t E+ N . 5.28 2.24 0.58 5.05 1.13 ·0.46 5.45 2.8(} 0.99 
~ f •. 















-HE H 0.81. ·-. 0.55 . 0.12 N.S. 0.92 : 0 •. 06 0.03 -· -N.S. t 0.78 0.60 . 0.17 . N.S. 
·-
. . 
.:p: E N . 0~24 0.09 o.oo 0.28 0.07 o.oo ~ 0.21 o.·og 0.03 
. . . 
.HA+HE - '· u· .0.37 0.65 0.16 N.S. 0.36 - .. 0.26 ' 0.15 N.S. 0.38 ·o. 73 0.2i . N. S • 
"'* · 
. . 
-Total ,- -~ . :N 9.36 5.-19 1.34 lb38 6.82 3.-78 7 .·78 2.44 0.,86 
' 
. . 17-KGS · .-- ·u 4. 72; 3.47 . 0.89 o.q1 5.05 3.00 ·-1.23 N.S. . 4.62 . . 3.60 1.-08 0.05 .. . . 
... 
•' '. 
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Table 32 
- . . * ** Sigri~ficance of differences in ~he excretion of 17-ketosteroids derived from the 17-Retogenic steroids · 
~d expr~ as TIJ.g/ g creatinin~ *~* as. compared to -~g/~4h~ in . the urin~ o·~ NORMAL and HYPERTENSIVE ~j ects . 
Steroids · 
· Individual values 
E 








. Total. H-KGS *** 
* ' 
't' test' Student 
** Glucuronhles plus· 
































0.05 N.S • . 
o.os N.S. 
N.S. ·. N.S. · 
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No.evidence, however,. wa~ obta~ned for the pres~nce of the ~- ·reduc~d 
steroid, androsterone, in the urine of the normal and hypertensive subject,p. '• 
. ' 
The mean excretio~ of E was -slightly increased in the hyperten~ive group 
over the normal group, but the difference was not statistically signif~cant. · 
,. 
·,· 
11-Qxy-17-ketosteroids derived from the 17-ketogenic steroids 
The mean excretion of both the Sa- (RAJ an~ 5~- (HE) ll-oxy-
17-kE7tosteroid was higher in th~ hyp'ertensive .gr6up' as compared t~ the .group 
of normal subjects. When the ratio of HA/HE was· compared in the two gro~ps, 
no. signific~n.t difference was evident, presumably indicating equal Sa.- and 5~ 
reductase activity in the formation of these metabolites which are derived 
- 0 
from the corti~osteroids. 
. ' ' 
The ~ummations of HA ~nd HE indicated ~ greater 
excretion. ol' these. 'll-oxy-17-ketosteroids by- the hypert-ensives~· · 
. -
I . . 
The colorime~ric analysis of the. 17-k~~og~nic s .teroids_ revealed a 
' -
decreased excretion of these coropounds by the hypertensive· group that was 
. statistica~ly significant (P 0.01). However, the summation 9f the individual 
. . 
major 17-ketogenic steroids, namely E,"HA and HE, as measured by GLC, again · 
failed to correlate well with- the colorimetric assay' since the former group 
- . ' ( 
·~ of co-mPounds , was signif~cant1y ele~ated in the hypertensive group (P 0. 001). 
'11-oxygenation index 
ll 
The ratio of the· 11-deoxy-'17-'ketosteroid, E and the 11-oxy-17.:.keto-. 
steroids, HA and HE gives an !'11-oxyg~mation index". No significant · 
difference was foUnd in this value when calculated for the normal and hyper-
"" c~ . . ,.: 
tensive groups.· This, may sugg--eBrthat no significant--difference ·exlsts in 
- t~e 11~-dehydrogenase enzyme activity in the met~bolism of corticosteroids 
by the two groups. 
.. 
,. (iv). Relative 5a- and 56- reductase activity : 
' ' 
In the previous section the excretion· of ~ and 5~- ·reduced 
. .. . 
. • t . ~ 
17-ketosteroids by the · no~1 and hypertensive subjects · we~e ccimpared. 
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In Table 33 a comparison is made of the relative Sa- and sa- reductase 
.  
activities among the norm~! subjects, and a'!so among the hypertensiv:e 
subjects -by comparing the level~ of_ 118-hydroxy androsterone and 118-hydroxy 
etiocholanolone obtained from the c21-corticosteroid fraction in each group.' 
The mean excretio~ of 118-hydroxy etiocholanolone was slightly· 
higher than ll~-hydrox1 andro~terone in both the normal and hypertensiye 
• ' < 
groups, but ~~e differences were not statistically significa?t• This may 
.j..,. ' 
suggest th~t in the metabolism of corticosteroids by both ·normal and hyper-
J 
tensive .subjects, the Sa- an4 S8-reductase;·activities were.· approximately. 
. , . . . . . . I 
' . ' . ~ ' 
equal, and may reflect the influence. of b~th the 11-oxy function and the . 
,. ! 
~ . 
cortico'steroid side chain. ·/ 
(v) Effeat of age on the excretion of 17-ketosteroids qerived fro~ the 
·17-ketogenic steroids 
Fig. 18 illustrates the 'effect of aavancing age on the excretion 
I 
of 17-ketosteroids·by normal and hypertensive subjects. The -regression curve 
. . 
does not show any signifi~ant change .in the ~evels of these steroids with 
incr~·asing 'age. The major·ity of the hypertensive subjects excreted higher 
l~;~ls . of 11~-hydroxy androste~one and 118-hydroxy etiocho1~nolon~ than .the 
normal subjects over the age range studied. _ .... - -
.. 
. (vi) . Effect of blood pressure on the excretion of 17-ketosteroids derived · · 
from the 17-ketogenic steroids 
e 
The. effect of ~ncreasing diastolic and·systoltc 'blood pressu~e. on 
. . . 
the. excretion of '17-ketosteroids is shown in FigQ. 19 and .20 respectively.· · 
No correlation between these parameters was found." 
.I 
· . . 
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Differences in the mean exc-retion of Sa.- and 513- reduced_ 17-ketosteroids * (mg/24hr) . d.erived 
from the 17-ket~genic steroids excreted in the urine of0 NORMAL and of HYPERTENSIVE subjects 
.., 
Normal subjects , 
Total Po;2ulation Males Females 
Mean ±S.D ±SE P yalue Mean - _ ±SD . ±SE P value Mean · ±SD ±SE 
J 
L.75 1.23 0.32 1.50 0.83 . 0.34 1.95 1.47 0.52 
2.46 o. 71 0.18 N. S. 2.43 0-.38' 0·.15 N.s. 2. 48 o. 83 . o. 29 
-
Hypertensive subj~cts 
3.23 2.07 0.52 3.56 2.35 1.35 3~13 1.97 0.57 
3.91 1.76 • 0.44 ~ N.S. 3:83 2.07 1.2q N.s. 4.01 1.64 0.47 
• 
* ... . . . 
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DISCUSSION 
Steroid metabolism -'has been extensively investlgated in the normal . 
healthy human anp in a variety of ~isease states during the past thre~~ 
decades, but relatively little attention has been given to alterations, in · -
-
steroid metabolism that occur i~ essential hypertension unt~ relatively 
" Several rep_orts have indicated that essential hyp~rtens:f:~a may · 
. . 
' . . . . . . 
~xcrete'abnormal levels of pregnanediol,.pregnanetripl, pr~gnenetriol 
. . . 
(Nowaczynski et al, 1960, 1964; Vermeulen anq. Vender Straeten, 1963), .DHEA-
• Q • • : ..... .,.-:=-. w • 





Motohashi, 1965; Kornel and Takeda, 196 7, Kornel et al, 1969) ~ · In additicm', 
- . 
' Edwards has isolated .an ubusual 11-oxYgenated steroid metaboli~e from the ~ 
. ' . 
urine of hypertensive children (Edwards . et al, .1968). : 
'r-q ~he pres.ent thesis these studies "have been extended by 
. systematically investigating the .11-d~oxy and 11-oxygenated 17&ketosteroids, 
. . / ' . . 
tpgethet with. the 17-hydroxycorticoster~ids that· are excreted in ~he urine of 
"' 0 
' . 
normal and essential hypertensive subjects. • The majority of the normal and · 
. ' 
. ' . essentia~- hypertensive19ubjects resid~d . in ~our Newfou~dland communities and 
. . . . ., . . . c • . 
had·take~ part in a hypertension surv~y • . The epidemiological aspects of this 
. . .· '· : . . I , - .. ' . ·. . 
· SUfVey have bee':l reported els~wherE7·. ~bott et al, 19-71~,b; Fodor et al, 1973). 
I "' 1 }J ~ ..; 
' . 
Single 24 hour urines, collecte~ from .both male and female vo~unteers in each 
•'· ' . . . . . . ~ 
communi:ty' and were . fro~en i1J:!llled1ately ~after collection and kept deep-froz~n 
' . 
~ntil ~alysed~ A second group of subjects was drawn from among normal 
laboratory personn~i:in- gqod health, and ' formed part ·,of the normotensive gr~up •. 
. ' . . · . 
The' · distriltution. of ages in both . male and female groups is rather 
. . ' 
' . 
. 
~ ~ '. . . ~ ' . 
broad since the: urines were collected from all individuals who were willtng to 
. . . ~- . .... . . 
'-'! . " 
participate in the .study: . In 'this respect the· -s~lection of subjects was ·un- · · 
•• :.. • '•, I . . . 
~ . . ~ 
'biased and included··a broad spectrum of individuals • . However, the failure to ·. 
·, ~ . . .. 
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select subjects at 'this stag~ required that the. results b~. examined in 
s~veral ways as discusse~ below. 
It can be see~ from Tables 14 and 15 t~at there was considerable 
variability in the · body weight; .v~lunies of urine voided and grams of creatinine · 
If 
' excreted by individuals Although it· is recognized that the excretion of cre~~ni~e· is a f~nc~i~~ of body .muscle ~ss, ~o significant correlation·~ould 
·be Jde in the present s~tydy. I~erestingly, sev~ral -~f. the normotepsive 
• Q 
subjects f~om a~ong'the normal ' laboratory personnel excreted less than~lgm 
' of cieati~ine per _day. In or.der to i~~lude · as many supjects '~s poss;lble for .. .. 
" the steroid studies, it was d~cided to analyse all the urines collected, 
. . . . ' . . ... . 
. ~ ~ ) -: .. .,.-_ . ' ,. 
ir~~spective ol: the a~~; body_ weight or ~reatinine excretioll. Steroids were 
. - I . • . 
then expressed in two ways; as mg/24hr urine and .as mg .steroidlgm c~eatinihe • 
. , . . ' 
. ':(h~ latter •wa·s·. included in order to overcome varia~ions in the completeness 
of urine coll~~tion which may ha~e occurred; I Tables 16, 20, 22, 28 and 32 
. ·. 
indicate that;. the results -eJti>re~sed in this{'iray_ wer~.tno~ significantly 
. / ·-'S . 
different· from r-esults exp1;.essed ~·a ~k/24llr urine: (' ~ ---- · ·---· " 
• • (I' . , • • • • r . . ... ........ .... ..... J .. ~.. "" 
• 
1 Thre'e normotens'iv~oand seven· h}rpertensiv:~~ubJ~~ts ·excreted less 
' . .;,) 
than !o.Sg creatinine per 24hr, whi~was .more than one standard deviation 
below the mean ·as calculated for the pop~lation 9-t:udied. When these._ subjects 
. . . 
were excluded from the calculations,· it was OQserved that the statistically 
• • • • • ~ • 0 
significant· differences which had been found' in the excretion of several 
, , r'" • , , , • • l , ' ' '. 
0 6\ . t ' 
steroids were ·not altered. It ··was therefore c·oncl:U4ed . that the. analysis. of 
. . . ,. 
.r~~ults obtained from all of the individu~ls st~died was valid and was ~ot 
. " '\ . . ' ,. . 
biased by incl~diri.g those 'sub~ ec~s . with low creatinine, e~cretion r.at_es • 
. 
Excretion of aldosterone· ~n essential hYpertension 
I 
J . 
The urinary extretion of aldosterone was dete~ned for the 
' ·. . . ., .. ' .. . ... . . 
• r -- • "" .. ·' • 
· subjects in 'the"pr_esenf ·study primarily in order to ·eliin:J.nate· primary -· 
. . . .. . . : ; \ . ' . . ' 
·, , 
aldosteronism as a 'cause of . the _bypei"tepsi~n .• . There .i~ ~o~s!derabie contr~yersy 
a 
.. . 
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·· · · hr 
I ' ,,~) 
as t'o •whe~her .the 'excretion·· of alaost.eJ?one ·is altered in ess~nti~l hyper-
I L, ~ ten~:!on, so it was Q,f interest to c_ompare. the result's with ·"ather workers. . .. _ :· · 
\ ~: do~bl~~· 'isotope · deriva$-e ~ assa~ .proc~dure ·th~t . ~" ;de_vel~~~d. . ;;.0~ 
. ·._for·. the estiniation 'Of urinary aldosteron~ inyolves several m~?.di.ficatisms_ ~.f.--~~J · \,_ 
• • ,. to • ..; l ..... d···· 
... , · 
«; • 
· ... existing pro·cedures ·as discuss.ed in the Methods section, anq';·reported by 
• " • t q • c;. .. \ • "'. :' • ~ . 
Dey~~ al, (~972). The-overa~l r~c~very was rather low (9.3% ± 1.8), but 
both. precision and repra'duclbhity were goo<l. Since . the ~s~ay includes,p~e .... 
• ': • • • • • J , • • 
liminary 'hy.dro,lys~s 'wi~h cold acid, it ~ea!:W~es bot.h 'th~ · fre.e and ac.id. labile 
. . ~ 
·' . ~ 




















f • I _ I _. t ' -
cedure. fo.r"the estimation of urinary~ aldosterone~ .. · {1 . . , • . . 
, . • Thirty-three•normal aubj~ts excreted 1~1 - ~0.4ug' ajdo.sterone' per 
·24 hot,~rs"as com~ared to 2.6- 18.7~g/241lr .extr_ete.d ·by.: thirty-seven hypertensive 
~ 
subjec:ts.. The difference between the two _group,s was· therefore not stat7istically 
significant. There is arl extensive literature on aldosterone excretion in 
·~, 
essential hypert~sion and diff~rent ranges have be·en .reported by several 
• 0 • • 6 • 
.. 
· . 
• J J • • .... 
workers • Both normal and hypertensive grou9s'have bee~ reported as excreting 
. ~ 
~similar r~ges .of aldosterone-by: Slaton and Biglie.~i, 1965. (5-25ug/i4hr),, 
' . . . . . . . . . . . ' 
Ledinghaut et ill ;·~967 (2-3~ug/24hr) , · B~glierf 'e.t al; 1970 (4-l?ug/24hr), 
. . " . .,.. . 
- • , , • • - ~ • • I il 
.. . 1972 (2-2.3ug/24hr), -Brunner et al, ·1972b (1-25ug/24hr). Others helVe .reported 
- , • \ I 
. . ; f . 
" ~ 4 • · eleva~ed values for the hypertensive .group: "NoW"aczynski et ·al, 1957 (N~2 •. 2-10· 
~ . 
' and H:l.5-40ug/24hr), ' Gar~t· et al:. i960.· (N:3.1-21.1 · ~nd H:3.1-.39.'lug/24hr), 
, . 
Q ' • " • 
. ~ne_st et al, 1960a (N:l-11 and H:l,-36ug/24hr)-, ,1961 (N :1-9 and H:'~-36ug/24hr) . 
u. 
. . . . . .. -
. ·and V~im~g et. g-1,~. 1961- (N:2-12 ~n.d ~·:3.3 .- . 19.6ug/24hr). 
- • • # ,. 
. ~ the secte~ion rate ·of ~~dosterone . in benign ess~ntial hypertension 
. .. 
.. · may· J>e either normal (Laragh · et al, 1960a, b; 1963; Kaplan and Silah ,· 1964; 
.... . . , . 
- .. ·.; · ~ - . . . . ,. ( , " .. 
· · Sla~o~ and ~iglieri, 1965)., or low (Nowaczynski et al, 1971, 1972), although 
• J 
reC:en~ evid~nce suggests ~ha~ ~he met.abolic. cl.eatiance . rate · of aldo!it~rone 
·may be .decrea~ed"-:in be~gn essential hypertens,;l.on (Nowaczy~ki. · et al, 1971, ~ 
' . . 
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. . , j 
-hypertens~on, one(wou1d expect the excf.~tion rafe of aldosterone to also be .· 
.\ ' :1 
., reduced, but• as indicated above this ~s nc,>t inyariabli so. ·An alteration in 
• I I ~ , ' r • 
. ,~ . . . ' 
' the. hepatic metabolism· of aldostero~e _in essential hyPertension has been 
~ . 
- . . -~ : . . . 
suggested from observations that the urinary-excretion of ,the "oxo~conjugate" 
. - .. ~ 
.. 
of a~dosterone~is higher ~~ari its 'tetrahydro glucuronide conjugate. The ' 
sianificance of this finding is not clear but may indicate a possible alter-
. . 
\ J 
ation in the ~epatic inactivation of aldost~rone in e~ential hyperten~ion 
,(Nowaczynski et al, 1972). ~ 
. ' I 
.-
•, 
Excretion of dehydroepiandrosterone 
. I • . 
. The first ~eport that the excretion of dehydroepiandroste~one was 
reduced in the ' urine of hypertensives was ba~ed on the failur~ t~ detect any 
_,. 
D!fEA (Kolb~l et al, 1964) ·• MOre precise methods however, have ·revealed a 
. . . 
marked r~duction in the excretion o~DHEA-sulfate in the urine o~ essential 
.. ~' 
qypertensives ·as compared to no~l s~bjects (Nowaczynski et al, 1968). 
. . 
The hypertensive subjects studied in the present work also e~ibited a 
significant reduction in the excretion of DHEA-sulfate with a mean of 
' -
0.46mg/24~r .as comp~red to ; mean of 3.07mg/24hr (P 0.001) excr~~ed by the 
~ormal subjects. By contrast~ the excretion of the glucuronide conjugate of 
r ' , .. 
DHEA was not altered, which also confirms the wo~k of NowaczynsKi ~t al (1968). 
' . 
The reduced excretion of DHEA-sulfate is therefore unlikely. to be related to 
If 
its possible hydrolysis and reconjugation with glucuronic acid. When the 
. . ' 
'· to~~ · excr~ti~n of ~H~ by the two gro~ps ' was ~ ~ompa;ed by ·a~mmatio~ of bot~ 




. a~~ glucuronide conj~gates t it was evident that the lower total . '· 
on of DHEA .by the essential hypertens~ve group was the result 00f the 
. ~ . . 
. . ' 
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The total excretion of. DHEA (glucuro~ides .. plus ·sulfates) b~ the 
.. 
normal subjects ranged from 0.42 ~ 7;lmg/24hr, which is comparab~e to the 
. ' 
. • I I - ' 
results of Vestergaard (1962, 0.4- 9.3mg/24hr), Nowaczynski et al (1968, 
0.8~ - · 6.4mg/24hr), and Jungman et al (1967, .0.45-:- 6.lmg/,24h~). · Lower 
I • I • ' • 
... v~lu~H~ve bee'n z:eported by Keu~man and Maso~ (1967), Brooksbank·.and 
. • ' l. ' 
Salokangas (1959), Beale et' al (197la) and Faucette and CawleY. (1971). 
The reason for these variations is not known, but may reflect differences 
in methodology. In adpition, considerable dpily variatio~s in the . excretio~ 
. " . . . ... . . 
. ' 
of ~HEA have been reported (Keutman and ·Mason, 1967), and more recently DHEA 
.., I 
has been found .to be secreted episodi_cally, rat~er . than · diurnally (Saxena · . 
~ 
~ . et al, 1970; Rosenfeld et al, 1971). The latter might ~e expe~ted to affect 
1 
th~ estimations on single blood samples, but is probably not ~o critical .for · 
. urine that is collected over a 24 hour period. 
Keutman and Mason (1967), in a detailed study of ·the influence of 
~ , 1 I · 
. age on the excretion of 17-ke'tosteroids ,, found a pro_gressive decline in the 
.r.;. 
' 
. excretion of D.HEA' by subjects of 'both ... sexes age~ from 20 years to over 60· . 
• .1 • 
. _:,years. In the present study, the · number of subjects at each age was limited, 
but Fig. 9 ~llustrates that the excretion of-DHEA did not decl~ne ~aticeably . 
with advan~i~g age. The largest', group consisted of hypertensive females (28) · 
. . 
who excreted a m~an of 0.7omg DHEA/24hr in ~he age range 39- 69 yea~s, 
. . . 
· whe;eas the normal female subjects (io) excreted a mean of · 2.64m~ · DHEA/24hr 
. . . . ' ·· \ . . ' . 
. . ~ . . 
in ~~e age range 21 - . 7~ years. Keutman had· t~e highest values for , DHEA in 
' ; . . 
the females aged 29 - 29 . y~~rs (1.18mg/24~r) and then found a rapid decli~~ 
·to __ Q.~8. (3_0 .- 39 ye'ars), 0.2~ ·. ~40 -: 49 years),- · o.os (SO - .. 59 years) and . . ' ·;.' · · 
l .1 
0.38mg/24h;-· (60 years). Th~se values . are consider~b~y . ·lower than have . bee~1 . 
. found in the present study'._ 
' . . , 
'\ . '• 
. . ~ 
,· .. 
. :' . • . 
'. '· ·. 
• , 
. •.. . . ~ . 
. = .' . . ·. .. .... .';..· , ~ , • '·: : . . . ..... , : 
. ' , ' 
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The reduced excretion of DHEA-sulfate by essential hypertensives 
! . .' ' 
·appears. to be rat~er anomalous in that th~ secretion rate of DH~A _ and DHEA- . 
sulfate is 'five tjnd six times higher respe_ct:ively in benign ~ssential hyper- rl 
I . ~ 
. tension (Shao et al, 1~70). There could be three reasons for this: · 
' / 
(l) Since' the circula~ing, DHEA-sulfate is most~d to protein 
(Plager, 1965) , a change in the protein binding of this compound in essential 
hypertension could alte~ its ·excretion' rate (Shao et al, 1970). 
I 
r 
In this r 
c6n~_ext, it is of interest ' to note that in the ·normal s':lbjec~ the_ biological 
. i 
..,. 
half-life of DHEA-sulfate is considerably ext:ended, being 8 - 11 hours for 
/ I • ' h 
; 
,.the sulfate as 
; .. 
compared ~.o only 30 minutes for the free compound . (Baulieu . · 
' et al, 1965). So far, the effect of protein binding on the half~life of .. 
. ' ' ' 
. . ~ . 
· ' DHEA-sulfate has not been investigated in essential hypertension. 
(2) The second· alternative is that the metabolic clearance rate of 
. . j 
. . . 
DHEA-sulfate may be altered in essential hypertension. This would seem a 
likely possibility, since the metabolic clearance rate of aldosterone has 
~!ready been found to.' be reduced ~n t~is group (Nowaczynski et al;, 1971; 
: Lommer et al, 1972) , but so far no study has be-en made with DHEA. 
(. ___ .... :~-.. - - .. .. - '·\ ('3')\JI·. ,th"i'~ ~lternative could be that DHEA is further metabolised ( 
. . 
prior. to its excretion. Thi~ possibility was exa~ned in the presen~ work by 
comparing· the excretion of two of its major metabolites, androsterone and · 
I 
etiocholanolone. 
Excretion of ' androsterone and etiocholanolone 
Andros~eron~ and etiocbolanolone are formed primarily by the ' . 
metabolism ~f DHEA, though it is recognised. that they are not ' the exclusive 
metabolites of . this compound. Th~y ·-may_ als_o be derived from andr~stenedione' 
- ' 
· testosterone and several other minor sources such as, sa-'androstan-3, 11:...dione, 
~drost-1 ,.4-diene-3 ,17-dion~ S:nd 21-deoxyco.rtisot · (Dorfman and Unger, 1965) ·• · 
: ' ',' • . - . ' . . . .. ~ . : I I , '·. j, , . ,.~ • 
\ 















Twenty-four percent . of the total 11-deox1-17-ketosteroids. comes from the 
I 
. . 
testicular hormone,. test?s.terone, of, ~hich 70% consists of androsterone 
81. 
and etiocholanol~ne (Rubin et al, 1954)·. The male also metabolises testos-
'terone.to' androstenedione, . whic~ in turn gives rise to androsterone and 
etiocho1anolone (Horton and Tait, ·1966). 
The excretion of ·these two co~ounds . by normal. and hypertensive 
• /1 . . 
. subjects haE:J .been studied ·by estimating bot~ the glucuronide and sulfate 
. fractions in~ividually. In a s~cond group ·of subjects the· total excretion 
• I . . 
·. of androsterone and etiocholanolone (G+S) was measured. 
' ' 
The excretion of androsterone and etiocho1anol.one by ·the normal . · 
· subjects are compared with the results of Q~~er investigators .in the following · 
\~ . . :: . 
. ·table. The differences observed may be due t'Q the differences pres~nt in the 





Beale et al (l97la) · 
Faucette and · Cawley (197~)" 
~a~ndia et al (l97~) 
Keu~an· and Mason (1967) 
Rivera ·et al (1967) 
I : 
\~ 
\ \ .. ~ ' 
. ;lo 
. Range (mg/24hr) · 
Total Populatfon • · 
,, Androsterone · ·~f'~ocholanolone 
/ 
r 
0.95 .::- 3.30 r' i . 0.57 3 •. 60 /.·· 
1.00 ,- 4 -.70.' r 1.20 3.00 
0~12 - .5.00 i 0~20 - 6.80 ' I I 
0.32 
-
5.70 I 0.09 - · 1.20 
0.68 ·- 6.6Q . ' ' 1.50 5.10 
: 
1.20 





·Keutman ~d Mason (1967) and Pincus et a1 · (1955) have found ·: that·· · 
' . . . . . . ' . ' . ' . .l . . 
. . tti~ · e~~re~ion of an~ro~tte~~ne ~d .e~io~}Jola~o1o~e · d~c~ne~ . wi~h . advan~ing · .. · .. I 
.r, 
age • . However, the limited ~umber of· subjects studied in this report failed / · 
. . . 
~ · 
I 
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to show a'similar decline. Since in' our. study the number of fema~e ~ubjects 
. ' 
· (~0) p~edominated over the males (13), the excretion of· A and E by the females· 
in-different age· groups may be compared with other reports. Keutman and ' Mason 
\ (1967) fourid that females aged 20 - 29 years excreted a mean of 3.29mg/2~hr of 
bot~ A and E, which dropped to I.92 and 2.93mg/24h~ in the age range 30 - 39 · 
years. A and E continued to decline to 2.04 and 2.27mg/24hr at 40'- 49 years 
' ' 
and 0.68 and 1.52mg/24hr for those aged 60 . and over. - ~Y comparison, tne females 
' 
stud;i.ed _ in the present work exc~eted the following: 2.2'8 and 1.39mg/24hr of · · 
A and ·E ~espectively (20 - 29 years), 2.25 and 2.10mg/24hr (30- 39 years), 
. . 
., . . 
'~-~ r 2.12 and 1.50mg/24hr (40 
I . . 
. . . . -
~ - · - --·· - f " 
-~-
49 years) and 2.30 and 1.70mg/14hr (60 years' aqd 
I • . . . 
over). Pincus et al (1955) have n~ticed a four-fold decline in the excretio~ 
. 
of these two steroids by both sexes in the age range ~f 20 years to over 70 
. y~ars • . Although a general decline with age was concluded to occur by Keutman 
t -
and Mason (i967), it can be seen .from their results that sev~ral individuals 
?Ver -sixty years of age were exceptions to this rule in tha~ they excreted 
considerably higher levels of A and' E than'the mean value. The ,actual mechanism 
of the effect 'of age cin steroid excretion is not kriown. . . Both Pincus and Keutman · 
l 
~h~ve suggested that th~ lower excretion of A and· E' with _old age may reflect a 
' . 
reduced -production -of precursors such as testosterone and androstenedione. 
' • • ' \. • I .:: • '~ 
This 'may be the result of a decline in the processes involved in side chain 
'~ .... t , r " 
cleavage at . C-17, ·which leads to the · ·f~rmation of androgenic precursors_. 
(Pincus et al, 1955; ·Keutman and ~son, 1967). 
The _excretion of etiocholanolone glucurolJide by the e_ssen,tial 
hypertensi~e group was found t~ be signiff~antly les~ - (p(o~OOl) than for the 
normal group. By contrast, the exc~etion of androsterone glucu~onide ,was 
increased (P<O.Ol) and no differences were found in the excretion of· the .· 
' ,. 
sulfate ~ conjugates of thr8 co~_ouncf.or · _etiocholanolone. -The tot~~ _excretion 
e 
.. ~f etiocholanolone (G+S) again was .reduced. (~0.001) . in the hyPertensive . 
. . ' . ' ' . . ' . 
. group mainly due to a marked reduction in 'the ex~r~tion ' of etiocholanolone 
' '· 
( . ,. 
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glucuronide,'b~t no difference was found for androsterone (G+S). Since the · 
total excretion of these two 17~k~tosteroids was reduced rather than increased 
. . - ~ 
in the hypertensive. group' ~-· refutes the hypotheses that the reduced 
., ' . 
~ excretion· of dehydroepiandrosterone.was the resu~t of further peripheral 
metabolism to these compounds. : 
Porportions of Sa/sa-reduced metabolites 
, Comparison o! the levels of androsterone and etiocholanolone 
• I '/ • - I 
-excreted by the normal and essential hypertensive subjects gives an indication 
' . . . 
of the sterotd-5-reductase. activities lnvolved ln the formation ·~£ these 
. 
compo~nds. Since the normal group excreted more etiocholanolone than 
androst~rone in th' glucuronide ' fraction (ratio 3:1); this suggested that t~e 
sa-reductase activity was greater ~eading to the ex~r~tion of ~ore glucuron-
ides. By contrast, the rati'! of etiocholahQlone ,to androsterone in the! s\11.:. 
fate fraction ·was .,.1 :4, suggesting ·that Sa-reductase activity is gt'eater, and 
giVes ~o-re · sulfate conjugates • . 
- --::: 
. ,<fl . 
The ·ratio of androsterone over ~tiocholanolone :gives a measure of 
the relative Sa/Sa-red~ctase acttvities. ·Thia·ratio was ~rkedly r~duced · 
-. among th~ es~en~ial_.hypertensfves probably d~e t,o the signific1~tl~ reduced 
• • I * 
excretion of etiocholanolone glucuroni~e, which suggests that there is a · 
. I 
relative deficiency of. sa-reductase activity in this group. The generally 
' de~reased 5-reductase activity which has been found . for the metabQlism of . 
. corti~osteroids in essential hzyer~ens.fon by ,Kornal and Takeaa (~9~7) wili be 
• • , I 
discussed later, but it is apparently 'not confined to either the ~ or the 
. I . 
. sa-reductase activity specifica'lly. .;. . 
The inteniretat.ion · of ·the si~flcanc& of ,the differences in the · · 
. exc~etion - qf and;oste~one . and etiochol~nolone and, the androsterone/etiocholan~ · 
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is 4ecognized that · severai factors can alter these -values~ · Administration 
• I 
. of triiodothyro·nine (Bradlow et al, 1956). and thyrotoxicosis (Peterson, 1958) 
favours the production of androsterone over etiocholanol~ne. In addition, 
.. ~. 
. . . . T - , 
alterations in t .he excretion .. ~f both .~drosterC?ne an~ . :ttiocholanolone h'~r· 
· been found in several 'forms of cancer which inc~ude myf!logenous leukeJ.a ;' 
> ' 
.; 
(Gallagh~r et. al, 1.962), cancer of the breast (Bullbropk et al ~ 1960, 1962, 
. \ 
19iO; Atkins et al, 1964; Mannorsto.n et al, 1965), prostate (Gailagher et al, 
1963; Mannorston et al, l965), -and lung (Mannorston et .. al; '1965). 'whether 
. . 
these alterations in the peripheral metabolism-of 17~ketosteroids are direct 
consequence~ of the' $pecific disease or are "non _specifier consequences of 
illness" as has been suggested ,bY Z~moff et al (1971) is debatable. Obviously 
( ' 
the different , medications r~ceived by the patients in these diverse studies 
.• 
~~y influence the metabolism of the 17-ketosteroids arid this makes the 
dJ;awing :o; conclusions hazardous. 
J 
However, the essential hypertensive 
• . • • 4/iJ. • . 
subjects investigated in the prt;eent study were free ·'from m~dications and the 
differences detected may be related more direct~y to the effects of ' the 
. . 
elevated blood pressure. · 
Excretion of androstenedione 
Since it was ~ound that -the essential hypertensives excreted 
significantly lb~ levels of the '513- reduced c;ompound·~ · etiocholanolone, .it ~as 
of interest to determine whether the excretion of one' of .its precursors, 
-. • I 
. 4 . 
. androstenedione, was als~ altered. This compound is a "!1 -3-keto" steroid, 
which is both an intermediate in the . biosynt~esis of· androgens and· a 
metabolite .of dehydroepiandro~terone. ~ts metabolism is rather. co)Itplicated_, 
. . 
. . . . . . • . . . 4 . 
but basically involves reduction ·of the l1 -d~u~le bond arid the ketonic 
groups at G-3 _and C-171 Dorfman and Unger (1965) have· listed 33 possible· 
c~ounds that may arise from androstenedi9ne; however·, two major ones are 
I I 
~rostero~e ·~rid etiocholanolone. 
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In the 'present study, the e~~retion ·of free . ~ndr~~tenedione was , 
measured in the urine of 13 normal (3 males • .. 10 ··females) · and 15 hypertensive 
(4 males,,. 11 females) subjects. ~Since ·the ·number of male subjects studied 
'· 
-was limited, no att~mpt was made to divide the resul.ts between the· :se?Ces, 
~ . r·~, 
The normal subjects excreted 0.23 - ·s.9ug_ of androstenedione per 24hr urine 
in the .total population • . 
· · Th~re have been relatively few "reports on the excretion of 
anaros~enedione ·. in tqe urine of normal subjects (Tajic, .l96~; Longhino et al, 
•' . 
' . 196~; Scho~lberg and Hubl, 1968; Sli'ollberg et al, 196.9; Hubl et ·al, 1971)', 
Considerable higher values than -those reported·here have ·been found for both 
. . ' 
females (5 -·52.8ug/24hr, Schollberg and Hubl, 1968; 1.1- 11.4ug/24hr. 
Taj~c, 1965); and males (6 - 65ug/24hr, Hubl et al, 1971; 6.0 - '18.3ug/24hr, · 
' ·, ' t • • I 
·:: Tajic, 1965). The reason for the markedly lower values obtained in the 
present study is not clear, b~t triay be related to the levels· .of free androstene-
dione estimated by us as compared ~o· the "total"1 urinary levels measured by · 
' . . 
others. 'thus, Tajic (1965), Schollberg (1968) and Hubl _(1971) incubated -the 
' . 
·.: ur~ne _with e-gluc~ronidase in orde~ to hydrolyse any enol-glucuronide co~.ug~tes . 
of androstenedione (Wotiz, , l962) that may be present. However, the~~ibution 
of the enol-glucuronide type conju~ate of androstenedione has not been. 'fullly 
evalua~ed. A single report ·f~und that the concentration of the ~nol~glucuronide 
' ' 
..,.· " . /-' 
was less than 5ug pe~· 24hr ~Schub?rt, 1958). The high~r ·levels · of andros~ene;.. 
. . ....... ... -~ ·~ (. 
dione reported by these workers is .more likely to be related to . differ~nces in· 
,. 
methodology; primarily tlie 
6 
use ·_of . f _luor1;mietric methods which are considerabiy 
·less . specific than the GLC ··procedures ~sed in the pre~ent study. 
·. 
In the present"study, .the normal group ·excreted a mean o,f 2.26ug of .. · ·· 
' . .. . . . ' . 
androstenedione p~r 24 hours which i .e lo~e~ t~an that excreted _by_ the _hyper.:. 
. . 
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It is tempting to speculate that the increased ~x~retion of 
androstenedione by the hypertensive grO?P may reflect the reduced sa-
reductase activity which has already been noted for this group of subject's. 
· ~ . . 
Excretion 'of 11-oxygenated-17-ketosteroids 
' 
Effects of sub~tituents of the steroid nucleus on ring-A reduction 
The ·presence of an "ox)r" function at C-11 'of the steroid nucleus 
" 
has been shown to influence the activity o·f steroid-5-reductas~ enzyme 
systems (Brown-Grant et al, 1962; ·Dorfman and Unger, 1965). ·It orients the 
0. 
· . reduction of the · doub~e bond between C-4 and C-:-5, so that · the maj.ority of the 
metabolites are 5a~'reduced compounds. Two of the major ring A-unsaturated 
• .. - • [J 
sterqids, namely 1113-hydroxyandrostenedione and andr.ost-4-en-3 ,11-17-trione 
o, 
(adrenostero~, are metabolised primarily to the Sa- reducea compounds, 
. . . 
n~~ly, 11~-hydroxyandrost~rone and 11-ketoandroster~ne~ with on1y 20% of the 
metabolites having the Sl3..:. configuration (Dorfman and Unger, 1965; Cop·e, 19'7~). 
4 ' • .. 
The presenc~ of the· 1713-corticosteroid side chain o! lcorti~_ol and. 
:..-....._ .. ~. 
cortisone #recta the formation of se- r'~duced co~o~nds and . yields primari~y . 
'· . ' . f . . . . 
· ·.- 1113-hydroxyetiochol anolone ·arid 11-ketoet\iochoiano~one after aid~ chain cleavage. 
' ,' , ~· I , 
Whereas metabolism of the cortices tero:f.4.s produces four times more 513.... than 
- . . . {~ . . 
Sa- metabolites (Cope, '1972), the total contribution of these c~mpo~nd's to the · 
... 
l f 1. 
ll-oxyg~nated-17-ketosteroids is relatively small~ .Following. adndnistraiion 
. ' - ~ \ 
of cortisol to humans, only 2% is . converted to· 11- oxy- 17-ketosteroids 
· (Gallagher, ~~54; Bradlow and .Gallagher,· lQ57;_ J?orfman and' Unger, 1965), .and 
r~centl;-y the con'versi~n o.f ·3a., 1~13, 17a~ 21-tetrahydroXy'-S~pre~an-2q-one ­
(allo-3a-tetr~hydrocortisol) into 1113-hydroxyandrosteron~ by h~mans - was . found ' 
. . . . . . , . . 
to be less than 7%. This indicates that this compound does not contribute . 
. . 
• signfficantly to formati~n .of the 11-oxy-17-ketosteroid- fraction (Goldzieher-
and Axelrod' 1971) ~ . . - ~ 
. . 
-. 
. .. . ..  ' . ~ 
' .· ·. ·, 
a:- :·· ' , .. 
,. ' 
~ • • . I •. 
.. ~ ... ' : . 
, ' 
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The effect of these· ring substituents on the rela~v~ proportions 
-
' ' ' .. . 
of Sa- and 5~- reduced metabolites was examined in the present · study by 
measuring the levels of 11-ketoandrosterone, lla-hydroxy~ndrosterone, 
11-keteietiocholan~lorie and lle..:hydroxyetiocholanolone in the c1903 fraction. 
. . 
' , , 
In addition, the three. major 11-deoxy71~·-ketosteroids, Le. androsterone'; 
. ( . 
: . etiacho~anolone and dehydroepiandrosterone were analysed simultaneously in 
. ' 
the ~1-deoxy plus 11-oxy-17-ketosteroid fraction, since it was found that 
·these seven compounds could be adequately resolved on a 2%.XE-60 column 
. . 
(Fig. 5). The methodology o_f GLC analysis deyeloped incorporates the procedures 
. \ . . 
. .. 
' Matthijssen .and Goldzieher, 1971). · The· -metabolites were purified and resolved 
n • • · 1 
into ~re~ major groups, namely,, il-deoXy-17-ketosteroids, 11-oxy-17-
ketosteroids and ·c()rticos~eroids ,. prior to· GLC analysis, by chroma~ography on 
silica gel columns. ~is was pre~.erred to ~revious procedures_ that involved 
either thin layer, or paper chromatography~ As indicated above the 11-deoxy 
~nd ll..:.ox)r-17-ketosteroid fraction~ separated by silica gel ch,romatography_ 
. . 
were recombined for GLC analysis when it was determined that ~he. componerl~s 
could be effectively resolved. 
3 . .· . . . . . 
. lf-118-Hydroxyetiocholanolone wa~ prepared 
by oxidation of 3H-tetl!~ydr.ocortisol and .was us·ed to correct for. loss~s 
. . . 
. 14 . ·. ' . 
incurred during tpe procedure_~ . C-Dehydroepiandrosterone was used as tpe · · 
radioactive tracer to calculate the recovery of the 11-deoxy-17-ketosteroids. 
' Excretion of 11-keto-and 11(3-hydroXy-androsterone and etiochol.anoione · 
1 
·· The excretion of 11-keto- and ·118-hydrox:yandrost~rone, and 11-keto-· 
{' . . . 
. . 
· and llt3-:hydroxyetiocholanolone by _the normal __ sub_j~c_ts in tJ.:le present. stu.dy 
is compare~ in the following table with the results o~ other workers. 
-· . 
I 












Author and Method 
·········· 
. ·' 
This report: Amberlite,. glusulase, 
silica gel ~nd GLC as .TMSE · . 
• J 
(2) Faucette and Cawley (1971) :·.Amber lite, 
g1usulase and GLC as TMSE 
i (3) Beale et al (1971): -Free removed,. 
' ' Ketodase, solve~lysis, and GLC as 
forma tea 
(4) Roberts et al- '(1968): Glusulase, 
paper chromatography ·and· 
, , colorimetry " · 
(5) Keutman and Mason (1967): Ketodase, 
solvolysis, and GLC as TMSE • 
(6) Vestergaard (1962): Ketodase, · 
simu:(tarteous acid hydrolysis 
and-benzene extraction, g~adient 
elution chromatography and 
colorimetry 
(7) Brooksbank. and Sa1okangas ·(1959): 





Mean excretion, mg/24hl7 · 
~Total Po2ulation~ 
KA : KE HA HE 
0.65 0.68 1.03 0.68 
0.35 0.65 1.20 0.95 
0.07 0.73 0.63 0.65 
0.10 1.18 0.61 . 0.34 
o.76 ·o.a6 0.78 
0.51 . 1.:,._4 1.41 o. 90' 
0.14 0.83 0.94 0.68 ' 
No decline in th_e· urinary excretion of the 11-oxygenated 
88. 
-17-ketosteroids , occurred with advancing 'age, which. is in agreement wit~ the 
report of Keutman ~nd Mason_ (1967). The latter_ workers (K~u~man and Mason, 
1967) together with Pi~cus (1955) have sugge~~e·d. that the . capacity fo-r; . 
\ 
corticosteroid production and .,reduction is continued into adv~ncing ·age, 
which cont!asts with · their findings for the - 11-d~oxy-17-~etoster~ids. 
tl 
" 
" . Pro'2ortiotis of 5a/5a- reduced metabolit~s 
; · The hypertensive s~'J>jects ex~reted more Sa- reduced compounds 
, · (3.46mg/24hr) th~ the normai subjects . (1.68mg/24hr) ~nd . this resul.ted in a 
. - . . ,. . - . 
·a.ignificant (P<O.Ol) elevation 'in the ratio of 5a/sa- reduced compounds;. 
I 
• . • 0 · . •. 
·Within the hypertensive group the excretion of 5a- · reduced compounds 
.. . , . 
I •. • . . 
(3. 46i:ng/24hr) was significant·lj highe·r· than the 5~ r_educed comp.ounds 
. . 




. -;.. . . 
I • ' • 
'• ' , . 
. ! ' • 
.-





()' >. ~·. : .. 
~ . ~ ' .. : ' .. 
. '- 89 • 
• ~11 
(1;79mg/24hr), whereas -within ~he normal group the slightly increased 
excretion of Sa.- compounds ·was not significant. These findings may 
~ 
indicate that in the formati~n o~ ·the c19o3-17-ket~steroids·in esse~tial 
, .. ~· . 4 
hypertension, the inflt.Jence of a sa- directing 1111-oxy" function is 'more 




~t was originally suggested bt · Dorfman that the measurement of . 
urinary 17-ketosteroids would reflect t e intensity of the production of 
their andro~enic precu.rsors (~bin ·et a , 1954)_. · Subseq!Jently, th;ratio 
• (. ~ I 
of 1113-hydroxy plus 11-ketoandrosterone to 1113-hydroxy-plus 11-keto-
. ' . 
!!tiocholanolone (HA+KA/HE+KE) was used as an index of the proportion of 
I t - • ' • 
'• I ; 
androgen to cortisol precursors produced by the adrenal in'. the clinical 
assessment of hirsutism (Bush and Maheah, 1959) ~ ~owever ~ · these conclusi~ns 
have recently been ~evie_wed e_~!~nsively by cOpe w~~ ·bears the view that the 
. . . 
. urinary ,1'7-ket:gsteroids . are deriv~d ,from several different phy~io_logical 
precursors and· their levels . fluctuate _from time to tJme·. For this reason 
. . 
it is difficult. to draw clinically valuable conclusions from the urinary 
anaiysis · of individual 17-ketosteroids and the information obtained is" 
r~l~tiv~ly limited (Cope·, 1~72). . . - . . . /~· . ·.. . . " 
The estimation of the 11-oxygena~d 17-ketosteroids excreted, -~y 
' . . ' ~ .,. . 
. ' 
- essential hypertensi~es .w~s pf _interest in view 0~ the relatively reduced 
' . . 
513-reductase a~t~vity found from an examination of the -proportions of ~-
~ . 
I .- and 513- reduced 11-deoxy li-ketoste~~· . How~ver,' in th~ \ formation of . 
11-oxygen~ted 17-~etosteroids it ' may be concluded, that the essential· hyper-·. 
' ' . ' . . . . 
. . ' 
I • • te~sive group excreted significantly_ more sa-:- .re~uced ~etabolites than ·the 
normal g~o~p. In addition, within the normal . and -hypertensive groups -the 
• • • ' ~ I ' ' 
. excretion of Sa.- , reduced compounds was higher than the 5J3- i'educed . COJDpOunds t 
. . . . ' . ' . . 
• · \ a 
although .the' differenc'es were only s 'igrtificant in the hyper~ensiv7: ~oup •. 
.· 
·· .· 
. . · .. 
. ' . 









. f. ' 
.. •• • ... t.. ' • 
Excretion of. 17-ketogenic steroids 
I 
(l •• t, t -
-. . 
o.' 90 • 
The 'excretidn of 17-hydroxycorticoste~oi~s by essential·hyper-
· tensives and normal subjects was evaluated "indirectly by converting these 
Q ' • y& • .... " 
compounds to 17-ketogenic steroids. '!Jlis required side chain Cleavage "by 1 
.. 
.. . , -
. -
reduction with sodium borohY.dride followed by oxidation ~ith sodium· periodate. 
0 . • ' 
• r) j • ..- .. • 
Durin~ tnis reaction the 11-~eto group was converted tp 'an lla-hydroxy. 
Since the CO!ticosteroids•were i~o~ated by silica· gel chromatography before 
. ·, 
' reaction, they ,.w~re eessentially free of. other 17;::-ketosteroids._ · The three 
' major 17-ketosteroids derived - f~om the corticos~eroids· were the 11-deoxy 
' . 
' compound, etf?cho~anolone~ and the li-oxygenated compounds, 11a-hydroxy 
' I 
androsterone and 11a-hydro·xy etiocholanolone .-
~ ~ . ' 
Etiocholanolone has two potential. precursors; namely pregnanetr~ol 
t! . b 
and tetrahydro 11-deoxy-cortisol. .Allo-tetrahydro cO'rtfsone, aallo-cortol 
" . . . . ' 
c.• • • t , ' 
-. ~~~ :~llo-cortolone - ~r~· ti:te_ p:ecurs.ors "~} ~~~hy~r.oxy~ 'and~o~te~r?ne, .! and 
. .....~---· ···· , ' 
-' tetrahydro~ort~sol, tetrahydrocortisene, cortol and _cortolone are t4e 
.. ' 
p~ecursors of 1113-hydroxy etiochola~oipne. · There was no · evidence in the 
' . 
g~s chromatograms from normal atld hyp~~tensiv~ .sub.jects 'for the presence of ·· g 
' : . . . ~ 
the sa-reduced ' compound, androster6ne.: This compound ,would pave been derived 
0 • ' • • • • • • ., 
fr01p allo-pregnanetrioi. and alio~tet~.~hydro~l~-deoxy c.ortl~o~. · This is in ··-
. 
. a~reement · wit~ previous r~ports th~t the ~xc~etion of these two metabolites 
,by humans is not ·significant . (Rubin and Dorf~p,' 1954_; · Edwards et al_, 1964; 
~ . . 
Dor~man and vnger:, 1965 ;: .Makin~ 197~). ~ 
. 
' EXcretion of·the 17-ketosteroids de~ived . from the 17-ketogenic 
I 
_,:' .. 
The' excretion of the derived 17-ketosteroids ,''·etiocholanolo~e {Ii), 
•0 l I ' 1 
lie-hydroxy androster¢e (HA), and 1113-hy!Jtoxy .'etiocholanolone (~E) by .the ·· 
- ' . .· • ! - • . •. ' ' ·~ • • . ,, • • . .. • • .. . .. 
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· This report • • 0.41 - 2.58 0.64 - .3.30 0.61 5.-20 
·Menini and Norymherski, 1965 
. .' 
0.30 2.14 o. 33 - •3.53 2.'10 7.90 
· ·Layne. et . al, 1962' · ) 
· Ro~n~ff et al, . i961) 
0.30 - 1.40 4.80 -10;10 





Her~ again, meth~dologica~ differences are present_ between the 
. investigators ~hlch may be the reason for the variations found. · 
: ., . ,, ' 
. . ' \ . 
In the hypertensive group, the excretion of ' the derived 
• <? . . • • . 
etiocholaJlol~n~~g/24-ilr) w~s slightly_ above Jhi!t ' of the normal subjects 
(1.96mg>/24hr), but ~~ difference was,· not s~gnificant~ ·.On the other hand, 
. ,,,] .. . . . . ' 
. . the exc·retioq of deri'lied na-hydroiyandrosterone (3.22mg/24hr) and lla--
. . ' ~ . ~ydroxye_ti~chol~nolone.t {3. 97mg/24hr) ~as signific~ntly increased·· in the 
~ . . ., . . i ' . hypertensive group. As a .result of these increase the ratio of the 
Sa/S~' reduced co~~unas ~as n~t ~~ter~d. ' It .may e of interes~ · to ~o~are 
' . . 
I 
~e:e res~lt_s with ~ho~e ~iy~n ~n the paper of Ko~el ~t a·l (1969) pn c rticoster6id metabolism in essential. hypertension where the metabolites . . . .. . . . , . . . 
were s~parated into several fractions and analysed.· In this paper ring-A 
unJaturated .compounds were c~nspicu9us in the urin~ of .the hypertensive 
~ . . . ' . 
• I . I ~ ' ~ ; ~ 
su~j~cts • Thus,' cortisol ~nd cortic~ste:rone predominated if!. the. ~fee· -~teroid 
' .. 




. . , . . ·. . I , ' 
·· fr:action. - By c·ontrast, ring_-A reduce_d compounds e~creted a_s gludtironide .. 
~ 0 
conjugates ~ n~mely tetrahydro reciticed,-,metabo.l:i'tes of . corti~o~, cortisone, 
- 4 I ' I • • ' ' • ' • ' • S,. I - • - • 
·/ 
• 
11-dehydroco-rticosterone and . corticosterone were quantitatively les·s 
i-mport~nt in the tirin~ of the hypertepsives ~~ :1C~~a;ed to~ the no~l- subjects.~ . 











' o . 
. ' 
.. 
to /\ tPa. ,· 92.1 
'These findings led Kornel to postulat~ that essenti~l hypertensives hGve 
.. 
. ~ 
a characteristic defect in tne steroid ring-A reducing s~stems (Kornel et ~i, 
I · 
·. 
1969). ' H~ did not, however, indicat~ whether this was more pronounced for the 
'Sa.:. or 5{3- ·reducing system. Kornel 's methodolog_y al.~o diff":red from the 
present report 
' • . ( I 
in several ways. Notably, several meta~~lites: namely, 
. . . - :[ . . . :; . . _· . 
cortols and coftolenes, were excl~ded but were measu~ed as 
~ ' ' ' I 
. ' 
pregnanetriol, 
· ·1~;-~etogenic ~terofds ln .the pres~nt study •. \ The: Contr~butiOJ?- :of pregn~ne'triol ' 
• • • ~ • • I • • 
· i\signi,ficant's,ince normal sub~e.cts ,exc;o~~e \0.93. - 2.0ID.gi per 24hr. (Genest 
et al, 1960; Rivera. et· al, l96~')' and COrtOlB and COrtOlOOeS C00trib1,1te a I 
' . . 
•. 
. . . . . 9 ' 
further 7 - lU% and 20 - 25% respectively .to' the· total corticoste:z;-oid fraction 
~Fukus.~ima et al, 196~~\~omanoff e~ al, ~ ;l~~l;. B.es~~ ~nd Barry~ 1964; ~B~ale 
et al ,. 197lb) • ·. · 
. . 
· ' In Kornel' s report, the total excretion of corticosteroids . 
/ · . 
. · . . (Por~.er-Silber chromo gens) .by the hypertens;l.ves' (14. 8~gi~4hr) was higher · 
• ' • - ~ J • • ... • ~ • \ \ ' " • • ~ . ' ~ • \ ~ ., • • • • • 
than ·· tJle normal. subjects (12 .~25mg/24hr), but. the differedce was·no~.signifi-
:·ant . (P<O.l). In.. the pre·sent r~~o~ -the excret:{.on df l;~~etog~~ic .s·~~roids , · 
~ 
r ' . . r 
as estimated- by GLC, was · also . higlier in the hypertensive group (mean 8. 78mg/ 
' ..... , # • I - . f • " . ~ , , " 
24hrS ··a.s· co~·ar~d to. a .mean of s·. 28mg/24hr· e;Xcreted ·by' the normal ,subjects •. ' 
- ' . . . ( 
. ••\ 
· x~ .- ~hi~. case ·the a~~fer,nce ~as statistically si..snif.fcant (P<o·.ool). 
Pro oxtions 'of 5ar- and 513- reduced' li-keto enic metabolites 
· ... 
: " 
. In the previous section it. was noted that . during the ~etabolism, · '· 
\ ' I 1 I ' • " , • 
l ' 
· o·f corticostero.ids, the ' C-17- side chain pri~:r;i.ly orientates . th~ r~duc'tion~ · 
1 • 4 · ·. ~ ~ · . - · · r-. 
· o( ,the: 6. _:double bond to give 513- redu~ed comp~~nds_ (Brown-Grant et al, 
' . ' . . ~ . . . . ? . . 
19~~; no·rfman and .. Ung~r, ' 1965.;; Cope, .. 1972). 
~ , .. • • I 
,~,~ .· .: . . . ' . 
- .· "- :l-. It was evident from the' present study. that although the formation 
. -<,,:·· . . . . 
.• of the· dJ~ive.~~:! ~~d 513- teduced ~taboiites. (il-oxygenat~d). ~.as .: i , . . "' . . . ,.. . '. . 
< 
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.. ' . 
.· 
... . 
. • f . 
.. \ 
·r ··· • • I I 
' ' 
the.re was no significant difference. in the ratio of these 5a./5f3- · reduced ( • ~ 
' -
' ' . \ 
compounds between the two .groups. However', 'the total excretJlon .. ._o.f. thE!; 
derived 513- c'OmPO~nds ~ etiocholanol~l)e plus llr3-hydroxyetipcholanolone, . Was 
· higher than the major~- compound, lit3-hydroxyandrosterone in both ' normal · 
. . ... 
and hypertens~ve groups. Also the . ex~retion of the total 17-ketogenic steroids, 
. ' ' . ~· 
E+HA+HE, was significantly higher in· the hypertensive group compared to the '. 
normal group • 
' ' I • 
These findings may reflect the infiuence of ~oth an "ll~oxygen" 
. ~uncti'?n and the C-17 corti.coste:t:"oid side ·chain, but the .overall influence .. 
... of ·the side· . cha~n appears to be greater • . 
" 
11-oxygenation Index 
From the measurement. of the 11-deoxy and ll-~xy-17~k~togenic 
ster9id~ · it is possiple to ·derive a potEmt:l;ally us-eful factor, ·the l'll-
. I ·• , 
.oxygenation index", which i~,. the .ratio b.~ the ll:-de~xy~l7-~~tost~roids/l'r- · . 
'oxygenated-17.,.~etost~roid,s derive_d from the corticost~roid~. The 11- , · · 
oxygenation ' index may indicate the presence of an-1113-hydroxylase.enzyme 
/ . . . . . -. 
. , . ·, 
defici~~cy·, ~hich ' would primarily result in the ove~ pr!lduction of 11-cieo~- .. ' 
' . . 
cortisol. The "index"· has been of value in "the diagnos;i.s of ,ongenital 
adrenal hyperplasia, ~hi~h is an inborn metabolic abno:rm~li·ty involving 
• I • I • 
ll~~hyd:oxyiase deficiency ,in o~e of its forms. This blocks the biosynth~~is 
.-
of cortisol and other ·11~o~-corticosteroids (Hill, ~ l960; "Edwards ~tal, 1964; 
Bondy, 1969; Makin, _1970) • 
'In our study, the. ·"index" for the· ·n~rmal subjeC:ts ~ang~d · from=· 
. . ~ . 
0.11 0.37 while the _hypertensives had 0.08· - 0.36 • . The "in.dex" · for the 
. • • • ,' ' • • I • , • • -
t1ormal su~ject:s f~und by other~ .. ~ere _.in th~ .rang'es . of. ·~o.o~ ... o.s7:, Hil~.; 
1960), -(0.1~ .·_. 0.62, 'Edwards et al~ 1964), (0.09 ~ o·.6, Makfn, :·197o): It · 
t \1 . ~ .. ' • • • ' • /1 ' I ' ' ~ . I • 4 • 
ma~ therefore be concluded that '11~-hydroxylase · activ!ty is normal in -the 
• ' • • <Ill~ "' 
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Evaluat.ion of the colorimetric assay of .17-Jtetoster6ids, 17-ketogenf.c 
. - i 
steroids and-17-hydroxycorticoste~ds \ .. 
• . • 0 ' 4 .. 
· It has been noted 'th~t-the group esti~ti9ns of 17-ke~steroids,· 
.- . 
. _: A! - .. . 
• L\ ., 
17-ketog~~lic ste:oids, and 17-hydr~xycorticostero~~s do not co_rr~late well · 
. . \ . - ' · 
~ith the -values obtained by the· su~tion of _the gas -liquid ch~omatographic, 
. . \ 
. . . I . 
results. In the. following table·, colorim~tri~ and GLC values are' compared 
. l 
, • I 
.in th~ normal· and hypertensive grouls • . 
Steroid determination Mean excretion (mg/24hr) 
. •, 
Normal Hypert~nsive .' 





Total 17-ketogenic steroids 








Total 17-hydroxycorticoste~oids ?.07. 2. 76 .i -, 
. ; . 
'•! 
·' 
There may. be several re tor these d,iscrepancies ._ 
~ . . ./ 
. "general, 77% and 83% of the total ~rinaiy 17~ket~s~~roids !~ th 
0 • 
. femal;s respec~ively, comes from art·d~osterone, etiochol~nolon , 






. 8. 78 
. I 
and 
epiandrosterone-; li~ketoandros~ero.ne and e.~io_choianoione_, an _ llf3-!lydr_oxy-· 
' . 
androsterone and etiocholanolone ·: ~Cope·, 1972). . . Duri~g co~ori~etric assay 
of total 17-ketosteroids, hot acid hydrolysis · caus~s. partial destructio~ of .. 
" I ' I 
deh~droep.:Landrosterone, · 1~13-hydroxyandrosterone ·a~d _eti~cholanol_o~e~ . This_ · 
treat~ent is also dep~n~ent on. pH, ~emperature and duration of -hydrolysis . 
(Lie~erman et . ai., 1954; Munson and .'Kenny,. 195!+ ;- Cawley et al, t965; . 
. , _ , . 
Metcalf, 1971) ... 
The ~c;e of car~~hydtate ' compaunds . in the urine interfer~a· -
~ . - .r • 
. . , I 
.-~ith the. fo~on of . the Zimmei'l!Um . . chromoge~s and . pJ;:oduc:es non-:spec:f.fic . 0 • 
J.• . I . . ' 
') 



















' ' I ~ 
. ' 
~ . ... . 
chromogens. ,.. This react~~n is also dependent on the concentration of 
. alkaii,' temper·~~ture artd d~ration . of incubation .'(Ernest et al; ,~9~.4; · 
• • ,: "' J " -ft ~ 
l).eutman. and Mason, 1967). ' .. The proportion 'of .non-specific chromogens fo~ea · 
I I , \ . ' 
could- be · as ;high as · 80%, if': the experimentai conditions are· not cont~oll~d · · 
l : i . 
· properly Sif~ldzi'eher ~n~ Ax~lrod, 1962). . . However, this prQblem is. corrected 
to· a gre~,tf extent by E[x~ra;·tion 'of the chromogens with org~ic solvents 
(Peterso~-and- Pierce•l ·1~6.0) · a~d by application of a coior-correction fofmula 
I 
(Allen, 1950). 
In . the determination of Porter~Silber chromogens, it has b~en 
. ! . . ' . 9 
found 'that ·20 - 25%. of cortisol,.· cortisone ~n~ tetrahydroC~l;ti~orie, and 
.· 40 - 45% of tetr~~ydrocortisol suffered ioss (Peterson et al·, 1957; . Cope, 
1972) .• 
.., 
& • • • 
Vermeulei1. (1957) and krnest · et al (1964) have ·accoun'ted . ~or 40 - '50% 
and 76%. respectiv.ely, .of the total uri~ary 17-hydroxycorti~osteroids · b~ the · 
colorimetric method. He·re a~a:i.n, ·. appli~~tion of c~lor.-co;rr~ction formula . o 
ha·s improved the .. estima~i~ns ~sr-:~tl)r' (H~~tog~~ et al, 19;55) • . 
-. .. ) ; • I 
. . ' - - - f!l, ', .. ' 
In spite of ~11 these· drawbaek:s, however, the .. ~qlorimetric assay -I 
I \ 
'procedures are still wideJy.used in routine estimations (Vermeulen, 1957; 
Muehlbacher and Smj.th; 1970) ; · 
' . 
. " . . . . ~ . / 
Stero.id "5- reductases and the possible influence of. ·elevated blood pressure. 
The 'diffe·rences that; _ have bee~ found in the . proportions of Sa• 
~nd . 5f3- reduced .metaboliteB excreted by no~ and hypertens~ve ~uoj_~cts 
have so far been considered .in relation to the effects · of differ~nt subs'tit-
u ' 
uents in' the steroid ring · s~~tetn8_. . Th~s .; ' an '!ill-oXJgen'~ functio~ d:f,rects 
·- reduction a't c-5. to' give primari_ly sa- reduced metabolites, ~nd a "corti"":' 
I • • • ' # 
"-~ 
. . ' . "' 
costeroid side chain11 ·favours the formation of · prima~ily se- reduced metaboli~es 
' . ' 
. . . . . . ·.' . ' . : ~ . . 
(Brqwn-Gran~ et ·al, 1962;· DoFfman and Unger, 1965= . Cope, 1972). This :infers 
' . . 
that the 5- .. reductase .enzyme activities · will ~ary according tp the ~YP~ of 
. . ·. , ·. I, · .
. ' . · .. 
-. . . ·' 
Cl . 












subs·trate. Early· studies have indicated tti.at ·a 5a- reductase · is located 
.. 
. , . 
. · iri ' the microsomal fraction ' and a 5e- · reductase in the soluble fraction of 
. - ' 
. ·" 
the live~ (Forchielli and Dorfman, 1956; Brown-Gr~nt ·. et al, 1962; Van Doorn 
et al, 1973). · · 
Differenc~~ ,in the exc.retion of 5a- and 513- reduced metabolites. 
by the normal and hypertensive sub.jects stu'died i:n "the present work . may bes~ 
be_ ·explained by co~sider:i,.n~ ' that there are .several Sa.7 · and .,?~- reductase 
.. -. . 
en~yme systems t ·hat are specific for different substrates. Several rep~rts 
support the ~oncept of substrate specific steroid~red~ctase e~~yme·systems 
in . the l~ver (Tomkins et a1, ' 1957;-- McGuire and Tomkins"· 1960; . BroWn.-Gr~nt: · ' 
. . . . 
et al, 1962;-Briggs and Brotherton, 1970; Bock, 1971). 
• • I 
!t can be seen .from the _following _diagram that there is a trend,in 
. the relative propbrtions of ~a~ and se~· reduced· metabolites from the 11-de~~­
. ·~7 ~ket.~~~er.oidl ;~.~~g~ t~e 11 ooxy717-ketoster!'i:ds to th~ 11"ketoge~c . Steroids 
·.(derived froi.}tlie Corti0os·t~roi.d8). . ' 
I . i hypertensive subjects exc~eted ~igpificantly . lesa · ~a-11-doexy~ 
"· 
. . . .. . . . ·( ' ~ . . . . 
17-ket-oste oids than th~ normal subjects, and itf~as .suggested that the hyper-· 
. .. . ~ . . . ' . . .. 
• ' I •J 
tensives ad· a rel~tive . 5,13- .redue·t~~e ·deficiency. However, -whet;!- . the pro-
portion~ se- and Sa- reduced 11-oXyge~ated-17-ketostero~ds were compare~~ 
• I . : . . 1- . . , . ' . . . I ~ ·. . . . . 
it was ·evident that the' 5~ .reductase ertzyme. system .was as active' in the 
. . . . . :·· . . ' .· .0._\: .. :. . : . . . . . . . : ' _· 
hypertensi~e gro~p · as · for ·the pormal group. The incre~s·ed pr-o)?_ortion o~ 5a.- . 
reduced ·met"'!-b~~ites · may be explained by the· predominant:j.y Sa.-_ aireFting effect . · 
· . · ct . 
:of the ,"ll-oxyget:l" function. ·· BU:t fn ot d.er . to explain· the ''increased" Sf3- ·. 
# • • • • • 
,. .. . , (~ " .. . ' 
reductase . activity by the hypertensives for t~e 11-oxygena~ed-17-ketosteroids 
' as' 'compared to the- ll-deoxy-17.:.ketosteroid~. cit may be nee!essary to hypoth-
. . • , , I , • , 
.. . 
esise· either (a) · the. p'rese~ce of ·one or more specific· 5(3- reductase enzyme· ~ · 
systems, one : for _the l~~deoxy-.,. the other· for the 1~_-oxy7"17~ketosteroids, o~ 
.... . 
., j · 
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(b) the r~d~~ed . activity of . a sin'gle '5{:3- reductase enzyme _systel!l towards 
the l l-deoxy_-17Ks as compared to the ll~oxy-17-ke!=osteroids. ·· I • 
Again:, . for the 17-ketqgenic steroids · de~ived from the·. 
corticosteroids, th~ · 5~.- directing ·effect c:>f ·the '.'17.13-· side chain" was 
' ~ . . 
97 •· 
·noted. It may be sp'eculated that the markedly increased excretion of both . . 
't: i· . . 
Sa- and 5{:3- reduc~d metabolites by . the h;pe~tensive. subjects may···be the 
. . 
result · of: (a) different s~·reductase ehzyme systems for · this group of 
• ' 4 i) ster~ids, or (b) greater 5- reduct.ase·. enzyme activity in the . hypertensive 
·. group due to increased ~e~sitivity · to the dire~~ing effect of the ·ll-oxy and 
I 
' I • • , 
corticos.teroid side '"'chain substituents. 




a~tivity of \ . 
. . . . l · 
. . I . 
. certain enzyme . s'yatenis has been. suggested by ~e~eral studies on the hepat_i~ . 
' •' . . . . . . 
. . metabolism ot cortic'.c,>ids by the . \ hypertensive rat • . (Silah, 1970; .Turcotte 
. ./ 
U~timately, one ~~s to relate the differences . J and Silah, 1970 ; . Silah, 1971). 
• o 1 I o I 0 ° o , ~ 
tliat ·have .. been found . in the ~roportions of reduced steroid. metapoli~~s ·, and . 
• • I ' ' 
i . 
presumably ·diff~rences in enzyme activi.ties·, in ,_the hypertensive group, to 
\ ~ . . . . ' . - . . 
! ' . 
the. influence of th~ elevated blood pressure. · So far evidence for these 
... ' 
effects has be~n indirec.t, _ but future studies may reveal a more direct 
caus~-effect relationship:'between eleva.ted blood piess~re and the formation 
of differe:rtt mei:ab'olites • . ; 
' · . 
. . : p 
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TPe ~esults· gi~en in 'this th~sis suggest ~hat eleva~ed 
. . 
. . . 4 .· . 
blood pressure may a;Lter the enzyme activity such as A :-5-reductases,, . 
' . . 
involved in. the metabolism of steroids. F't\._ture· .efforts may be 
·directed towards un~erstanding · whethe~ elevat~d .~lood .'pressure has 
. ' 
a · 'direct ef~ect on ,steroid metabolistp ~nd how it exerts such e.ffect." 
· · ~tud:i.es ·on essenti~l ~y.p~rtension 'befor~; during and after treatsnent 
. ~ , . . . ·. . 
I . · , I • , • , 
with 'anti-hypertensive agents, ·could indicat~ whether certain steroid 
. . . ' 
en~yme 
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